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i. intRoDUCtion AnD oUtlinE of thE thEsis
To understand the current practice of awake craniotomy and the challenges and op-
tions linked to this procedure, this introduction will address the historic development 
of awake craniotomies, some general ideas behind the resection of brain tumors and 
some general ideas of patient centered care. These three aspects create the fundament 
on which the research presented here is founded.
The historic development from trepanations to today’s awake craniotomies:
The history of awake craniotomy actually starts with trepanations, perhaps the oldest 
form of neurosurgery. Whilst a classic trepanation is just a burrhole, craniotomy is de-
fined as the removal of a bone-flap. The oldest trepanned skull (estimated 7000 years 
old) was found at a Neolithic burial site of Ensisheim in France. Because the brain itself 
does not have nociceptors, this quite invasive procedure in principle can be performed 
with local anesthesia only.
Therefore, it is not surprising that skulls with evident signs of “successful” (the patient 
survived the procedure long enough to show even some kind of wound-healing of the 
skull) have been found in almost all cultures: Mesoamerican Indians, Ancient Egyptians, 
Romans, Greeks and Chineses.
Even Hippocrates (460-370 BC) has published some ideas about trepanation as 
therapy for fractures and/or contusions of the skull in his manuscript “on the injuries 
of the head”. Hippocrates also described the fact, that brain and body are linked in a 
crossing manner: damage to the right hemisphere causes functional damage to the left 
part of the body and vice versa. 
On the way to today’s awake craniotomies some side-paths have been followed: 
Eristratus (about 290 BC) claimed that there exists a relationship between the number 
of gyri and sulci in the brain and the intelligence of the person. Galenus (129-199 AC) 
believed, that there was no relevant function located in the brain cortex. In his ideas, the 
“soul” of humans was located around the heart and the diaphragm and up to the 17th 
century many people considered the brain cortex just as a protective layer without a 
relevant function.
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On the other hand, the Dutch-Flemish painter Jan Sanders van Hemessen painted 
between 1550-1555 his famous scene “The surgeon or The Extraction of the Stone of 
Madness” (©Prado-collection), which depicts a frontal awake craniotomy for the treat-
ment of psychiatric derangement:
The operation of Trepan, from Illustrations of the Great Operations of Surgery: Trepan, Hernia, Amputation, An-
eurism and Lithotomy, by Charles Bell, 1815. (John Martin Rare Book Room at the Hardin Library for the Health 
Sciences, University of Iowa.)
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We also find clear instructions how to perform trepanations and craniotomies in the 
“Armamentarium Chirurgicum” by Johannes Scultetus, published 1655:
However, it finally lasted up to 1861, when Paul Broca discovered by autopsy of a patient 
with a well described motoric aphasia, that his gyrus frontalis inferior (later referred to 
as “Broca’s area”) was not well developed:
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This can be considered as first scientific demonstration of the fact, that a certain brain 
function - in this case: being able to speak - is linked to a certain area of the brain.
After Broca’s finding a lot of research was done under - with our view from today - unethi-
cal circumstances. The papers of Bartholow (1874)1, Foerster (1926)2 and Penfield (1937)3 
must be named as the milestones to our current understanding of the somatotopic 
organization of the cerebral cortex. Dr. Wilder Penfield finally described the homunculus 
illustrating the motor and sensory representation of the body within the brain cortex.
The following picture shows a figure created by Sharon Price-James. This figure is an at-
tempt to visualize the relationship between different parts of the body and the cortical 
surface they are representing. Obviously, not the actual size of a part of the body, but 
the complexity of the sensory (and motor, respectively) functions determines the size of 
the cortical representation.
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Whilst the principle findings of Penfield are still valid today, we know that there exists a 
lot of variation between patients, making it mandatory that every single patient oper-
ated awake undergoes his personal cortical brain mapping to identify the functional 
relevant areas of the brain.
In the early years of neurosurgery, an awake craniotomy was a standard procedure due 
to a lack of anesthesiological alternatives. It was also performed in cases, where being 
awake did not provide an advantage for the patient’s neurological outcome, except of 
avoiding a possibly dangerous general anesthesia. In the 20th century, driven by the 
development of modern anesthetics and anesthesia machines, most craniotomies were 
performed under general anesthesia, which provided much more comfort to the patient 
and the surgical team. It took until the late 1990’s, when awake craniotomies started 
their “renaissance” on the neurosurgical OR as a conscious choice for selected patients. 
The pharmacokinetic properties of propofol enabled the anesthesiologist to control the 
patient’s level of sedation with a previously unknown precision and predictability, which 
finally encouraged the neurosurgeons to operate on brain tumors they would not dare 
to resect under general anesthesia.
Brain tumor resection:
In general, brain tumors can be treated by surgery, chemotherapy and or radiation. 
Common feature of all axial tumors (growing from neuronal tissue like astrocytoma, 
oligodendroglioma or glioblastoma) is the disappointing fact that a complete resection 
without risk of recurrence of the tumor is quite impossible. Therefore, brain tumor resec-
tion aims to resect as much as possible of the tumor - because cytoreduction is linked to 
a better effect of the subsequent chemo- and/or radiotherapy and thus a longer survival 
of the patient4 -, but this cytoreduction should create a minimal risk of neurological 
damage to maintain the quality of life for the patient as high as possible. 
Brain tumors can occur in all lobes of the brain, and the majority of tumors can be 
removed safely under general anesthesia. However, if a brain tumor is located close 
to functional, eloquent areas of the brain, which cannot be monitored during general 
anesthesia like speech or the whole motor cortex, many neurosurgeons will hesitate to 
perform a tumor resection under general anesthesia, because of the risk of neurological 
damage to the patient. 
Before the technique of awake craniotomy became more popular, a common approach 
to these tumors was “wait and see”. Some neurosurgeons performed small biopsies in 
these tumors to get a clear diagnosis of the type of tumor, but even a biopsy could cause 
fatal neurological damage to the patient.5,6
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The technique of awake brain tumor resection with brain mapping enables the neuro-
surgeon to resect brain tumors in or close to these eloquent areas with the intention of 
a maximum cytoreduction on the one side and a minimal risk of neurological damage 
for the patient on the other side. Tumors which have been considered surgically untreat-
able 20 years ago have become at least partially resectable by awake craniotomy, and 
the indications for awake craniotomies are still growing.7,8
Patient centered care:
Being awake whilst undergoing brain tumor resection is an idea which spontaneously 
causes unpleasant feelings for the majority of the patients. However, the role of the 
patient is crucial for the success of this procedure, because only a cooperative, alert 
patient can interact with the whole team in a way that makes safe tumor resection 
possible. Therefore, the importance of a good preparation and guidance of the patient 
throughout the perioperative period cannot be underestimated. Coping with the fact of 
suffering from a malignant brain tumor, being exposed to the OR-environment which 
can be experienced as hostile and feeling the need to cooperate as good as possible 
for a successful resection is just a rough summary of the psychodynamics in patients 
undergoing awake craniotomies for brain tumor resection. These special feelings and 
needs must be addressed by the medical team, and exactly this is a great example of 
“patient-centered care”. All measures taken have two priorities: safety and comfort of 
the patient – with safety being the absolute number one. The challenge to cooperate 
with the patients as a kind-of-member of the OR-team without asking too much of them 
physically, but especially mentally cannot be compared with any other type of surgery. 
However, most patients undergoing awake craniotomies are quite young and highly 
motivated to contribute to the success of the procedure. Canalizing this motivation 
and also coping with possible disappointments (e.g. incomplete resection, [temporary] 
neurological worsening) requires a special doctor-patient-relationship and also involve-
ment of the patient’s family.9
Outline of the thesis:
Based on the background described above, this thesis summarizes the research ques-
tions and possible answers based on the clinical and scientific work of the author in 
more than 300 patients undergoing (awake) brain tumor resections during the last 22 
years. The publications presented here are clustered around 5 key-questions:
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Question 1: What are the pre-requisites for a successful awake craniotomy?
Chapter 1 reviews the role of the anesthetist in the perioperative care for patients 
undergoing awake craniotomies. From preoperative patient selection to perioperative 
management the most relevant issues are addressed in this invited review. Chapter 2 
summarizes the use of local anesthetics for brain tumor resections. Furthermore, this 
review addresses the technique of infiltration (surgical field block vs. direct nerve/scalp-
block).
Question 2: is an awake craniotomy for the patient more or less stressful than a 
brain tumor resection under general anesthesia?
The research published in chapters 3, 4 and 5 focusses on the metabolic (and emotional) 
impact of an awake craniotomy on the patients. Because all patients with axial brain 
tumors are treated with dexamethasone perioperatively, measuring cortisol as the 
most physiological stress hormone was not feasible. Therefore, we decided do look at 
the plasma amino acid profile (chapter 3) and the inflammatory profile (chapter 4) as 
“objective”, physiological markers of the subjective phenomenon stress. Chapter 5 is a 
review dealing with current options and concepts how to further improve the patient’s 
experience for those undergoing awake craniotomy.
Question 3: the patients undergoing an awake craniotomy must be cooperative 
during the procedure, but: what do they remember of the perioperative period 
and how do they deal with it?
In chapter 6 we focus on the subjective experience of the patients undergoing an awake 
craniotomy and the quantity and quality of their memories of the perioperative period. 
In chapter 7 we applied the same questionnaire on another group of patients undergo-
ing brain tumor resection not only awake, but also under general anesthesia. In this 
second study we also addressed aspects of anxiety and coping, both known to have 
an impact on the quality and quantity of memories. Furthermore, we were interested 
how anxiety in patients and their relatives is related and how it changes between the 
pre- and postoperative period.
Question 4: What is the added value of an awake craniotomy in selected patient 
populations? 
In chapter 8 we give a detailed case-report of a 9-year-old boy who underwent an awake 
craniotomy for glioblastoma resection. From 2004-2017 this was the youngest patient 
ever published for this type of procedure. Chapter 9 focusses on patients undergoing a 
brain tumor resection in the insula. Brain tumor resections in this deep subcortical region 
are challenging and not frequently performed. However, we have been able to collect 
a relative big group of patients operated either awake or under general anesthesia and 
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have been able to compare these groups and their perioperative outcomes. Chapter 
10 addresses the question, whether patients suffering from a (suspected) glioblastoma 
multiforme have advantage by an awake craniotomy. Considering the poor prognosis of 
this disease, a technique offering a maximum resection with a minimal risk of functional 
deficits might be of added value. Nevertheless, until today the majority of these patients 
is not operated awake.
Question 5: What is the adequate postoperative pain-treatment after an (awake) 
craniotomy?
Chapter 11 is an analysis of the efficacy of the postoperative pain management in neu-
rosurgical patients in general with special attention for patients after craniotomies. In 
the final general discussion, we review the findings of the papers presented and address 
future perspectives.
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Chapter 1
Awake craniotomy for brain tumor resection  
– what does the anesthesiologist do?
Based on: Klimek M, Vincent AJPE.  
Wachkraniotomie in der Tumorneurochirurgie – Was macht der Anästhesist? (invited review) 
Anästhesiol Intensivmed Notfallmed Schmerzther 2011;46:386-91
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AWAkE CRAniotomy foR bRAin tUmoR REsECtion – WhAt DoEs thE 
AnEsthEsioloGist Do?
introduction:
From a historical point of view, awake craniotomy is more a quite old surgical technique 
experiencing a kind of renaissance, than it can be called an innovation of the 3rd millen-
nium AC.
As we know, successful trepanations were performed centuries before the first 
anesthesia. We also know for about 100 years, that the sensory and motor cortex are 
organized by representation of the “homunculus” and that the Broca-motor speech area 
is located at the frontotemporal lobe.
This article describes the technique of awake craniotomy as it has been successfully 
performed by the authors for years in more than 200 cases.
Definition: 
The term “awake craniotomy” for this procedure is actually not correct, because the 
craniotomy, the opening of the skull is performed with the patient under sedation. Once 
the craniotomy is performed, the special feature of this technique is that the patient will 
wake up and stay awake whilst the neurosurgeon is removing the brain tumor.
indications: 
Tumors close to functional relevant areas of the brain
The awake craniotomy has shown its added value in patients, where a tumor of neuro-
nal tissue (e.g. glioma, astrocytoma) is located close to functional relevant brain areas 
(e.g. speech, motor function), and if the integrity of these areas cannot be monitored 
adequately during general anesthesia. (fig. 1)
figure 1: fMRI of a temporoparietal tumor 
close to functional relevant brain areas. The 
red color indicates an increase of perfusion 




In patients with these kind of tumors, the neurosurgeon in general has three options:
1) Wait and see: If the tumor is growing slowly, this can be done well for years.
2) Taking a biopsy: If the radiological picture suggests a primary brain tumor, we do not 
recommend taking a biopsy. Taking a biopsy from a tumor located close to functional 
relevant areas still includes the risk of a functional damage to the patient without the 
advantages of a tumor resection.
3) Performing an awake craniotomy: Aiming for a maximum of tumor resection with a 
minimal risk of functional damage.
better prognosis for adjuvant therapies:
Recent literature provides good evidence that aiming for the most radical resection of 
the tumor improves the chances of all adjuvant therapeutic measures (chemotherapy 
and even more radiotherapy) and hereby can prolong the survival of the patient for up 
to 50% (e.g. in case of a glioblastoma multiforme 13 months in place of 8) [1-3].
Thus, the added value of an awake craniotomy for the patient is based on the prolon-
gation of life with maintenance of the quality of life – and even re-craniotomies in case 
of possible tumor-recurrence are possible.
Patient selection:
When screening and selecting patients for an awake craniotomy we apply the following 
criteria:
State of the patient:
The patient must have a maximum level of consciousness, must be cooperative and 
alert. A successful awake craniotomy requires a patient, who can communicate clearly 
and gives correct feedback about possible effects of the electrical stimulation during the 
cortical mapping (“I feel a warm wave in my left arm”). 
In general, patients are highly motivated to undergo an awake craniotomy. Most 
patients are quite young and they understand that this technique offers some extra 
options in their difficult situation. In contrast to almost all other types of surgery, the 
patient himself essentially contributes to the surgical result, and the majority of patients 
experiences this fact as much more motivating than threatening.
The patient should not have a predictable difficult airway, because a general anesthe-
sia with orotracheal intubation is always the first alternative in case of an intraoperative 
emergency.
The patient should not have any coagulation disorder. In case of major bleeding intra-
operatively, the risk of brain edema increases, but the options to treat this adequately 
are limited in this case of an acute emergency in a spontaneous breathing patient.
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In the two weeks before the planned day of the procedure, the patient should not 
experience an epileptic grand-mal insult. This time-limit is somewhat arbitrary and not 
based on higher levels of clinical evidence, however, during the procedure the brain will 
become stimulated electrically. If this stimulation finds a brain in a level of higher excit-
ability, the risk of a grand-mal insult on the operating table with a patient fixated in the 
Mayfield clamp will be increased. Smaller, focal insults are no arguments to postpone 
the procedure.
Age of the patient:
With an age of 9.5 years the authors have successfully treated one of the youngest 
patients worldwide ever undergoing an awake craniotomy for brain tumor resection. 
We consider the age as a number less relevant than the psychomotor and psychosocial 
development of the child. In our case, the father of the child has been present on the 
OR throughout the procedure and has significantly contributed to the smooth course 
of events [4].
Weight of the patient:
More interesting than age as a number, we consider the weight of the patient, because 
it defines the toxic upper limits for the amount of local anesthetics which can be used 
safely. This amount can be quite limited in older and cachectic patients, too.
In these situations, we recommend to perform a classic skull block on the relevant 
nerve-exit-points in place of the common surgical field block in the area of the planned 
incision. The amount of local anesthetics needed to perform the classic skull block in 
experienced hands should be less than for a field block (15 vs. 30 ml in average). We 
recommend the use of bupivacaine 0.375% with adrenaline 1:200.000.
Location of the tumor: 
The tumor must be accessible for the neurosurgeon with the patient in the supine or 
lateral position or any position in-between. We do not perform awake craniotomies in 
prone or sitting positions. This is due to the increased risk of air embolism in case of 
spontaneous breathing patient in the sitting position and the difficult airway access and 
the limited patient comfort in case of 4-5 hours lying prone awake.
Tumors located in the insula are a special challenge for the patients and the medical 
team, but can be performed as an awake craniotomy. Before the beginning of the resec-
tion of the tumor the neurosurgeon has to perform a fissurotomy, which prolongs the 
duration of the procedure. This fissurotomy should be done with the patient sedated.
During the tumor resection from the insula, we see much more frequently exhaustion 
of the patients than in case of a cortical tumor resection. 
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Tumors located close to the temporobasal skull-base and dura can cause trigeminal 
nerve pain during the procedure. If the diathermic electrocoagulation is triggering the 
nerve, pain and vegetative reflexes (bradycardia) are possible. However, by good com-
munication between neurosurgeon and anesthesiologist and the use of small amounts 
of remifentanil (0.5-1 μg/kg) these situations can be managed quite well.
Grade of the tumor:
In patients who had biopsy performed in other centers or the radiological findings 
were highly suggestive for a glioblastoma, some neurosurgeons are quite reluctant to 
perform an awake craniotomy. Also in our population about 65% of the patients have a 
low grade primary brain tumor.
However, based on the recent findings, showing an improved survival in case of an 
extended resection even in glioblastoma patients, we do not consider (suspected) 
glioblastoma as a contraindication to awake craniotomy [2,3].
Recurrent tumor:
Tumor recurrence is common in case of primary brain tumors. However, also the second 
and even third procedure can be performed as an awake craniotomy with suitable 
patients. In case of a second awake craniotomy in one patient, special attention for suf-
ficient analgesia is mandatory. Due to scar formation, the spread of the local anesthetic 
in case of infiltration anesthesia of the surgical field can be limited. Furthermore, due 
to wound healing after the first procedure scar formation including a tight connection 
between the dura and the skull can have occurred, which makes a second craniotomy 
possibly more painful, and vagal reactions cannot be excluded.
Premedication / patient preparation:
Keystone of the anesthesiological preparation of the patient is an intensive (in aver-
age about 100 minutes lasting) dialogue between the anesthetist responsible for the 
procedure and the respective patient - and, if possible, at least one relative of the 
patient. During this dialogue, which in general takes place about two weeks before the 
operation, with slides and movies the whole course of events during the procedure is 
presented to the patient. Furthermore, the patient receives a collection of lay-journal 
articles about the awake craniotomy to be well informed and prepared. The following 
aspects are especially stressed during this dialogue:
Need to rest without moving on the operating table: 
We have excellent experiences with letting the patients train the perioperative position 
at home. In general, we recommend 3 sessions of 3-4 hours each, so that the patient 
can already detect possible pressure points and choose the most comfortable position. 
Awake craniotomy for brain tumor resection – what does the anesthesiologist do? 29
1
Furthermore, we also ask the patients in case of any itching not to scratch themselves, 
but to ask another person to do so, which will be the case on the OR, too. Our key mes-
sage is: speaking is always possible, but any body movements should be avoided.
Possible sources of discomfort: 
Pillows, jelly-matrasses and other means are used to make the patients lie as comfortable 
as possible. Urinary catheters induce a feeling of urge, especially in men. Once informed 
about the fact that this feeling is caused by the catheter, most patients are able to relax 
their pelvic muscles and to suppress this feeling. Infiltrating the skin for placement of 
the Mayfield clamp and infiltration of the surgical field are the most painful moments 
of the procedure. However, by administration of a small bolus of remifentanil (50-75 µg 
respectively), this can be managed very comfortably.
Glasses, false teeth, hearing aids: 
During an awake craniotomy communication between the medical team and the pa-
tient must be intense and as unrestricted as possible. Patients who cannot talk clearly 
without their false teeth, patients who cannot identify the pictures of the aphasia test 
without glasses and patients who cannot understand the neuropsychologist without 
their hearing aids have to take these devices with them to the OR.
Fasting, use of alcohol and nicotine: 
If the patients develops a state of substance withdrawal, the ability to cooperate is en-
dangered. Coffee-withdrawal induces headache, nicotine-withdrawal induces coughing 
and agitation, alcohol-withdrawal can cause vegetative disturbances and psychomotor 
agitation. Therefore, all our patients undergoing an awake craniotomy are allowed to 
consume up to 60 minutes before anesthesia induction the substances they are used to 
consume at home during the early morning. 
Drugs used for premedication: 
Criteria for continuing or discontinuing the drugs the patients is used to take from home 
are not different from patients undergoing any other type of surgery under general 
anesthesia. If the patient is using antiepileptic drugs, continuing them is crucial [5]. 
On the evening before surgery the patient is offered 1-2 mg lorazepam p.o. for a 
good night rest. In the morning, about an hour before anesthesia induction, 25 mg 
promethazine and 7.5 mg piritramide are given intramuscularly. We have chosen this 
combination of drugs because the quality and duration of sedation of benzodiazepines 
in the morning of the procedure were too unpredictable (will the patient be awake, as 
soon as the dura is opened?)
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Other aspects: 
The possibilities to lower an increased intracranial pressure during an awake craniotomy 
are limited - the patient cannot be e.g. temporarily hyperventilated. Therefore, we ask 
the patients to sleep in the night before the procedure with an elevated head (20-30 
degrees). Finally, all patients are given anti-thromboembolic stockings.
Anesthesia induction:
Limiting the stress: 
All awake craniotomy-patients are planned as the first of the day, in order to keep the 
stress due to fasting and mental excitement as limited as possible. During the whole 
procedure “vocal anesthesia”- a distracting dialogue with the patient - next to clear an-
nouncements of all actions taken is essential for the success of the procedure.
For anesthesia induction, basic monitoring is connected. Patients receive an i.v. ac-
cess (18 G) and a nasal oxygen probe (3 l/min). As soon as this is inserted, induction is 
performed with propofol (bolus of 0.5-1 mg/kg) and continued at a dose of about 4 mg/
kg/h. 
With the patient asleep, but spontaneously breathing we insert under local anesthesia 
(1% Lidocaine) an arterial catheter (radial artery), a central venous catheter (v. basilica) 
and the urinary catheter. After insertion of all these lines propofol-sedation is stopped.
The awake patient can help actively by finding the optimum position on the operating 
table. Afterwards the surgical field is shaved and prepared and local infiltration anesthe-
sia is performed.
the agitated patient:
We found that especially young male patients who obviously had not yet coped suf-
ficiently with the fact that they were suffering from a brain tumor showed a high level 
of agitation under the influence of propofol in the doses mentioned. Therefore, the 
need of a good emotional work-through, if necessary supported by a psychologist, is 
stressed during the preoperative dialogue. In case of agitation and unrest during se-
dation, a complete stop of propofol has turned out to be the better choice than even 
more sedation. As good local anesthesia alone is sufficient to undergo the craniotomy, 
gaining back consciousness will make the patient cooperative again. An increase of the 
propofol-dosages in case of agitation does not automatically stop the agitation, but 
might also cause a need of intubation with loss of neuropsychological monitoring.
local anesthesia: 
In our practice, we rely on the following combination of drugs:
For the local anesthesia of the three fixation points of the Mayfield clamp: 12-20 ml of 
a mixture of lidocaine 1% and bupivacaine 0.25% (final concentrations) with adrenaline 
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1:200.000. For the infiltration of the surgical field 25-40 ml bupivacaine 0.375% with 
adrenaline 1:200.000. The local anesthesia mixture is prepared by the anesthetist but 
injected by the neurosurgeon who is performing the painful procedures. A small bolus 
of remifentanil before the injections of the local anesthesia clearly increases patient 
comfort.
Craniotomy / trepanation:
Second period of sedation: 
After the surgical field is anesthetized and all drapes and blankets are installed, the 
patient is sedated again with another bolus of propofol (0.5-1 mg/kg) followed by 
continuous infusion (average 4 mg/kg/h). Here we see a high variability between the 
patients, which can be explained by the use of antiepileptics and other (social) drugs.
During our first awake craniotomy procedures, we kept the patients sedated from the 
first iv-line until the opening of the dura mater. However, we saw frequently problems 
with patients who had difficulties to orientate themselves under the blankets, because 
they woke up in a completely different environment compared to the situation when 
sedation was started. 
Airway management: 
During craniotomy we keep the patient on spontaneous breathing; an oxygen nose-
probe is the only kind of airway-management we use routinely. In case of emergencies, 
of course, all necessary anesthesia drugs and devices to perform intubation are prepared 
ready to use.
In literature, all possible alternative regimens of airway management are discussed 
(laryngeal mask, intubation-extubation, other supraglottic airway devices etc.) without 
any convincing evidence of a superiority of one technique above the others. An arte-
rial blood gas analysis during this period can be useful to verify the adequacy of the 
spontaneous ventilation.
Fluid management: 
We strive for normovolemia and rely on NaCl 0.9%, balanced crystalloid infusions and 
in case of blood loss above 300 ml also Hetastarch-solutions. Blood transfusions are 
extremely rare in these procedures.
Other drugs: 
During craniotomy, we also give routinely 200 ml mannitol 15% in case of relevant brain 
edema formation. Furthermore, we give dexamethason 8 mg i.v. and pheytoine 250 
mg i.v. The latter is given with the idea, that this dose is too low to suppress a proper 
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response on the cortical electrical stimulation, but high enough to suppress a secondary 
generalization of an epileptic insult which might be induced just by a cortical stimulation.
As soon as the dura mater is opened, the propofol-infusion is stopped and the pa-
tient’s awakening is expected.
brain mapping / neurostimulation:
Supported by a neuropsychologist / linguist, the patient has to undergo several psy-
chological tests, which are adapted to the location of the tumor and possible preexist-
ing neuropsychological deficits of the patient. During these tests, the neurosurgeon 
stimulates the cortical surface in the surgical field with an electrical tweezer. In case of 
a motor or sensory response to the electric stimulation, the cortical area is marked. The 
neurosurgeon tries to identify cortical zones without any response or interference with 
the tests, which enable him to approach the tumor safely.
This period of brain mapping can be challenging, if the neurosurgeon induces an epilep-
tic insult by the electrical stimulation. In that case, a few milliliters of iced water, which 
must be kept available are applied by the neurosurgeon directly on the stimulated brain 
surface. This will stop a local insult in most cases. If the insult does persist or starts to 
generalize, intravenous thiopentone (0.5-1.5 mg/kg) will stop the epileptic activity, 
whilst keeping the patients able to breath spontaneously.
management during tumor resection:
Keeping the patient awake: 
After a safe approach to the tumor is found, the authors prefer to keep the patient awake 
with a distracting dialogue (“vocal anesthesia”). This enables an immediate stimulation 
of deeper located brain structures during the progress of the procedure, to identify safe 
resection margins. (Fig. 2) 
During this dialogue, the patient is also instructed to announce if he wants some 
fluid on his lips or whether he would like to change position to avoid pressure sores. In 
coordination with the neurosurgeon this can be facilitated. In general, blood pressure 
during an awake craniotomy is higher than under general anesthesia, but it is only rarely 
necessary to decrease it actively by administering urapidil (0.2-0.5 mg/kg i.v.). 
Tumor resection ends with a final control of all relevant neurological functions of the 
patient and hemostasis by the neurosurgeon.
Complications:
All patients survived the procedure and the early postoperative period. We have seen 
focal epileptic insults in several patients; 3 patients showed generalized grand-mal 
epileptic insults. All insults could be managed without intubating the patient.
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No patient panicked on table or requested a switch to general anesthesia. In most of 
the cases with a less radical tumor resection than we preoperatively had hoped, this was 
due to the high risk of functional deficits based on the findings at (subcortical) electrical 
stimulation. 
In 5 cases we had to stop the tumor resection before we reached these limits, because 
the patients became exhausted and/or less alert, which made reliable feedback during 
neurostimulation impossible.
No patient needed intubation and ventilation intraoperatively due to a respira-
tory problem. Two patients postoperatively developed severe generalized brain edema, 
which made an intubation on the 2nd or 3rd day postoperatively necessary.
Wound closure:
During the closure of dura, skull and skin patients are sedated again with propofol, bolus 
and continuous infusion. In general, lower dosages are needed than at the beginning of 
the procedure (initial dose -20%).
Skin closure is done with staples because they can be placed much faster than sutures 
without any disadvantage for the cosmetic result. After in average 3.5 hours time from 
incision to wound closure the procedure is finished and the administration of propofol 
is stopped. 
figure 2: Surgical field after tumor resection: The sterile numbers indicate, where during cortical and sub-
cortical stimulation functional brain areas have been identified.
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Postoperative management: 
All patients wake up whilst the wound bandage is placed and are transferred to our 
Post-Anesthesia-Care-Unit, which is more a high-care-unit than a recovery. The patients 
spend here the first 24 h postoperatively and undergo frequently neurological checks. 
Once arrived there, they are allowed to eat and drink. After 6 h postoperatively prophy-
lactic low-dose heparines will be given, if the patient shows no neurological abnormali-
ties. Postoperative mobilization starts just on the first postoperative day in order to keep 
the risk of postoperative bleeding low.
Analgesia: 
Patients undergoing an awake craniotomy in general have only low pain scores. Once 
the local anesthesia has been faded, paracetamol and opioids are sufficient to provide 
excellent pain control [6].
Discussion:
The authors are aware of the fact, that the available literature is full of variations and 
alternatives on the regimen described here [7,8]. 
These alternatives mostly affect 
•	 The	technique	of	local	anesthesia	(field	block	vs.	wound	infiltration,	choice	of	drugs	
and additives),




In several studies we could demonstrate, that the subjective experience of patient com-
fort and patient satisfaction with our regimen is very positive. Also, when focusing on 
objectively measurable stress parameters, it meant clearly no higher level of stress for 
the patient than a tumor resection under general anesthesia [10,11].
Because there is no evidence showing superiority of one technique above the other, 





datory and the specific aspects of the procedure must be kept in mind.
•	 The	intraoperative	cooperation	of	the	patient	is	based	on	an	intensive	preparation.	A	
preoperative dialogue of 100 minutes is usual.






•	 “Vocal	 anesthesia”	–	a	distracting	dialogue	with	 the	patient	–	 is	 a	 keystone	of	 the	
anesthesia regimen.
•	 The	 quite	 minimalistic	 airway	 management	 we	 practice	 for	 years	 (continuously	
spontaneous breathing patient with oxygen nose probe) is safe, feasible and suc-
cessful.
•	 After	an	awake	craniotomy	–	just	like	after	all	similar	tumor	resctions	under	general	
anesthesia – patients are treated for 24 hours on our PACU/High care unit.
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loCAl AnEsthEtiCs foR bRAin tUmoR REsECtion:  
CURREnt PERsPECtivEs.
AbstRACt
This review summarizes the added value of local anesthetics in patients undergoing 
craniotomy for brain tumor resection, which is a procedure that is carried out frequently 
in neurosurgical practice. The procedure can be carried out under general anesthesia, 
sedation with local anesthesia or under local anesthesia only. Literature shows a large 
variation in the postoperative pain intensity ranging from no postoperative analgesia 
requirement in two-thirds of the patients up to a rate of 96% of the patients suffering 
from severe postoperative pain. The only identified causative factor predicting higher 
postoperative pain scores is infratentorial surgery. Postoperative analgesia can be 
achieved with multimodal pain management where local anesthesia is associated with 
lower postoperative pain intensity, reduction in opioid requirement and prevention of 
development of chronic pain. In awake craniotomy patients, sufficient local anesthesia is 
a cornerstone of the procedure. An awake craniotomy and brain tumor resection can be 
carried out completely under local anesthesia only. However, the use of sedative drugs 
is common to improve patient comfort during craniotomy and closure. Local anesthe-
sia for craniotomy can be performed by directly blocking the six different nerves that 
provide the sensory innervation of the scalp, or by local infiltration of the surgical site 
and the placement of the pins of the Mayfield clamp. Direct nerve block has potential 
complications and pitfalls and is technically more challenging, but mostly requires lower 
total doses of the local anesthetics than the doses required in surgical-site infiltration. 
Due to a lack of comparative studies, there is no evidence showing superiority of one 
technique versus the other. Besides the use of other local anesthetics for analgesia, 
intravenous lidocaine administration has proven to be a safe and effective method in 
the prevention of coughing during emergence from general anesthesia and extubation, 
which is especially appreciated after brain tumor resection.
keywords: brain tumor, craniotomy, local anesthesia, neurosurgery, scalp block
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intRoDUCtion
Craniotomy for brain tumor resection is carried out frequently in neurosurgical practice. 
While about one-half brain tumors do not grow into neuronal tissue (like pituitary 
adenomas and meningiomas), the other half (e.g. oligodendrogliomas, astrocytomas, 
glioblastomas and metastases) do. Definitive cure of a tumor of this second group can be 
considered as impossible. On the other hand, it is known that a maximum of cytoreduc-
tion and tumor resection is associated with a better long-term survival. Therefore, these 
tumors are frequently resected by awake craniotomy with cortical (and subcortical) 
mapping, enabling a maximum of resection with a minimal risk of functional damage 
to the patient.1,2
If the patient is conscious and responsive at any time during the procedure, it is referred 
to as an awake craniotomy. An awake craniotomy can be carried out with three different 
forms of anesthetic care. In the sleep–awake–sleep technique, the patient is anesthe-
tized during the placement of the skullpin head holder and the craniotomy whereafter 
consciousness must be regained in order to map cortical areas. Another option is to 
perform the procedure under monitored anesthetic care where the patient is mildly se-
dated to control anxiety and pain. Finally, the awake–awake–awake technique involves 
no sedation but only requires analgesia and special attention to non-pharmacological 
interventions such as hypnosis.3 In all awake craniotomy techniques, the use of local 
anesthetics is mandatory. 
Neurosurgical procedures cause more pain than anesthesiologists expect,4 and post-
craniotomy pain is not always well understood.5 However, clinicians have become more 
aware of the incidence and intensity of post-craniotomy pain. There is a large variation 
in the occurrence of postoperative pain and the requirement of analgesic medication in 
neurosurgical patients. Pain scores have a large variation ranging from a visual analog 
score of approximately 15 to more than 60 in two large studies.6,7 In a recent review 
of 26 studies assessing different aspects of postcraniotomy pain, 15 studies reported 
pain percentages in the first two postoperative days up to 60%–96%.5 It is unclear why 
this great variation of the incidence of postoperative pain exists in craniotomy patients. 
Attributable factors could be the perioperative opioid and analgesic regiment used, the 
exact moment of the first postoperative pain score and the composition of the neuro-
surgical population. A recent review studied several factors such as age and gender, 
surgical site, surgical technique, psychological factors and tumor characteristics, but the 
results are conflicting and inconclusive.8 The surgical site has turned out to be the only 
reliably identified factor: infratentorial surgery tends to be more painful and requires 
a higher cumulative opioid dose than supratentorial surgery, possibly because of the 
surgical-induced stretch and trauma of the neck muscle mass.9,10 A review by de Gray 
and Matta provides further details about the pathogenesis of postoperative pain.10
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The treatment of postoperative pain in neurosurgery is characterized by a balance 
between swift neurological assessment and the prevention of sedation, hypercapnia 
and opioid side effects such as vomiting on one side and patient comfort and the 
prevention of hypertension on the other side. Although opioids are frequently used in 
nonneurological surgery, their side effects raise caution to use these drugs in neurosur-
gical patients. Interestingly, these theoretical adverse effects have not been observed 
in studies using opioids.11 Nevertheless, post-craniotomy pain should be treated by 
multimodal pain management where several classes of drugs are combined with local 
anesthesia.11,12 Since patient-related factors that can predict the occurrence of serious 
postoperative pain are not known, it is recommended to provide on-demand analgesics 
that need to be administered with minimal delay to all craniotomy patients.6 If an opioid 
drug is necessary, intermittent intravenous morphine provided on a medium- or high-
care postoperative unit or via a patient-controlled system may be an effective option 
with less side effects compared to codeine or tramadol.12,13
Besides acute postoperative pain, craniotomy patients are prone to develop chronic 
post-craniotomy headache where the incidence varies between 0% and 65%.9,14 Chronic 
pain can not only develop at the site of the incision but also develop as a moderate pres-
sure sensation involving the entire head. In one study, 18% of the patients developed a 
severe throbbing sensation associated with nausea and vomiting.15 Several preoperative 
factors associated with the development of chronic headache have been identified, 
such as depression, anxiety and temporomandibular disorders.16
Locoregional anesthesia has been shown to have an additional value in craniotomy 
patients, independent of the anesthesia technique used.17 In the intraoperative phase, 
locoregional anesthesia diminishes the autonomic responses during the application of 
the skull-pin placement18,19 as well as during dural closure and skin closure,19 which due 
to the lack of a sensory innervation of the brain tissue itself are much more painful than 
tumor resection. Even under general anesthesia and after an opioid was administered, 
heart rate and blood pressure can increase by 15% and 43%, respectively, after ap-
plication of the Mayfield clamp.20 This effect can be largely diminished by preoperative 
application of local anesthesia, via either a scalp block or local infiltration,20,21 leading to 
a more hemodynamically stable anesthesiological course.
In awake craniotomy patients, the use of local anesthesia is the cornerstone of the 
procedure and has been established as a standard of care.21–23 If the local anesthesia is 
effective, no other analgesic drugs are necessary during the whole procedure. However, 
additional sedation is commonly used during craniotomy and closure, the steps of the 
procedure where the cooperation of the patient is not required. This combination en-
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ables a comfortable emergence and adequate analgesia during the regain of conscious-
ness. The combination of sedation and local anesthesia has also been proven effective in 
the pediatric population.24,25 Sedation during craniotomy can be done with propofol or 
dexmedetomidine alone; it is much more a comfort measure than a medical need. The 
combination of local anesthesia with sedation has been used successfully in patients 
with a relative contraindication for a “typical” awake craniotomy, like fragile patients and 
patients with a poor neurological status, too.26 However, in our practice, we would prefer 
to perform procedures in these groups of patients under general anesthesia because of 
the better anesthesiological control of the intraoperative situation.
It can be discussed whether there is a place for shortacting opioids like remifentanil just 
before the injection of the local anesthetics; it increases patient comfort by damping 
some of the pain intensity of the local injections. On the other hand, the same injections 
are routinely performed without additional opioids in patients who need to be sutured 
after minor head traumas.
Regarding the additional value of local anesthetics for the postoperative phase of all 
craniotomy procedures, the use of regional anesthesia leads to lower pain scores and 
a reduction of opioid consumption in the early postoperative period.27 Local anesthet-
ics can be injected as a dedicated regional scalp (or nerve) block or as a diffuse local 
infiltration of the surgical field. Studies using scalp blocks have been meta-analyzed. In 
an analysis published in 2013, seven studies with a total of 320 patients were systemati-
cally analyzed out of 20 studies that investigated the effect of regional scalp blocks.27 
Several authors performed the scalp blocks at different time points of the perioperative 
course: a scalp block was performed preoperatively, before incision and after wound 
closure. The analysis showed an overall reduction in pain score 1 hour postoperatively 
(mean difference: −1.61, 95% confidence interval: −2.06 to −1.15, P< 0.001). A reduction 
in pain scores up to 8 hours for a preoperative scalp block and up to 12 hours with a 
postoperative blockade was observed. Application of a scalp block reduced morphine 
consumption, although this effect was small (n= 6 trials, standardized mean difference: 
−0.79, 95% confidence interval: −1.55 to −0.03, P= 0.04).27
Studies using local infiltration instead of application of a regional skull block were 
analyzed in a meta-analysis by Hansen et al.28 In total, there were five randomized trials 
including a total of 249 patients: Bloomfield et al described infiltration with bupivacaine 
0.25% pre- and postoperatively showing a significant reduction in pain scores imme-
diately on admission on the PACU that wears off after 1 hour.19 Other studies in this 
review looked at the effect of infiltration before suturing and skin closure using either 
ropivacaine 0.75% or bupivacaine 0.5%. They found that infiltration reduces morphine 
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consumption in the early postoperative period.29 Another study using ropivacaine 
0.75% could not replicate this effect, but patients in the intervention group (with local 
anesthesia) showed significantly reduced pain scores in the early postoperative period.30
A recent study using a mixture of lidocaine and ropivacaine addressed the question 
whether pre- or postoperative infiltration is more effective in reducing postoperative 
pain. The authors found lower pain scores and a reduction of morphine consumption in 
the group that received infiltration before incision.31 This supports the idea of “preemp-
tive analgesia” by local anesthetics due to inhibition of the pain-signal transmission. 
However, despite this weak support for local infiltration, there is an urgent need for 
more scientific trials addressing this issue.
For infratentorial craniotomies, a recent randomized trial showed that the scalp block 
blunts the hemodynamic response better during application of the skull-pin. Patients 
also had a slightly lower pain intensity score in comparison to local infiltration only. 
Postoperative morphine consumption was equal in both groups.32
Several studies addressed the effect of local anesthesia on the development of chronic 
post-craniotomy pain. Batoz et al found in a randomized trial that postoperative local 
infiltration with ropivacaine significantly reduces persistent pain 2 months after crani-
otomy.30 In a larger study with the same design, however, this effect was not found to be 
significant,33 leaving the effect of local infiltration on the development of chronic pain 
uncertain. 
One recent study found beneficial effects of intravenous lidocaine in craniotomy 
patients. Intravenous lidocaine has already been extensively described and reviewed, 
especially in visceral-abdominal surgery where it reduces pain in the early postoperative 
period.34 In the study by Peng et al, craniotomy patients were randomized to receive a 
bolus (1.5 mg/kg) and a continuous infusion (2 mg/kg/h) of intravenous lidocaine or sa-
line. No other local anesthetic application was used. The lidocaine group showed lower 
pain scores and a higher rate of absence of pain (NRS = 0) in the early postoperative 
period.35 Further research is needed to answer the question how intravenous lidocaine 
compares to the application of local anesthesia in terms of postoperative pain and 
morphine requirement.
Taking this all together, there is sufficient support for the use of local anesthetics to 
prevent pain during awake craniotomy, to reduce pain and pain response in patients 
undergoing craniotomy under general anesthesia and to prevent chronic pain after 
craniotomy.
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At this point, the technique of the local anesthesia itself must be studied further: must 
it be injected as a direct nerve/scalp block or is a local infiltration of the field sufficient, 
too? 
innERvAtion of thE sCAlP AnD DiRECt nERvE bloCk
The scalp is innervated by six different nerves on both sides (table 1 and figure 1). 
Excellent anatomical reviews have been published before describing in detail the loca-
tion of the nerves in relation to the surface anatomy.36–39 When applying a direct nerve 
block, several considerations need to be taken into account. While the landmarks where 
these nerves leave the skull are quite well defined, the area they cover shows an enor-
mous variability. The supraorbital nerve has the medial iris as a reliable topographical 
landmark, where the location of the nerve is within 1 mm from the needle, small enough 
to be reached by a deposition of local anesthetic.40 The supratrochlear nerve can also be 
reliably blocked at the point where it exits the orbita and before it enters the corrugator 
muscle.41 The zygomaticotemporal branch of the trigeminal nerve shows a variation 
in anatomy and branches. It also has an intramuscular course in 50% of the cases.42 
Although the innervated area of the scalp of this nerve branch is small, identifying the 
exact blocking site of this nerve can be difficult and varies in the literature.
The auriculotemporal nerve runs between a distance of 8 and 20 mm anterior to the 
origin of the helix, so the recommended injection site is 10–15 mm from this point tak-
ing care not to inject the superficial temporal artery or to block branches of the facial 
nerve.43 Both anatomical structures are of special importance in patients undergoing 
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awake craniotomies, as injecting in the first can cause epileptic seizures and blocking 
the second can cause (temporary) loss of nerve function, which can be confusing, if 
the surgeon operates near to neurons controlling facial function. More variation can be 
observed in the occipital nerves arising from the spinal plexus44 where some authors 
advocate a precise localization of the two different nerves36,39 while others recommend 
a field block approach to block the occipital nerves.38 However, in many patients, both 
occipital nerves can be identified with ultrasound,45 too, which enables a direct nerve 
block. 
Recently, a new study describing the use of a maxillary block in craniotomy patients 
found better analgesia compared to a regional scalp block.46 This innovative approach 
relies on the retrograde spread of the anesthetic along the maxillary nerve, leading 
finally to a complete block of all branches of the ipsilateral trigeminal nerve.
Local anesthetics for brain tumor resections: current perspectives. 47
2
APPliCAtion of A fiElD bloCk
When applying a field block, both the sites of the pins of the Mayfield clamp and the site 
of the incision must be infiltrated with local anesthetics. To improve patient comfort, it 
is our practice to precede the injection of the local anesthetic by a bolus injection of a 
short-acting opioid (we use about 0.8 μg/kg of remifentanil). For the Mayfield clamp, we 
routinely use an injection of 12–15 mL mixture of lidocaine 1% and bupivacaine 0.25% 
(final concentrations). Due to the fact that mostly there is only a short delay between 
the injection of the anesthetic and the placement of the clamp, we decided to add 
lidocaine for its fast onset. Epinephrine 1:200,000 can be safely added. We prefer the use 
of bupivacaine 0.25% over ropivacaine 0.75%. Although the local anesthetic duration of 
bupivacaine with added epinephrine and ropivacaine is comparable29 and microvascu-
lar changes are identical,47 the cumulative dose of local anesthetic is lower when equal 
volumes of either bupivacaine 0.25% or ropivacaine 0.75% are used.
For anesthesia of the incision site, an injection of up to 30 mL of bupivacaine 0.375% 
combined with adrenaline 1:200,000 is used. In our practice, the anesthetist prepares 
the local anesthetics, but the responsible neurosurgeon himself injects the local anes-
thetics to prevent misinterpretation between the planned surgical incision and clamp 
sites and the anesthetized scalp areas. To prevent local anesthetic toxicity, we recom-
mend this technique only for patients with a minimal weight of 50 kg in order to avoid a 
bupivacaine dose exceeding 3 mg/kg. Mixing lidocaine and bupivacaine does not have 
a synergistic (supra-additive) effect on cardiotoxicity.48
Similar to other blocks, the same precautions must be taken into consideration when 
applying a cranial nerve block. Careful aspiration and slow injection to avoid intravascu-
lar injection are mandatory. Furthermore, a direct intraneural injection, which will cause 
immediate severe pain, must be stopped as soon as the patient complains. This risk is 
especially high in case of the supraorbital nerve block due to its anatomical position. 
When injecting to block the supraorbital nerve, care must be taken to prevent injury to 
the eyelid. When blocking the auriculotemporal nerve, injection in the temporoman-
dibular joint, the superficial temporal artery and the facial nerve is a hazardous pitfall. 
The incidence of a transient facial nerve palsy after blockade of the auriculotemporal 
nerve has been described at up to 17%.49 
Besides general complications of the local anesthetic such as overdosage and intraner-
vous or vascular injection, there are specific complications described in the literature fol-
lowing a field or direct nerve block (Table 1). Direct injection of a local anesthetic in the 
cerebral ventricular system leading to a total subarachnoid block has been observed50 
which can be a direct lethal complication when not recognized and treated promptly by 
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protecting the airway and providing circulatory support. One must be aware of the risks 
of patients who have undergone craniotomy before or who have skull defects for other 
reasons like plasmocytoma. However, in a meta-analysis of seven studies of the scalp 
block, no adverse events were reported.27
Bilotta et al investigated the learning curve of seven residents in anesthesiology in order 
to achieve a “good–excellent” level of competence when applying a direct nerve block. 
The residents achieved an “excellent” rating after carrying out 10 procedures, conclud-
ing that a total of 11 procedures was sufficient to independently perform a direct nerve 
block in 95% of residents.51 
To conclude, an infiltration of the surgical field by the neurosurgeon is a simple, reliable 
and safe technique for the vast majority of the patients. However, in patients with lower 
body weight, or in case of longer-lasting procedures (e.g. insula tumors), or in patients 
undergoing re-craniotomies (where scars inhibit the spread of the anesthetic in case of 
a surgical field block), but also for postoperative pain treatment, a direct nerve/scalp 
block (performed by an anesthetist) is a valuable alternative. It can be performed with a 
smaller total amount of local anesthetic, but with equal or possibly even longer-lasting 
effect. However, the direct nerve/scalp block is technically more challenging to perform 
and needs more training.
thE UsE of loCAl AnEsthEtiCs to Diminish AUtonomiC REsPonsEs
In this review, we already discussed the role of local anesthetics to provide analgesia 
when administered via a direct nerve block, a regional field block and via intravenous 
administration. Another indication for the use of local anesthetics in craniotomy pa-
tients is the reduction of autonomic responses such as coughing around extubation 
after general anesthesia for a craniotomy. Coughing produces a rapid rise in intracranial 
pressure,52 which is an undesirable response in the early postoperative period. Several 
interventions have been studied in a study comprising 204 patients. The most effective 
strategies were the application of intracuff lidocaine and intravenous lidocaine (1.5 mg/
kg at the end of surgery) significantly reducing the incidence of coughing.53 Besides 
the prevention of coughing, lidocaine prevents the occurrence of a postoperative sore 
throat up to 30 hours after extubation.54 In another randomized trial, spraying the supra- 
and subglottic areas with lidocaine 4% gave a significant reduction of cough during 
tracheal extubation.55 
We recommend the use of intravenous lidocaine because the topical use of lidocaine 
spray might weaken laryngeal reflexes and thereby enable (silent) aspiration. Further-
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more, the use of lidocaine to fill the cuff of the tube is not recommended by the produc-
ers of the tube and might cause liability problems in case of a cuff leak. 
Besides lidocaine, a single bolus infusion of dexmedetomidine results in a reduction 
of coughing and an attenuation of hemodynamic parameters during emergence from 
anesthesia.56 It is an interesting question how lidocaine compares to dexmedetomidine 
in the reduction of autonomic responses during emergence. 
ConClUsion
In summary, this review clearly shows the added value of local anesthetics in patients 
undergoing craniotomy for brain tumor resection: local infiltration of the surgical field 
or a direct nerve/scalp block is an effective measure to reduce postoperative pain. In 
case of the awake craniotomy technique, local anesthetics can be so effective that no 
other analgesics have to be given intraoperatively. There is insufficient scientific support 
to promote one local anesthesia technique as superior to the other. In our experience, 
both have their advantages. Infiltration of the surgical field is easy to perform, effective 
and safe in most patients. Direct nerve/scalp block has clear advantages in patients with 
lower body weight, longer-lasting (> 5 hours) procedures and possibly in re-craniotomies 
but requires more training and good anatomical knowledge. Finally, in case of general 
anesthesia for brain tumor resection, the intravenous application of lidocaine before 
extubation can help to suppress coughing and hemodynamic instability leading to a 
smoother and better recovery from anesthesia.
Future research should focus on 1) imaging techniques, which help with the identifica-
tion of smaller nerves for direct nerve blocks, and 2) local anesthetics providing a long-
lasting effect with low toxicity. Finally, studies directly comparing a surgical field block 
versus a direct nerve/scalp block are also highly required.
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inflAmmAtoRy PRofilE of AWAkE fUnCtion-ContRollED CRAniotomy 
AnD CRAniotomy UnDER GEnERAl AnEsthEsiA.
AbstRACt
background. Surgical stress triggers an inflammatory response and releases media-
tors into human plasma such as interleukins (ILs). Awake craniotomy and craniotomy 
performed under general anesthesia may be associated with different levels of stress. 
Our aim was to investigate whether those procedures cause different inflammatory 
responses. 
methods. Twenty patients undergoing craniotomy under general anesthesia and 20 
patients undergoing awake function-controlled craniotomy were included in this pro-
spective, observational, two-armed study. Circulating levels of IL-6, IL-8, and IL-10 were 
determined pre-, peri-, and postoperatively in both patient groups. VAS scores for pain, 
anxiety, and stress were taken at four moments pre- and postoperatively to evaluate 
physical pain and mental duress. 
Results. Plasma IL-6 level significantly increased with time similarly in both groups. No 
significant plasma IL-8 and IL-10 change was observed in both experimental groups. The 
VAS pain score was significantly lower in the awake group compared to the anesthesia 
group at 12 hours postoperative. Postoperative anxiety and stress declined similarly in 
both groups. 
Conclusion. This study suggests that awake function-controlled craniotomy does not 
cause a significantly different inflammatory response than craniotomy performed under 
general anesthesia. It is also likely that function-controlled craniotomy does not cause a 
greater emotional challenge than tumor resection under general anesthesia.
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intRoDUCtion
General anesthesia using endotracheal intubation is the standard procedure during 
brain tumor resection. Vital parameters are monitored and intubation provides a safe 
airway; drugs ensure analgesia and suppress vegetative reactions. Immobilization is 
relatively simple, even for patients in an atypical position. However, the use of general 
anesthesia precludes intraoperative monitoring of higher brain functions, and lesions 
made to the central nervous system being detected when reversibility of damage con-
trol might still be possible. Therefore, awake function-controlled neurosurgery may be 
beneficial in that respect. During awake craniotomy, the cerebral cortex of the patient is 
electrically stimulated. This allows the surgeon to properly identify and spare function-
ally relevant areas of the brain. Awake craniotomy has been shown to be a well-tolerated 
procedure with minimal side effects. Nevertheless, it is considered to be more challeng-
ing for the patient. By allowing for maximal tumor excision while keeping healthy tissue 
intact, awake craniotomy has the potential for better patient outcomes [1]. In such a 
procedure, the need to provide sufficient analgesia and sedation without interfering 
with electrophysiological monitoring is essential [2].
Before, during, and after craniotomy all patients are confronted with anxiety, stress, and 
pain. These factors can all negatively influence the perioperative experience. Patients 
undergoing craniotomy using general anesthesia, however, have to endure additional 
physical stress factors like intubation, longer hospital stays, and mechanical ventilation 
[3].
Patient perspectives regarding awake brain surgery have been investigated and 
adequate preoperative consultation has been found to be essential for patient confi-
dence. In addition, scalp incisions and fixation of pin-holding sites were regarded as 
major sources of pain and discomfort. Still, the benefits far outweigh those of general 
anesthesia because awake craniotomy patients report less pain, anxiety, and fear [4, 5]. 
Even though there are drawbacks, the majority of patients tolerate awake craniotomy 
very well.
No study has attempted to compare the inflammatory impact of awake craniotomy 
versus general anesthesia procedures. Pathological inflammatory states can have far 
ranging clinical effects and negatively influence a patient’s neurological outcome [6–8]. 
Recent research has demonstrated that cytokine levels can be correlated to the degree 
of brain tissue manipulation [9]. Plasma cytokine levels could reflect stressrelated bio-
chemical pathways after surgery [10–12]. 
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Cytokines orchestrate the complex network of cellular interaction that regulate both 
cell-mediated and humoral immunity, as well as the acute phase response [13]. Cytokines 
are glycopeptide signaling molecules that act at extremely low concentrations, medi-
ating key immune responses. Several cytokines are released during periods of stress, 
including interleukin-6 (IL-6), IL-8, and IL-10 [14]. IL-6 is a proinflammatory cytokine 
secreted by T-cells, macrophages, and other cells. IL-6 is involved in both the immune 
response to trauma and the acute phase response; its targets being T- and B-cells. IL-8 
is a chemokine produced mainly by macrophages and epithelial cells and functions to 
attract neutrophiles towards inflammation sites. These proinflammatory cytokines play 
a key role in the physiological response to trauma and surgery, whereas IL-10 is an anti-
inflammatory cytokine produced by Th2-cells that cause a reduction in proinflammatory 
cytokine synthesis [15].
Our aim was to investigate whether awake function-controlled craniotomy causes a 
significantly different inflammatory response than craniotomy performed under general 
anesthesia. We thought both procedures would create similar inflammatory profiles de-
spite differing anesthesia techniques used. In order to test our hypothesis, plasma levels 
of IL-6, IL-8, and IL-10 were measured during the pre-, peri-, and postoperative periods in 
both patient groups. We also noted corresponding subjective outcome parameters for 
pain, anxiety, and stress to investigate whether performing an awake procedure causes 
more physical pain and mental duress.
PAtiEnts AnD mEthoDs
Study Design and Inclusion Criteria. 
This was a prospective, single centre, two-armed observational study with 40 patients 
(20 men and 20 women). The protocol was approved by the Medical Ethics Committee of 
the Erasmus Medical Center, Rotterdam. All procedures were performed in accordance 
with the Helsinki declaration. Written informed consent was obtained from all patients.
Plasma cytokine determinations were performed blinded, but randomization was 
limited. The decision to perform either function-controlled awake craniotomy or crani-
otomy under general anesthesia was determined by the neurosurgeon who based his 
decision on the intracerebral location of the tumor. The type or size (WHO classification 
of brain tumors) had no influence on whether or not awake craniotomy was chosen. By 
proxy, patients were allocated to the general anesthesia group unless the location of 
the tumor warranted the benefits of an awake procedure. Patients with tumors close 
to functional relevant areas like the motor cortex or areas related to speech require the 
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awake monitoring made possible by the awake craniotomy procedure. By allocating 
these patients to the awake craniotomy group maximal tumor resection is made pos-
sible with a minimal risk of functional neurological damage.
Eligible patients were >18 years of age and were undergoing craniotomy for an intra-
cerebral tumor. Patients were excluded if they were (1) ASA-classification IV-V, (2) did not 
provide written informed consent, (3) had a tumor location other than intracerebral, (4) 
had surgery beginning later than 11:00 a.m., (5) had a disease of the endocrine system or 
(6) were taking drugs that alter endocrine metabolism (like thyroxine). Noncooperative 
or noncompliant patients could be withdrawn from the study, as could patients who 
developed serious adverse effects. 
Anesthesia Procedure. 
Patients in both groups received 1.5 mg lorazepam on the evening before the surgery. 
All patients were on a regimen of dexamethasone 4 × 4 mg/day with the first dose 
given at least one day prior to surgery; regular personal drug regimens were continued 
during the study. In the awake function-controlled group, 7.5 mg piritramide and 25 
mg promethazine were given 30 minutes prior to induction. In the general anesthesia 
group, premedication consisted of 50 mg promethazine. In both groups propofol was 
administered for sedation and remifentanil for analgesia. The general anesthesia group 
received an additional 0.25mg fentanyl before intubation and placement of the Mayfield 
clamp. Cis-atracurium was used for muscle relaxation prior to intubation. In order to 
provide adequate pain control during awake craniotomy patients were infiltrated with 
bupivacaine 0.375% with adrenaline 1:200.000 at the site of scalp incision. Postopera-
tively all patients were offered 4 times one gram paracetamol per day, and if required, 
supplemental morphine. 
Outcome Measures.
Patient characteristics, medications used during and after surgery, fluid balance, and 
duration of surgery were documented. Pain, anxiety, and stress were measured at 12 and 
24 hours pre- and postoperatively, using visual analogue scale (VAS) scores (0 = none, 
10 = extreme). 
EDTA blood samples (7mL) for cytokine level determinations were collected preopera-
tively, during the opening and closing of the dura, and 12 and 24 hours postoperatively. 
Plasma was isolated by centrifugation at 2650 gmax for 10 minutes at 20 º C; samples were 
stored at −80 º C until assay.
Enzyme immunoassays for the quantitative determination of human IL-6, IL-8, and IL-
10 were performed with a sandwich ELISA (Pelikine Compact and additional Pelikine 
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Toolset, Sanquin, Amsterdam, The Netherlands) as described previously [16]. Data were 
calculated as pg/mL plasma and presented in Figures 1, 2, and 3 as (log) pg/mL. 
IL-6 level significantly increased with time in both experimental groups (main effect of time: 
F(1, 49) = 24.1, P < .001, observed power = 1.00).  
IL-6 level significantly increased with time in both experimental groups (main effect of time: 
F(1, 49) = 24.1, P < .001, observed power = 1.00).  
Inflammatory profile of awake function-controlled craniotomy and craniotomy under general anesthesia. 63
3
Statistical Analysis.
Data were analyzed using SPSS for Windows, version 16.0.1. The independent sample 
t-test was used to compare means for patient demographics (excluding ASA classifica-
tion) and perioperative characteristics. The Pearson Chi-square test was used to evaluate 
differences in ASA classification. All data were reported as the mean (SD), counts, or 
median (25%–75%). 
Sample size was calculated using the O’brien-Shieh Algorithm for the MANOVA repeated 
measures test. Assuming a medium effect, an effect size of 0.6 was used and a power of 
0.8. There were two experimental groups and 5 repetitions. The required a priori sample 
size computed by this method was 39. 
For the VAS scores and cytokine data the MANOVA test was used. Differences in VAS 
score or cytokine values between the experimental groups across all time points and 
interaction between experimental groups and time were analyzed using multivariate 
repeated measures. Experimental group and time were the independent variables. 
When Mauchly’s Test of Sphericity was significant, the Greenhouse-Geisser test of 
within-subjects-effects was used. When a significant difference was found between 
experimental groups a one-way ANOVA test with posthoc multiple comparisons 
the awake group was 2.00 (±5.48 mg). The mean postoperative paracetamol administered 
to the general anesthesia group was 2100 (±1483 mg), while the mean given to the awake 
group was 1900 (±1477 mg).  
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(Bonferroni correction) was used to analyze the relationship between the cytokines or 
VAS scores from the first preoperative measurement until 24 hours postoperative. The 
same Bonferroni correction was employed to analyze differences between experimental 
groups and time. A P-value < .05 was considered statistically significant. 
REsUlts
Forty patients were included in the study. The awake function-controlled and general 
anesthesia groups contained 20 patients each, stratified for gender (10 males and 10 
females). No significant intergroup differences were observed for age, height, weight, 
ASA classification, or Hb concentration (Table 1).
Perioperative characteristics are described in Table 2. As expected, the total amount 
of propofol administered throughout the operation was significantly less in the awake 
group than in the general anesthesia group. The general anesthesia group also received 
table 2: Perioperative Characteristics
General anesthesia function-controlled
Propofol during operation (mg) 3277 ± 1632 673 ± 313a
Operation time (min) 327 ± 104 275 ± 56
Blood loss during operation (ml) 400 (300–500) 450 (300–600)
Colloids during operation (ml) 500 (500–500) 500 (0–500)
Colloids after operation (mL) 50 ± 200 100 ± 400
Crystalloids during operation (L) 3.7 ± 2.0 1.6 ± 0.7a
Crystalloids after operation (L) 2.0 ± 1.0 2.0 ± 0.9
Urine during operation (mL) 1620 (1043–2050) 1042 (480–1483)b
Urine after operation (mL) 1759 ± 836 1668 ± 620
Remifentanil 8.4 ± 5.4 mg 200 μg*
Postoperative paracetamol (mg) 2100 ± 1483 1900 ± 1477
Postoperative morphine (mg) 1.60 ± 4.72 2.00 ± 5.48
Function-controlled versus general anesthesia significantly different: a P < .001 and b P = .004.
Data presented as mean ± SD and median (25%–75%). *Maximum total amount of boluses given.
table 1: Patient demographics
General anesthesia function-controlled
Age (years) 48 ± 15.4 44 ± 13.2
Gender m/f 10/10 10/10
Height (cm) 174 ± 11.3 176 ± 9.6
Weight (kg) 74 ± 16.5 81 ± 14.7
ASA classification 1/2/3 (number of patients) 9/10/1 5/15/0
Hb concentration (mmol/L) 9.3 ± 1 9.0 ± 0.6
Data presented as mean ± SD
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more crystalloids during the operation. The total amount of remifentanil used in the 
general anesthesia group was 8.4 ± 5.4mg. No more than 200 μg of remifentanil was 
given to the awake craniotomy group.
Plasma concentrations of IL-6, IL-8, and IL-10 during all time points are displayed in 
Figures 1 through 3.
IL-6 level significantly increased with time in both experimental groups (main effect of 
time: F(1, 49) = 24.1, P < .001, observed power = 1.00). 
However, there were no differences between groups (group-time interaction: F(1, 37) = 
1.3, P = .3, observed power = 0.20). Furthermore, IL-8 levels did not significantly change 
with time in both experimental groups (main effect of time: F(1, 48) = 2.2, P = .1, ob-
served power = 0.35) and no significant IL-8 differences between groups (group-time 
interaction: F(1, 37) = 2.8, P = .1, observed power = 0.37). 
The same applied for IL-10 levels, there were no significant change with time in both 
experimental groups (main effect of time: F(1, 39) = 2.6, P = .1, observed power = 0.36) 
and no significant differences between groups (grouptime interaction: F(1, 37) = 0.6, P = 
.4, observed power = 0.12).
There were no significant differences between groups in the amount of postoperative 
morphine and paracetamol used. The mean subcutaneous postoperative morphine 
administered in the general anesthesia group was 1.60 (±4.72 mg), while the mean 
given to the awake group was 2.00 (±5.48 mg). The mean postoperative paracetamol 
administered to the general anesthesia group was 2100 (±1483 mg), while the mean 
given to the awake group was 1900 (±1477 mg). 
Pain increased significantly with time in both experimental groups (main effect of time: 
F(2, 80) = 24.6, P < .001). However, a significant difference between groups (F(1, 35) = 7.6, 
P = .009) was noted with the awake group having less pain at the 12 hours postoperative 
time point (Figure 4). 
Anxiety significantly decreased with time in both experimental groups (main effect of 
time: F(2, 69) = 4.6, P = .013) and there was a significant stress decrease with time in both 
experimental groups (main effect of time: F(2, 85) = 7.9, P < .001).
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DisCUssion
We believe we are the first to compare the cytokine profiles of awake and general anes-
thesia craniotomy groups. Cytokine release is also a known physical reaction to tissue 
damage. The influence of surgery on cytokine plasma levels has been addressed during 
several studies. There is a great amount of evidence linking IL-6 to the degree of surgical 
trauma [17–22]. In addition, there are also studies that establish a clear relationship be-
tween dynamic IL-6 changes and cortisol plasma levels during the perioperative period 
[11,23]. The nonsignificant differences in IL-6 levels between groups found during this 
experiment suggest from an immunological perspective that both procedures are likely 
to be similarly stressful for the body. However, the low and medium observed power of 
our negative findings requires a larger patient group to provide more certainty.
It is interesting to note the significant plasma IL-6 increase despite the exact dexametha-
sone 4 × 4mg/day regime given to both experimental groups. Another study investigat-
Recently, plasma IL-8 has been measured as a key mediator for neuroinflammation in 
patients with severe traumatic brain injuries [27]. Central venous plasma IL-8 levels were 
significantly lower in survivors than in nonsurvivors. In our study, the insignificant in-
between- and within-subject plasma IL-8 change in both experimental groups was 
unexpected. Due to IL-8’s presence in neutrophils, microglia, astrocytes and endothelial 
cells of the brain [28–31] we expected damaged brain tissue to cause an increased release 
of IL-8 over time from these sources. However, the studies involving traumatic brain injury 
patients contain a different patient population then ours and different confounders. The 
additional hypoxia and ischemia experienced in these severely injured traumatic brain injury 
patients can be attributed to shock and resulting hypoperfusion and might account for 
increased plasma IL-8 levels [32].
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ing the effects of dexamethasone produced different results. Morariu et al. found that 
after receiving dexamethasone (1 mg/kg) before anesthesia induction, plasma levels of 
both IL-6 and IL-8 were significantly reduced, while levels of IL-10 increased periopera-
tively [24].
Our finding that there was a significant plasma IL-6 increase throughout time for 
both experimental groups and a significant increase in reported pain can be partially 
explained by the expected increase in pain after tissue damage. It is noteworthy that 
an increasing pain trend matches the increasing IL-6 tendency observed. The important 
role interleukin-6 plays in nociception and the pathophysiology of pain during a variety 
of different conditions might explain this trend [25]. A study done with rat models 
observed that higher IL-6 concentrations were linked to more intense hyperalgesia [26].
Recently, plasma IL-8 has been measured as a key mediator for neuroinflammation in 
patients with severe traumatic brain injuries [27]. Central venous plasma IL-8 levels 
were significantly lower in survivors than in nonsurvivors. In our study, the insignificant 
in-between- and within-subject plasma IL-8 change in both experimental groups was 
unexpected. Due to IL-8’s presence in neutrophils, microglia, astrocytes and endothe-
lial cells of the brain [28–31] we expected damaged brain tissue to cause an increased 
release of IL-8 over time from these sources. However, the studies involving traumatic 
brain injury patients contain a different patient population then ours and different con-
founders. The additional hypoxia and ischemia experienced in these severely injured 
traumatic brain injury patients can be attributed to shock and resulting hypoperfusion 
and might account for increased plasma IL-8 levels [32].
Awake craniotomy is considered a stressful procedure. It seems logical that being awake 
while a neurosurgeon removes pathological brain tissue would lead to a more intense 
emotional response than undergoing the same procedure under general anesthesia. 
However, perhaps good psychological support and active coping mechanisms may 
actually make awake craniotomy less stressful for the patient. This might be due to the 
awake group having decreased feelings of dependency and loss of control than those in 
the general anesthesia group.
Our results show that patients undergoing awake function-controlled craniotomy expe-
rience less 12 hours postoperative pain than their general anesthesia counterparts. The 
intensive preoperative consultation patients received might have influenced results due 
to the subjective nature of the VAS scoring system [33]. It could be argued that periop-
erative medication may also have influenced VAS score results. Patients who underwent 
awake function-controlled craniotomy received 25 mg of promethazine and 7.5 mg 
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of piritramide 30 minutes before surgery. In comparison, general anesthesia patients 
received 50mg of promethazine and two boluses of fentanyl, one prior to induction and 
another prior to placement of the Mayfield clamp. Piritramide and fentanyl are both 
opiates with additive sedative and euphoric properties. They are also accepted drugs 
for surgical procedures like craniotomy [34]. Additionally, the seven and six hours half 
life of piritramide and fentanyl make them unlikely to affect the first postoperative VAS 
score measurement taken at 12 hours postoperative [35, 36]. We think that the local an-
esthesia provided by bupivacaine infiltration at the site of scalp incision was the primary 
reason why VAS scores were significantly lower in the awake group.
The differing nature of awake craniotomy and general anesthesia techniques requires 
a larger amount opiates to be given to the general anesthesia group. There is some 
evidence that opiates can modulate the immune system [37–39]. However, our results 
reveal similar pro- and anti-inflammatory profiles for both groups with no significant 
difference having been found between groups. It is still important to consider that 
the larger opiate amount given to the general anesthesia group could have altered its 
immunological profile. However, the aim of this study is to compare the inflammatory 
profile of two different anesthesia techniques. General anesthesia cannot be performed 
without a greater amount of opiates being used by the anesthesiologist. 
The smaller amount of propofol administered to the awake group is due to the reduced 
need for sedation during the awake craniotomy procedure. On the other hand, the 
larger amount of crystalloids given to the general anesthesia group can be explained by 
the need to counteract the vasodepressive properties of propofol (Table 2).
A limitation of our study is that for ethical reasons allocation of patients to one group 
or another could not be randomized. This restriction could bias our results. However, 
keeping the previously mentioned limitations in mind, the plasma levels of pro- and 
anti-inflammatory cytokines measured during this study suggests that awake function-
controlled craniotomy does not cause a significantly different inflammatory response 
than craniotomy performed under general anesthesia. Furthermore, the nonsignificant 
difference in subjective outcome parameters for pain (with exception 12 hours post-
operative), anxiety, and stress insinuates that both procedures are equally mentally 
challenging. Therefore, it is likely that function-controlled craniotomy does not cause 
a greater inflammatory insult or emotional challenge than patients undergoing tumor 
resection using general anesthesia.
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AWAkE CRAniotomy inDUCEs fEWER ChAnGEs in thE PlAsmA Amino 
ACiD PRofilE thAn CRAniotomy UnDER GEnERAl AnEsthEsiA.
AbstRACt
In this prospective, observational, 2-armed study, we compared the plasma amino acid 
profiles of patients undergoing awake craniotomy to those undergoing craniotomy 
under general anesthesia. 
Both experimental groups were also compared with a healthy, age-matched, and 
sex-matched reference group not undergoing surgery. It is our intention to inves-
tigate whether plasma amino acid levels provide information about physical and 
emotional stress, as well as pain during awake craniotomy versus craniotomy under 
general anesthesia. Both experimental groups received preoperative, perioperative, and 
postoperative dexamethasone. The plasma levels of 20 amino acids were determined 
preoperatively, perioperatively, and postoperatively in all groups and were correlated 
with subjective markers for pain, stress, and anxiety. 
In both craniotomy groups, preoperative levels of tryptophan and valine were signifi-
cantly decreased whereas glutamate, alanine, and arginine were significantly increased 
relative to the reference group. Throughout time, tryptophan levels were significantly 
lower in the general anesthesia group versus the awake craniotomy group. The gen-
eral anesthesia group had a significantly higher phenylalanine/tyrosine ratio, which 
may suggest higher oxidative stress, than the awake group throughout time. Between 
experimental groups, a significant increase in large neutral amino acids was found 
postoperatively in awake craniotomy patients, pain was also less and recovery was 
faster. A significant difference in mean hospitalization time was also found, with awake 
craniotomy patients leaving after 4.53±2.12 days and general anesthesia patients after 
6.17±1.62 days; P=0.012. 
This study demonstrates that awake craniotomy is likely to be physically and emotion-
ally less stressful than general anesthesia and that amino acid profiling holds promise 
for monitoring postoperative pain and recovery.
Awake craniotomy induces fewer changes in the plasma amino acid profile than craniotomy under general anesthesia. 77
4
intRoDUCtion
General anesthesia using endotracheal intubation is the standard procedure during 
brain tumor resection; however, it does limit intraoperative monitoring of functional le-
sions made to the central nervous system. The anesthetic drugs used suppress neuronal 
activity making it impossible to monitor certain higher cortical brain functions unless 
the patient regains consciousness during the operation. Examples of higher cortical 
brain functions that can only be checked during awake craniotomy are speech, sensibil-
ity, and complex motor functions like drawing. Therefore, awake craniotomy is the ideal 
anesthetic approach for when function-controlled neurosurgery is necessary. During 
this procedure, the cerebral cortex of the awake patient is electrically stimulated identi-
fying and thus sparing functionally relevant areas of the brain. Details of our technique 
have been described previously.[1]
Public perception is that awake craniotomy is physically and emotionally more stressful 
than brain tumor resection under general anesthesia. However, with adequate local an-
esthesia and proper preoperative consultation patients undergoing awake craniotomy 
report less pain, discomfort and fear.[2,3] When proper steps are taken, the majority 
of patients tolerate awake craniotomy very well. In comparison, patients undergoing 
craniotomy using general anesthesia have to endure more physical stress factors like 
intubation, longer hospital stays, and artificial ventilation.[4]
Biochemical factors relating to stress and anxiety, the perception of pain, and the rate 
of postoperative recovery in neurosurgical patients have not been investigated. Cortisol 
levels have traditionally been used to indicate physical stress [5]; however, our standard 
operating procedure mandates the administration of dexamethasone, which influences 
cortisol levels. It was therefore decided to investigate whether or not plasma amino 
acids have potential to be used as biomarkers for pain and physical stress.
A number of amino acids play an important role in pain pathways. The neuropeptide 
bradykinin is known to increase sensitization of pain via the N-methyl-D-aspartate 
(NMDA) receptor in the central nervous system, which is turn, is stimulated by the amino 
acid glutamate.[6] The amino acid glutamine also plays a role in this pathway because 
it is the precursor for glutamate.[7,8] Glutamine, on the other hand, may inhibit the 
generation of the amino acid arginine, a precursor for nitric oxide (NO) and citrulline.
[9] Interestingly, the amino acid ratio of citrulline/arginine is used and accepted as an 
index of NO synthesis.[7] It is known that NO is a potent vasodilator. Less NO production 
causes vasoconstriction resulting in diminished tissue blood perfusion and increased 
pain intensity.[10]
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Glycine is an amino acid that acts as a coagonist with glutamate on the NMDA receptor.
[11] Both amino acids are thought to be mainly responsible for neuropathic pain and 
mood disorders.[12,13] 
Taurine is an amino acid known to play a significant role in neuromodulation.[14] Animal 
studies have shown that physical stress is associated with a sharp rise in plasma taurine 
levels.[15] It has also been demonstrated that taurine diminishes neuropathic nocicep-
tion.[16]
Current data about the effects of physical stress on large neutral amino acids (LNAAs), 
that is valine, leucine, isoleucine, tryptophan (trp), tyrosine (tyr), and phenylalanine (phe) 
are somewhat contradictory. A study performed with rats found that although rested 
rats had decreased plasma levels of valine and tryptophan, tyrosine levels increased.[15] 
Yet, patients undergoing cardiac surgery using general anesthesia had decreased levels 
of valine, leucine, isoleucine, and tyrosine, whereas tryptophan and phenylalanine levels 
increased.[17]
This is the first study to compare absolute plasma values of amino acids over time dur-
ing surgery between patient groups who received general anesthesia and patients who 
underwent an awake craniotomy procedure. Our aim was to determine whether or not 
the changes in plasma amino acid levels can be correlated to the type of anesthesia 
administered.
We also compared these plasma amino acid values to an age-matched and sex-matched 
reference group that did not undergo surgery. Furthermore, plasma amino acids were 
correlated with quality of life factors such as stress, anxiety, and pain.
When we compare the general anesthesia and awake craniotomy groups, we hypothe-
size that awake craniotomy patients will have fewer changes in their amino acid profiles 
while having a faster recovery and resulting shorter hospitalization time.
PAtiEnts, mAtERiAls, AnD mEthoDs
Study Set-up and Inclusion Criteria
This study was a prospective, single center, 2-armed observational study with 40 pa-
tients, stratified for sex. Sex stratification is necessary because there are known intersex 
differences in amino acid and hormone profiles.[18] The protocol was approved by the 
Medical Ethics Committee of the Erasmus Medical Centre, Rotterdam. All procedures 
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were performed in accordance with the Helsinki declaration. Written informed consent 
was obtained from all patients.
The patients were not randomized because allocation to an awake craniotomy proce-
dure or a general anesthesia group had to do with location of the tumour. The type 
or size (World Health Organization classification of brain tumours) had no influence 
on whether or not awake craniotomy was chosen. By proxy, patients were allocated 
to the general anesthesia group unless the location of the tumor warranted an awake 
procedure. Patients with tumors close to functional relevant areas like the motor cortex 
or areas related to speech require the awake monitoring made possible by the awake 
craniotomy procedure. By allocating these patients to the awake craniotomy group, 
maximal tumor resection is made possible with a minimal risk of functional neurological 
damage.[19]
Sex stratification was achieved by including consecutive patients to all groups until 
the maximum for a certain group (eg, women, awake) was achieved. Once a maximum 
number of patients for a particular group was attained, only patients belonging to one 
of the other still open groups (eg. man, general anesthesia) were included in the study.
Inclusion criteria were (1) undergoing craniotomy for a cerebral neoplasm situated in 
close proximity to an eloquent area, (2) age >18 years, (3) American Society of Anes-
thologists (ASA) classification I-III, and (4) written informed consent. Exclusion criteria 
were (1) ASA classification IV-V, (2) informed written consent missing, (3) tumor other 
than intracerebral, (4) surgery beginning later than 11:00 AM. (5) endocrine problems, 
or (6) taking drugs that influence endocrine metabolism. Operations starting after 11:00 
AM were excluded because Eriksson et al[20] found that essential amino acids are af-
fected by the circadian rhythm. Patients had the right to withdraw from the study at any 
time. Patients who developed serious adverse effects were to be withdrawn from the 
study. Examples of serious adverse effects include prolonged unconsciousness, severe 
bleeding requiring a blood transfusion, or any other event likely to strongly interfere 
with our protocol.
A healthy age-matched and sex-matched reference group was used to compare results 
obtained from the experimental groups. Blood plasma donors in this reference group 
donated blood after having had a light breakfast low in fat and protein. 
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Food Intake 
All patients were hospitalized the day before surgery. They were allowed to eat and drink 
until midnight. Afterward, only apple juice or tea with sugar were permitted until 06:00 
AM on the morning of surgery. Anesthesia was induced between 8:00 and 8:15 AM. 
After surgery, all the patients were transferred to the postanesthesia care unit (PACU) 
and monitored for 14 hours. During this time, morphine was available and if necessary 
titrated intravenously until acceptable pain levels were achieved. While in the PACU, 
patients were told that food could be requested and delivered at any time during their 
stay.
Anesthesia Procedure
Patients in both the groups received 1.5 mg lorazepam on the evening before surgery. 
Otherwise, all patients were on a regimen of dexamethasone 4x4 mg/d while regular 
personal drug regimens were continued. In the awake craniotomy group, 7.5 mg pir-
itramide and 25 mg promethazine was given 30 minutes before induction. Piritramide 
was used to reduce pain perception during skull infiltration with 40 mL bupivacaine 
0.375%+adrenaline 1:200,000. Benzodiazepines were not an option due to the paradoxi-
cal reactions that are sometimes associated with its use. In addition, benzodiazepines 
would reduce the responsiveness of propofol, making it less effective for sedation. In the 
group undergoing general anesthesia, the premedication consisted of 50 mg prometha-
zine. In both groups, propofol was used for sedation and remifentanil for analgesia. In 
the general anesthesia group, cis-atracurium was used for muscle relaxation.
Postoperative Pain Control
After surgery, patients were transferred to the PACU where they were monitored and 
primarily treated with paracetamol for pain. If pain control was not adequate, morphine 
was administrated until adequate pain control was achieved. Postoperative pain medi-
cation administered was documented.
General Outcome Measures
Patient demographics (Table 1) as well as perioperative characteristics were noted 
(Table 2). Quality of life was measured using the visual analog scale (VAS) for stress, pain, 
and anxiety preoperatively and at 12 and 24 hours postoperative (Table 3). Although 
there are overlapping elements relating to the concepts of stress and anxiety, VAS scores 
for each was obtained separately. 
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remifentanil used in the general anesthesia group was 8.4 mg whereas an average total 
bolus of 200 mcg was given to the awake group. 
Quality of Life Indicators 
The awake craniotomy group reported significantly less preoperative and postoperative 
VAS scores for anxiety than the general anesthesia group. The awake craniotomy group 
also disclosed having less pain postoperatively (Table 3). 
remifentanil used in the general anesthesia group was 8.4 mg whereas an average total 
bolus of 200 mcg was given to the awake group. 
Quality of Life Indicators 
The awake craniotomy group reported significantly less preoperative and postoperative 
VAS scores for anxiety than the general anesthesia group. The awake craniotomy group 
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Blood Sampling
Ethylene diamine tetra-acetate blood samples (7mL) for amino acid level determinations 
were collected preoperatively (t1), during opening (t2) and closing of the dura (t3), and 
12 (t4) and 24 (t5) hours postoperative. Plasma was isolated by centrifugation at 2650 
gmax for 20 minutes at 20 º C; samples were stored at -80º C until assay.
Plasma Amino Acid Level Determination
Blinded plasma amino acid determinations were performed. Each plasma sample was 
deproteinized with 5-sulphosalicylic acid (6%, wt/vol) containing norvaline and ho-
moserine as internal standards. Amino acids were assayed by high performance liquid 
chromatography using automated precolumn derivatization with o-phthaldialdehyde 
and fluorescence detection.[21] The amino acids measured were: the essential amino 
acids including the LNAAs tryptophan, valine, leucine, isoleucine, tyrosine, and phe-
nylalanine; as well as lysine, histidine, threonine, and methionine; and the nonessential 
amino acids (NEAAs) glutamate, glutamine, glycine, serine, taurine, asparagine, alanine, 
ornithine, arginine, and citrulline. The trp/LNAA ratio was calculated by dividing 100 
times the plasma concentration of trp by the sum of all other LNAAs. The phe/tyr ratio 
was calculated to estimate the functional availability of the cofactor tetrahydrobiopterin 
(BH4). Hydroxylation of phe to tyr is highly dependent on this cofactor.
The limits of detection depended on the amino acid because of the different fluores-
cence responses and differing peak shapes of the derivatives. Typical values were 54 
fmol for glutamate and 167 fmol for serine. Concentrations of amino acids as low as 0.5 
mmol/L in plasma can be measured accurately with our method. The interassay coef-
ficient of variation was for all amino acids below 4%.
Statistical Analysis
Data were analyzed using SPSS for Windows, version 12.0.1. The Kolmogorov-Smirnov 
test was used to analyze whether or not amino acids values were normally distributed. 
All amino acid values except glutamic acid measured at time points 1, 3, 5, and taurine 
4 were normally distributed. 
For the non-normal distributed values, we still decided to use multivariate analysis of 
variance (MANOVA) test. Although MANOVA test requires that each dependent variable 
entered into the analysis be normally distributed it was still used because the Monte 
Carlo experiments have shown that for sample sizes of 3 or 5 it is still possible to analyze 
leptokurtic, rectangular, J-shaped, moderately, and markedly skewed distributions. 
These experiments demonstrated that the empirically determined rejection region of 
the F-distribution would be no larger than a=0.08 when the usual 5% rejection is used.
[22] The results are therefore presented as mean±standard deviation (SD).
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Differences in plasma amino acid levels between experimental groups across all time 
points (5 moments of time) and interaction between experimental group and time were 
analyzed using multivariate repeated measures. Experimental group and time were the 
independent variables.
When a significant difference was found between experimental groups, a 1-way ANOVA 
test with post hoc multiple comparisons (Bonferroni correction) was used to analyze the 
relationship between plasma amino acids and time from the moment of plasma dona-
tion until 24 hours after donation. The same statistical method was employed to analyze 
differences between preoperative and 24-hour postoperative plasma amino acid levels 
in the 2 experimental groups.
Differences relating to patient demographics (excluding ASA classification), periopera-
tive characteristics and preoperative plasma amino acid levels between experimental 
groups were tested using the t test for independent samples. This same test was used 
to compare the mean amount of postoperative analgesia given as well as the mean 
number of days until discharge for both experimental groups. Pearson χ2 test was used 
to evaluate differences in ASA classification.
Correlations between patient characteristics, amino acids, and the quality of life mea-
sures were evaluated using Pearson correlation test. Sample size was calculated using 
the MANOVA repeated measures test. An effect size of 0.6 was used and a power of 
0.8. There were 2 experimental groups and 5 repetitions. The required a priori sample 




A total of 40 patients were included in the study with 20 being allocated to both groups. 
The 2 groups of 20 were stratified for sex (10 males and 10 females). No intergroup 
differences were observed for age, length, weight, ASA classification, or hemoglobin 
concentration (Table 1).
Perioperative Characteristics
Perioperative characteristics are shown in Table 2. The total amount of propofol admin-
istered throughout the operation was significantly less in the awake craniotomy group. 
Total operating time in the awake craniotomy group was also less. The general anesthe-
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sia group had more blood loss, higher urine output, and as a result received significantly 
more crystalloids during the operation. The average total amount of remifentanil used in 
the general anesthesia group was 8.4 mg whereas an average total bolus of 200 μg was 
given to the awake group.
Quality of Life Indicators
The awake craniotomy group reported significantly less preoperative and postoperative 
VAS scores for anxiety than the general anesthesia group. The awake craniotomy group 
also disclosed having less pain postoperatively (Table 3).
Recovery, Food Intake, and Hospitalization
Both the patient groups were offered food postoperatively during recovery in the PACU. 
All awake craniotomy patients requested and received their first meals within 12 hours 
of surgery. As a result, the awake craniotomy patients had blood taken (t3) after their first 
meal. All the patients in the general anesthesia group, however, requested and had their 
first meal after the12 hours postoperative blood sample (t3) was taken. Consequently, 
the general anesthesia group had blood taken before their first meal. 
From the moment of arrival in the intensive care until 24 hours postoperative, all the 
patients were offered 4 times 1 gram paracetamol, and if required, nurses titrated IV 
morphine until acceptable pain levels were achieved. There was no significant differ-
ence found between both groups in postoperative morphine and paracetamol use. 
The mean postoperative morphine administrated in the general anesthesia group was 
1.60±4.72 mg, whereas the mean given to the awake group was 2.00±5.48 mg; P=0.806. 
The mean postoperative paracetamol administered to the general anesthesia group 
was 2100±1483 mg, whereas the mean given to the awake group was 1900±1477 mg; 
P=0.668.
A significant difference in mean hospitalization time was also found. Awake craniotomy 
patients left the hospital after an average of 4.53±2.12 days. Patients in the general 
anesthesia group left on average after 6.17±1.62 days; P=0.012. 
Preoperative Plasma Amino Acid Levels
We detected no differences in the preoperative plasma amino acid levels between 
craniotomy groups (Tables 4 and 5); therefore, anesthesia procedure assignment did not 
affect preoperative amino acid levels. However, significant preoperative sex differences 
were observed for glutamate (males, 104±47 mmol/L; females, 73±44 mmol/L; P=0.040) 
and tryptophan levels (males, 36±8.1 mmol/L; females, 30±9.1 mmol/L; P=0.037). 
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There are significant differences in the preoperative and postoperative levels of a num-
ber of amino acids when comparing the experimental groups with the reference group 
(Tables 4 and 5). Preoperative fasting could have influenced these levels. However, when 
comparing the plasma amino acid levels of experimental groups to the reference group 
at the 24-hour postoperative time point when fasting is not a problem, it was found that 
the general anesthesia group still had decreased levels of tryptophan and ornithine. 
In addition, postoperative levels of lysine, arginine, glutamate, and alanine were still 
increased in both experimental groups.
At t5, citrulline and phenylalanine are worth noting. Citrulline is decreased in both 
experimental groups in comparison to the reference group, whereas the inverse was 
true for phenylalanine. 
Time-related Effects of Anesthesia and Surgery
We analyzed the time-related effects of anesthesia and surgery on the plasma levels 
of amino acids. Figure 1 shows the plasma levels of tryptophan and the other essential 
LNAAs. During anesthesia/surgery, both experimental groups demonstrate a similar 
affect preoperative amino acid levels. However, significant preoperative sex differences 
were observed for glutamate (males, 104±47 mmol/L; females, 73±44 mmol/L; P=0.040) 
and tryptophan levels (males, 36±8.1 mmol/L; females, 30±9.1 mmol/L; P=0.037).  
There are significant differences in the preoperative and postoperative levels of a number 
of amino acids when comparing the experimental groups with the reference 
group (Tables 4 and 5). Preoperative fasting could have influenced these levels. However, 
when comparing the plasma amino acid levels of experimental groups to the reference 
group at the 24-hour postoperative time point when fasting is not a problem, it was found 
that the general anesthesia group still had decreased levels of tryptophan and ornithine. In 
addition, postoperative levels of lysine, arginine, glutamate, and alanine were still increased 
in both experimental groups. 
At t5, citrulline and phenylalanine are worth noting. Citrulline is decreased in both 
experimental groups in comparison to the reference group, whereas the inverse was true 
for phenylalanine.  
Time-related Effects of Anesthesia and Surgery 
We analyzed th  ime-related effects of anesthesia and surger  on t e plasma levels of 
amino acids. Figure 1 shows the plasma levels of tryptoph n and the other ssential 
LNAAs. During anesthesia/surgery, both experimental groups demonstrate a similar decline 
in plasma tryptophan levels. However, worth noting is that tryptophan levels were 
significantly lower in the general anesthesia group when compared with the awake 
craniotomy group both during anesthesia/surgery and 12 hours postoperatively. 
Figure 1 also shows a plot of the phenylalanine/tyrosine ratio. The ratios before and at the 
start of surgery are remarkably elevated for both groups when compared with our healthy 
nonsurgical reference group. The ratio then peaks at the end of surgery. However, 
postoperatively both experimental groups experience a considerable drop to levels similar 
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decline in plasma tryptophan levels. However, worth noting is that tryptophan levels 
were significantly lower in the general anesthesia group when compared with the 
awake craniotomy group both during anesthesia/surgery and 12 hours postoperatively.
Figure 1 also shows a plot of the phenylalanine/tyrosine ratio. The ratios before and 
at the start of surgery are remarkably elevated for both groups when compared with 
our healthy nonsurgical reference group. The ratio then peaks at the end of surgery. 
to the healthy reference group. It is worth noting that throughout time, the general 
anesthesia group has a significantly higher ratio then the awake group (P=0.016). 
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However, postoperatively both experimental groups experience a considerable drop to 
levels similar to the healthy reference group. It is worth noting that throughout time, 
the general anesthesia group has a significantly higher ratio then the awake group 
(P=0.016).
The rest of the LNAAs show a general trend with a major increase occurring postop-
eratively, except, a faster increase with significantly higher LNAA levels is noted in the 
awake craniotomy patients. This reflects the faster recovery awake craniotomy patients 
experience during their first 12 hours in the PACU.
The levels of NMDA receptor-related NEAAs glutamate, glutamine, and glycine 
are presented in Figure 2. Glutamate and glutamine exhibited time dependent level 
changes, although no group differences were found. On the contrary, glycine showed 
no significant time dependent or group differences.
Plasma levels of endothelium-related NEAAs arginineand citrulline demonstrated a 
time-dependent decline but there were no intergroup differences (Fig. 3).
The rest of the LNAAs show a general trend with a major increase occurring 
postoperatively, except, a faster increase with significantly higher LNAA levels is noted in 
the awake craniotomy patients. This reflects the faster recovery awake craniotomy patients 
experience during their first 12 hours in the PACU. 
The levels of NMDA receptor-related NEAAs glutamate, glutamine, and glycine are 
presented in Figure 2. Glutamate and glutamine exhibited time dependent level changes, 
although no group differences were found. On the contrary, glycine showed no significant 
time dependent or group differences.
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Correlations Between Patient Characteristics, Amino Acid Levels, and Quality of Life
Preoperative stress and anxiety were correlated to each other (r=0.77, P<0.001). How-
ever, none of the quality of life factors like stress, anxiety, and pain related to amino acid 
levels. Additionally, levels of citrulline (r=0.40, P=0.011), serine (r=-0.53, P=0.001), and 
methionine (r=-0.38, P<0.001) were found to be related to patient age.
DisCUssion
Pain and Amino Acids
As is expected after surgery, pain is significantly increased 12 hours postoperatively in 
both groups. However, this increase was significantly greater in the general anesthesia 
group. Anxiety and stress, however, declined similarly for both groups (Table 3).
The subjective nature of pain could explain why the awake craniotomy group reports 
feeling less postoperative pain than the general anesthesia group. Administration of 
postoperative pain medication cannot be a factor because in both groups no significant 
difference in the amount of pain medication given was found. Intensive preoperative 
consultation might have helped reduce fear in the awake group by giving patients the 
opportunity to know what to expect during and after the operation.[23] It is also possible 
Correlations Between Patient Characteristics, Amino Acid Levels, and Quality of Life 
Preoperative stress and anxiety were correlated to each other (r=0.77, P<0.001). However, 
none of the quality of life factors like stress, anxiety, and pain related to amino acid levels. 
Additionally, levels of citrulline (r=0.40, P=0.011), serine (r=-0.53, P=0.001), and methionine 
(r=-0.38, P<0.001) were found to be related to patient age. 
Discussion
Pain and Amino Acids 
As is expected after surgery, pain is significantly increased 12 hours postoperatively in both 
groups. How ver, this increase was significantly greater in the general anesthesia group. 
Anxiety and tress, however, d clined imilarly for both groups (Table 3). 
The subjective nature of pain could explain why the awake craniotomy group reports feeling 
less postoperative pain than the general anesthesia group. Administration of postoperative 
pain medication cannot be a factor because in both groups no significant difference in the 
amount of pain medication give  was found. Int sive preopera ive consultation might have 
helped reduce fear in the awake group by giving patients the opportunity to know what to 
expect during and after the operation.[23] It is also possible that postoperative pain might 
have been lessened by the 7.5 mg of piritramide given to the awake craniotomy group, 
although the 7-hour half life of piritramide and relatively low dosage makes this less 
likely.[24] A synergistic effect with remifentanil given during surgery is also not very likely 
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that postoperative pain might have been lessened by the 7.5 mg of piritramide given to 
the awake craniotomy group, although the 7-hour half life of piritramide and relatively 
low dosage makes this less likely.[24] A synergistic effect with remifentanil given dur-
ing surgery is also not very likely considering the remifentanil half life of 3 minutes.[25] 
In retrospect, although selectively giving piritramide to the awake craniotomy group 
inorder to make scalp infiltration more bearable might be a confounder, we think the 
confounding influence is limited considering that around the same time a much more 
than equivalent dose of opioids is given for the purpose of anesthesia induction in the 
general anesthesia group.
In both craniotomy patient groups, plasma glutamine levels decreased 24 hours postop-
eratively (Fig. 2). Despite the administration of analgesics, patients reported mild pain. 
Reduced levels of plasma glutamine have also been found in burn patients, for whom 
immunologic function and wound healing are the most prominent issues, in addition 
to pain.[26] Preoperative levels of plasma glutamate were significantly elevated in both 
patient groups as compared with our healthy reference group (Fig. 2). Pain perception 
was not determined at that time, but patients with brain tumours generally have little 
or no preoperative pain. Preoperative stress and anxiety were mild to moderate in the 
general anesthesia groups and were lower in the awake group (Table 3). Although not 
significant, plasma glutamate was 15% lower in the awake craniotomy group, suggest-
ing that physical stress and anxiety might influence levels of the NMDA receptor-related 
glutamate. Lastly, glutamate levels in the general anesthesia group are noteworthy 
because it has previously been reported that propofol causes a reversible increase in 
plasma glutamate.[27] We were not able to confirm this trend.
Sex, Age, and Amino Acids
As Table 1 shows, observed differences between groups cannot be accounted for by sex, 
however, glutamate and tryptophan were an exception. They were found to be greater 
in males then in females. Age was positively correlated with preoperative levels of ci-
trulline, suggesting that more NO formed in older individuals. Nonetheless, serine and 
methionine were negatively correlated with age. These findings agree with data from 
aging studies[18,28,29] and suggest altered uptake and/or production with advancing 
age. However, the levels of these amino acids did not undergo significant changes dur-
ing surgery or anesthesia.
Effects of Premedication, Fasting, Stress, and Anxiety
Dexamethasone, a selective glucocorticoid-receptor antagonist, has been found to 
increase plasma levels of glutamate, glutamine, and alanine.[30] On the contrary, both 
tryptophan and tryrosine are diminished after administration of dexamethasone.[31] In 
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this study when comparing to the reference group, preoperative levels of glutamate 
and alanine are indeed increased, although glutamine showed no significant changes. 
Preoperative fasting probably affects plasma amino acid levels. A limitation of our study 
is that our reference group was not fasted. This influenced the level of essential amino 
acid levels as illustrated in Figure 1. Preoperatively, levels of essential amino acids in 
both experimental groups were in all cases, with exception of phenylalanine, lower than 
in our reference group.
In rats, fasting plus physical stress reduces the plasma levels of the NEAAs alanine and 
arginine whereas increasing glutamate and glutamine.[32] However in our patients, 
plasma levels of alanine, arginine, and glutamate were increased.
Time-related Effects of Surgery and Anesthesia
It is known that surgery can cause a decline in fasting plasma levels of alanine, arginine, 
glutamate, glutamine, and glycine relative to fasting control groups not undergoing sur-
gery.[33] In another study involving patients undergoing thoracic surgery, perioperative 
plasma levels of tryptophan, glutamine, glycine, and arginine declined rapidly, whereas 
the levels of valine, leucine, and phenylalanine were slightly or not affected.[34] A study 
with patients experiencing abdominal aortic aneurysm surgery had glutamine levels 
decline and remain below preoperative levels for at least 7 days.[35]
Results from this study reveal that only levels of tryptophan are lower during surgery. An 
additional anesthesia-dependent effect was demonstrated by tryptophan levels being 
significantly lower in the general anesthesia group. This observation agrees with those 
of Nunn et al[36] who found a 15% reduction in plasma tryptophan after short-term 
routine surgery (mean duration 88 min).
Recent research has revealed a remarkable stress mechanism likely to explain the levels 
tryptophan and phe/tyr ratios found in Figure 1. Stress induces the enzyme indole 
amine dioxygenase responsible for metabolizing the amino acid tryptophan via the kyn-
urenine pathway.[37] This causes a decrease of available tryptophan in blood plasma. 
Our results confirm this with the general anesthesia group having a more significant 
reduction in tryptophan than the awake craniotomy group. Furthermore, it is known 
that oxidative stress causes a decrease in the cofactor BH4. This cofactor is necessary for 
the production of serotonine, dopamine, NO, and the conversion of phenylalanine (phe) 
into tyrosine (tyr).[38]
Therefore, the phe/tyr ratio serves as a reflection of the cofactor BH4 concentration. 
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The phe/tyr ratio shown in Figure 1 nicely symbolizes expectations before, during and 
after surgery. In comparison with our healthy reference group the ratio for both experi-
mental groups is increased pre-operatively. At the end of surgery the ratios peak, a time 
when the body has experienced the maximum amount of physical stress. Twelve hours 
post-operatively, levels are drastically reduced being lower than pre-operative levels 
and close to levels found in our healthy reference group. Throughout time, the general 
anesthesia group has significantly higher ratios than the awake group suggesting that 
this group experienced higher levels of oxidative stress. 
NO
The results show a marked preoperative increase in arginine levels in the two ex-
perimental groups with a decrease after surgery but still being increased 24 hours 
postoperatively relative to our reference group. Considering that citrulline is a marker 
of NO synthesis, the continuous decline of this amino acid could indicate diminished 
postoperative c-GMP-dependent vasodilatation. If so, this would result in diminished 
tissue blood distribution and the spread of pain.[10]
ConClUsions
Preoperative plasma levels of all LNAAs, with the exception of phenylalanine, were 
decreased in craniotomy patients when compared to levels in our reference group. On 
the contrary, the NEAAs glutamate, alanine and arginine were markedly increased prior 
to surgery. Only tryptophan, the precursor of serotonin, decreased significantly during 
general anesthesia and surgery. 
The phe/tyr ratio needs additional study in order to establish whether it can be used 
as a molecular marker for emotional and/or physical stress. Furthermore, patients un-
dergoing awake craniotomy showed rapid postoperative improvement, as displayed by 
a faster and significant increase in plasma LNAA levels and shorter hospital discharge 
times. This fits with our clinical impression that these patients experience less periopera-
tive physical stress than patients undergoing general anesthesia. 
This study indicates that amino acid profiling holds promise as an extra physiological 
tool that could potentially help monitor postoperative recovery. Therefore its value for 
monitoring surgery-induced stress and pain should be investigated further. In future 
studies, levels of kynurenine will also be determined along with tryptophan to unravel 
more direct changes in the activity of indoleamine dioxygenase during surgical stress.
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AWAkE CRAniotomy: imPRovinG thE PAtiEnt’s ExPERiEnCE.
AbstRACt
Purpose of review
Awake craniotomy patients are exposed to various stressful stimuli while their attention 
and vigilance is important for the success of the surgery. We describe several recent find-
ings on the perception of awake craniotomy patients and address nonpharmacological 
perioperative factors that enhance the experience of awake craniotomy patients. These 
factors could also be applicable to other surgical patients.
Recent findings
Proper preoperative counseling gives higher patient satisfaction and should be indi-
vidually tailored to the patient. Furthermore, there is a substantial proportion of patients 
who have significant pain or fear during an awake craniotomy procedure. There is a 
possibility that this could induce post-traumatic stress disorder or related symptoms.
summary
Preoperative preparation is of utmost importance in awake craniotomy patients, and 
a solid doctor–patient relationship is an important condition. Nonpharmacological 
intraoperative management should focus on reduction of fear and pain by adaptation 
of the environment and careful and well considered communication.
keywords
awake craniotomy, communication, patient management, patient satisfaction
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intRoDUCtion
An awake craniotomy remains an intriguing procedure for the anaesthesiologist, as the 
need for prolonged active cooperation of the patient during a surgical intervention 
is quite unique. Thereby awake craniotomy stands in stark contrast to other regional 
anaesthetic techniques in which the patient (or the procedure) profits from a passive 
cooperation or reduced consciousness of the patient. The need of prolonged vigilance 
of the patient comes at a price because the patient is exposed to a range of stress factors 
on different domains and with various intensities. These stress factors range from the 
diagnosis of a malignant brain tumor and hospital admittance up to the experience of 
fear, pain and the discomfort of the positioning on the OR-table [1]. Pain during the 
procedure ranges from mild pain in 14–56% of the patients to severe pain in 5–20% 
[2,3]. Incidence of anxiety and fear during the procedure also has been assessed in 
several studies, and ranges from 5 to 50% of the patients [2,4,5]. The overall experience 
of patients during the procedure has recently been extensively reviewed elsewhere [6]. 
Although the short-term response of patients who underwent an awake craniotomy 
is largely very positive, it comes as no surprise that patients can even exhibit post-
traumatic stress disorder symptoms directly attributable to the procedure itself [7]. 
In the recent literature that evaluates the patient’s perception of the awake craniotomy, 
only a few articles explicitly mention the role of the anaesthesiologist during the preop-
erative phase [4,8,9]. This may reflect local practice or the relationship between anaes-
thesiologists and neurosurgeons. However, we believe that the success of this procedure 
is made as a team effort. Therefore, we see a crucial role for the anaesthesiologist, being 
responsible for the vital functions of the patient and creating conditions that enable the 
neurosurgeon to perform a smooth tumor resection with a cooperative and unstressed 
patient. Previous reviews on awake craniotomy in this journal focused on the feasibility 
and safety of the procedure and medical and pharmacological aspects [10–13]. In this 
review, we want to highlight techniques and measures that the anaesthesiologist can 
apply to optimize the patient’s experience. The studies we refer to were not exclusively 
performed in patients undergoing awake craniotomies, but also in other clinical set-
tings. However, we are convinced that many of these findings can be transferred to the 
awake craniotomy patient as well. 
PREoPERAtivE CoUnsElinG AnD PREmEDiCAtion
The psychological effect of preoperative counseling by the anaesthesiologist has been 
proven for decades [14]. Although straightforward at first sight, counseling can bring 
along several possible conflicting interests [15]. General aspects that are important dur-
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ing the preoperative counseling are listed in Table 1. Here, we emphasize certain aspects 
in this process that are important during the counseling of awake craniotomy patients.
More than for any other procedure, a trustful, solid doctor–patient relationship between 
the anaesthesiologist who carries out the procedure and the patient is mandatory for a 
successful awake craniotomy. A personal relationship is in the patient’s perspective one 
of the most essential aspects of the premedication visit as found in a general preopera-
tive population [16]. The authors emphasize the anxiolytic aspect of the premedication 
visit and the desire for patients to build a personal doctor–patient relationship. This 
is understandable because patients experience the perioperative process as a loss of 
control and ‘giving up’ to strangers. Aust et al. [16] describe that patients cope with 
this process by focusing their own fear and uncertainty onto the person(ality) of the 
physician, giving the patient a strategy to direct his emotions. Keeping emotions under 
control has been described as an important psychological factor in awake craniotomy 
patients [1]. This is supported by other studies, which found that ‘the key element of 
patient satisfaction’ is ‘spending time establishing a trusting alliance’ [17].
There is a controversy going on to what extent and what level of detail the patient has to 
be preoperatively counseled in preparation for the surgical procedure. There are sugges-
tions that proper counseling before the procedure alleviates anxiety before and during 
the operation [18], especially with other forms of information provision such as short 
films [19]. In a large interview study, the need for information was assessed in patients 
planned for noncardiac surgery. Generally, patients were satisfied with the information 
from the anaesthesiologist, but there is a relatively large proportion of patients that 
either have more or less need of preoperative information. ASA-score, education and 
quality of life were independent predictors for the need of information. This underlines 
the amount and kind of information needs to be tailored to the individual patient [20]. 
It is unknown whether the extent of the surgical procedure plays a role in the informa-
tion needs; one could argue that the need for information in patients undergoing an 
awake craniotomy is considerably larger, given the invasiveness and the character of the 
procedure. Shaping perceptions, managing expectations and preventing surprises by 
preoperative counseling are listed in Table 1. Here, we emphasize certain aspects in this 
process that are important during the counseling of awake craniotomy patients. 
More than for any other procedure, a trustful, solid doctor–patient relationship between the 
anaesthesiologist who carries out the procedure and the patient is mandatory for a 
successful awake craniotomy. A personal relationship is in the patient’s perspective one of 
the most essential aspects of the premedication visit as found in a general preoperative 
population [16]. The authors emphasize the anxiolytic aspect of the premedication visit and
the desire for patients to build a personal doctor–patient relationship. This is 
understandable ecause patients experience the perioperative process as a loss of c ntr l 
and ‘giving up’ to strangers. Aust et al [16] d scribe that patients cope with this pr c ss by 
focusing their own fear and uncertainty onto the p rson(ality) of the physician, giving e 
atient a strate y to direct hi  emotions. K eping emoti  under contr l ha  been 
described as an important psychological factor in awake craniotomy patients [1]. This is 
supported by other studies, which found that ‘the key element of patient satisfaction’ is
‘spending time establishing a trusting alliance’ [17].
There is a controversy going on to what extent and what level of detail the patient has to be 
preoperatively counseled in preparation for the surgical procedure. There are suggestions 
that proper counseling before the procedure alleviates anxiety before and during the 
operation [18], especially with other forms of information provision such as short films [19]. 
In a large interview study, the need for information was assessed in patients planned for 
noncardiac surgery. Generally, patients were satisfied with the information from the 
anaesthesiologist, but there is a relatively large proportion of patients that either have more 
or less need of preoperative information. ASA-score, education and quality of life were 
independent predictors for the need of information. This underlines the amount and kind of 
information needs to be tailored to the individual patient [20]. It is unknown whether the 
extent of the surgical procedure plays a role in the infor ation needs; one could argue that 
the need for information in patients undergoing an awake craniotomy is consider bly larger, 
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detailed descriptions seem important to prevent an acute psychological stress reaction 
or the acute withdrawal of the consent of the patient before or during the procedure. 
It is important to be aware of possible ’side-effects’ of a too detailed preoperative 
information, leading to a nocebo effect: the expectation of a negative outcome that 
could precipitate or exacerbate the corresponding symptom [21]. Nonetheless, besides 
psychological preparation, there is a legal obligation to inform patients about risks and 
complications because the preoperative consult has to end with the informed consent 
of the patient. Seemann et al. [22] describe several strategies that could be used to pre-
vent a nocebo effect. The first one is ‘linking’, which is the strategy to describe risks with 
possible benefits. An example of linking could be the description of the placement of an 
arterial line. Pain and a hematoma are possible side-effects, but these are rare and well 
justified against the fact that it helps to keep the patient safely and closely monitored 
during the procedure. The second strategy could be the explanation of measures that 
are taken to prevent complications and the treatment options in case of a complication. 
In general, it is important to empower the own responsibility and the autonomy of the 
patient with the aim to improve active cooperation and to reduce complications. How-
ever, personal experience shows that a significant number of patients – despite all active 
engagement during the neuromonitoring – feels fine with being directed through the 
procedure by the anaesthesiologist. This will work out much smoother if patient and 
anaesthetist do not meet for the first time on the OR table. 
Brain tumors can affect different brain functions, both simple and complex. Quality (e.g. 
executive functions, emotion and cognition) and quantity of the disruptions depend 
on the localization and the histology of the tumor. Recent work shows that patients 
suffering from temporal lobe gliomas have impaired neurocognitive functions. It is 
important to realize that these patients have difficulties or disruption of learning and 
memory, attention and executive functions [23]. More subtle changes such as changes 
of personality or disruption of social interaction and social cognition have also been 
described. These changes can be caused not only by the tumor, but also by the surgi-
cal intervention [24]. In the perioperative process, the anaesthesiologist needs to be 
aware of these possible alterations of the higher brain functions because they can 
interfere with the patient’s cooperation during the procedure. Furthermore, the patient 
and family members should be informed about the possible effects of surgery, like the 
previously described personality changes. Data on postoperative quality of life is grow-
ing, and this enables better patient education and management of expectations after 
surgery. Recent studies addressed not only fatigue, mood and cognitive dysfunction 
[25] but also sexual dysfunction [26]. 
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Besides nonpharmacological interventions mentioned above, pharmacological inter-
ventions could be of use to reduce anxiety and fear and optimize the patient’s vigilance 
during the procedure. Benzodiazepines and especially midazolam are the most used 
group of drugs in awake craniotomy patients, but there are many studies that do not use 
any premedication at all (e.g. [3,27]). There is accumulating evidence that the use of ben-
zodiazepines is not necessarily beneficial in awake craniotomy procedures. Drawbacks 
are respiratory depression (especially in combination with opioids given during the 
procedure), paradoxical agitation and interference with electro cortical recordings [28]. 
It was recently shown in general surgery patients that sedative premedication did not 
improve patient satisfaction or preoperative anxiety [29]. The use of benzodiazepines is 
also associated with a higher occurrence of postoperative delirium [30]. The use of other 
agents like clonidine, promethazine and dexmedetomidine as preoperative sedatives 
is also common and at least partially understandable considering the pharmacological 
profiles. Nevertheless, higher evidence supporting the use of these drugs is lacking. 
intRAoPERAtivE mAnAGEmEnt
Intraoperative awareness is indispensable in patients undergoing an awake craniotomy 
procedure. Phases of the operation that leaves the most significant memory are the 
positioning, the fixation in the Mayfield clamp and the craniotomy itself [1]. Given the 
results from research on perioperative pain, comfort, anxiety and the postoperative 
satisfaction, there is still ample room for improvement during the procedure.
Karlsson et al. [31] systematically interviewed patients under spinal anaesthesia. Patients 
experience a feeling of being left out and feel that they have no control, which they 
counterbalance by communication either way by eye contact or verbal communication. 
To improve eye contact and communication, we recommend that the drapes are placed 
carefully so that the patient can keep a certain field of vision and eye contact with at least 
the anaesthesia team and the neuropsychologist. If transparent drapes and blankets are 
used, even eye contact with the surgeon can easily be established and the patient might 
feel less claustrophobic. Although described first almost 40 years ago as an improve-
ment for the anaesthesiologist and the surgeon [32], the idea is still not widespread.
In general, VAS scores during the awake craniotomy procedure are below the accept-
able range of 4 of 10 (see [3,5]). However, there are significant numbers of patients who 
experience discomfort because of pain during the procedure [7]. This pain is not only 
because of the surgical intervention but also the continuous pressure on the lower parts 
of the body due to the positioning on the table. A simple measure that could improve 
the tolerance of patients is to do a preoperative ‘practice run’ [33]. Patients should also 
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be encouraged to practice this at home (e.g. lying on the floor, not moving, letting 
others scratch on their itching nose) to identify possible pressure points, to cope with 
unpleasant sensations and to get better used to lying on the OR-table without too much 
spontaneous movements.
Preoperative fasting could also lead to perioperative discomfort. In concordance with 
European guidelines [34] it is well tolerated to drink clear fluids 2h before surgery. In 
our practice, we reduced the fasting period to 1h without any perioperative complica-
tions. Because caffeine withdrawal has been identified as a major cause of postopera-
tive headache in fasted patients undergoing general anaesthesia, especially in awake 
craniotomypatients who are used to a morning cup of coffee, patients should drink it on 
the day of the procedure as well, to prevent this withdrawal headache [35]. To prevent 
a dry mouth, we use lemon glycerin swabs, although they have not been investigated 
in patients undergoing regional anaesthesia. In tobacco-addicted patients, we do not 
restrict smoking prior to the surgery. Although tobacco use is associated with various 
perioperative complications [36], acute nicotine withdrawal could lead to undesired 
side-effects like coughing or stress during the procedure. The question whether nicotine 
affects gastric emptying is also under debate [37].
It is at least questionable whether patients with an extremely high level of preoperative 
anxiety (panic) should undergo an awake craniotomy. In any case, perioperative psy-
chological decompensation must be prevented. Continuous eye and verbal contact 
(’vocal anaesthesia’) during the procedure could reduce feelings of helplessness [31,38], 
and some patients could benefit from physical contact with one of the members of the 
treating team, for example by holding the patient’s hand [33]. Physical contact serves 
two ways: on one hand it can give guidance to patients, on the other hand it can serve 
as a monitor that helps to detect stress quite early [22]. Inviting family members to 
support their relatives during the procedure on the OR table could also be considered, 
naturally in children [39] but under some circumstances also in adults. Whittle and Lim 
[40] described three patients in whom their relatives provided crucial support during 
the procedure; however, all family members had nursing qualifications. 
Patients describe noise as one of the most disturbing factors during the procedure 
[1,9,15]. Noise could arise from different sources, ranging from OR personnel to the 
surgical drill, and has an intensity of up to 120 dBA [41]. In non-neurosurgical patients, 
noise was experienced as annoying, disruptive and stressful. There was no correlation 
between the actual sound level and the perception of noise, which leaves the recom-
mendation to keep noise levels as low as possible [42]. A strategy to prevent the impact 
of ambient noise is ‘reframing’ disturbing noises such as reframing the noise of a surgical 
drill to that of the motorcycle [9].
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Another intervention is the application of music. In patients under loco regional anaes-
thesia, music led to lower anxiety scores, higher postoperative patient satisfaction and 
better sedation of patients [43–45]. Recently, the effect of music was also assessed in 
awake craniotomy patients in which the same results have been found [46& ]. Interest-
ingly, patients reported here that music acted as a distraction from the actual surgical 
procedure. 
To conclude, the anaesthesiologist can exert great influence by means of communica-
tion. There are two important aspects of communication. First, it is important to avoid 
negative suggestions. Although much used in the perioperative process and used with 
a good intention, these suggestions can lead to a higher experience of anxiety and pain 
[47] and lead to a nocebo effect [48]. As patients have a higher level of attention, it is 
not only important for the anaesthesiologist to refrain from negative suggestions like 
misinformation, denial or suggestive questions, but for the whole team to be attentive 
of their verbal and nonverbal communication. 
Reframing negative suggestions into positive suggestions is therefore an important 
other aspect. Positive suggestions have been shown to decrease pain, anxiety and the 
use of analgesics [49]. Positive suggestions show overlap with hypnotic techniques 
and can help patients to regain their own responsibility and use their own resources to 
reduce stress and anxiety [47,50].
The domain of positive suggestions can be extended to hypnotherapeutic techniques. 
These techniques are an example of a coping strategy for patients and have been suc-
cessfully used in awake craniotomy patients [9]. In short, patients are invited to imagine 
another place and situation, and the anaesthesiologist can encourage and invite patients 
to explore and revive these thoughts, resulting in a form of dissociation. Seemann et al. 
refer to this as a ‘safe place’ in which the patient can retreat, which is left to the patient’s 
imagination. An example could be a beach or a forest. Hypnotherapeutic techniques 
can help patients to explore and experience this well tolerated place [22]. There is no 
question that a strong doctor-patient relationship and a thorough preparation are es-
sential for successful application of this technique. Hypnosis and hypnotic techniques 
have been extensively studied in surgical patients (for a meta-analysis, see [51]). To assist 
patients in adopting a successful coping strategy, either aware or unaware, communica-
tion with the patient and the team is of utmost importance. The importance of ‘vocal 
anaesthesia’ cannot be overestimated.
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ConClUsion
In summary, next to all pharmacological developments of the last decades, there is 
growing evidence supporting the application of psychological techniques and simple 
interventions to improve the patient’s experience of an awake craniotomy. These tech-
niques should be used well tailored to the patients’ needs and personality and should 
be used by an anaesthesiologist who feels comfortable with applying them. Further 
research is necessary to assess the additional value of these techniques. Furthermore, 
the publication of new techniques, both pharmacological and nonpharmacological, and 
experiences in awake craniotomy procedures by anaesthesiologists should be encour-
aged. The patient’s experience during an awake craniotomy is largely depending on the 
anaesthesiologist’s careful preoperative preparation and professional intraoperative 
performance. It is beyond dispute that a professional patient–doctor relationship based 
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QUAlity AnD QUAntity of mEmoRiEs in PAtiEnts onDERGoinG AWAkE 
bRAin tUmoR REsECtion.
AbstRACt
objective: Awake craniotomy is performed with increasing frequency for brain tumor 
surgery in eloquent areas. However, little is known about patient’s memories of this 
procedure. Therefore, we retrospectively analyzed quality and quantity of memories, in 
our patients, treated following a standardized protocol.
methods: We treated 61 consecutive patients within 3 years. 48 of them were alive, 
when the study was performed. These patients received a questionnaire about their 
peri-operative memories and perceptions. The perioperative process was cut down to 
several steps, and for each step the patients had to judge quantity (nothing – every-
thing) and quality (very negative – very positive) of their memories. 
Results: 36 patients responded (75%). Quantity of memory was quite incomplete, even 
for intraoperative moments when patients were awake and cooperative. In average, 
quality of memories was neutral or positive. A higher quantity of memories was associ-
ated with a higher quality of memories. Most important sources of discomfort were the 
placement of the Mayfield clamp, followed by laying on the OR-table with movement 
restriction, and irritation by the urinary catheter in situ. 
Conclusions: Awake craniotomy can be performed with our protocol in such a way that 
it is experienced as (very) comfortable. However, there are moments of discomfort, which 
can be managed by the team. Extensive preoperative preparation may be considered as 
a crucial part of the procedure. Less amnesia seems to improve patient satisfaction. The 
results of this study can be used for protocol optimization, expectation management 
and information of future patients.
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intRoDUCtion
Evidence that extensive resection of brain tumors can improve length of survival has 
contributed to a renaissance of awake brain surgery in case of tumors in eloquent ar-
eas.1-3 This technique allows instantaneous control of higher brain functions and enables 
the neurosurgeon to perform a maximum of brain tumor resection with a minimal risk 
of functional damage for the patient. Despite multiple positive studies showing a high 
acceptance by patients, being awake during brain tumor removal is still considered as 
difficult to tolerate by some anesthesiologists and neurosurgeons.4 However, we dem-
onstrated that even a nine-year old child was able to tolerate this procedure by good 
psychological preparation and support.5 After years of studies only addressing safety 
and feasibility of awake craniotomies, just recently a rising number of studies addresses 
the perspective of the patient undergoing awake brain tumor resection. These have 
been mostly performed in small groups (<30 patients) and focus mostly on “satisfaction” 
in a general way.4,6-10 
However, we are not aware of any other study trying to quantify the amount and the 
quality of memories of the perioperative period in patients undergoing awake brain 
tumor resection. Preoperative preparation plays a key role in alleviating the understand-
able anxiety of patients undergoing an awake craniotomy. Providing data about the 
quantity and quality of memories around this procedure must be considered useful for 
preoperative patient information to decrease anxiety and to improve appropriate ex-
pectation management. We therefore performed this retrospective observational study.
mEthoDs
This voluntary, retrospective short questionnaire study was performed in accordance 
with the guidelines of our local ethical committee. Sixty-one consecutive patients were 
operated within a 3-year period for different types (including grade IV glioblastoma 
multiforme) of malignant brain tumors following a standard protocol for preoperative 
preparation, intraoperative sedation and postoperative care as published earlier.5,11 
The cornerstone of our protocol is an intensive preoperative preparation of the patients 
using a digital presentation (slides and short movies) of the whole procedure provided 
by the anesthesiologist scheduled. Intraoperatively we use a light propofol sedation with 
spontaneous respiration in combination with local infiltration of the surgical field and 
the insertion points of the Mayfield clamp during the craniotomy period and for wound 
closure. We do not use any invasive airway management or continuous remifentanil 
infusion. However, we give boluses (50-75 mcg) of remifentanil just before local infiltra-
tion anesthesia. After opening of the dura all patients stay completely unsedated until 
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the end of tumor resection, so that not only a cortical mapping can be performed, but 
also intraoperative deeper stimulation and mapping of the resection field is possible. A 
neuropsychologist/linguist is available for neuropsychological testing and distracting 
chat during this period.
When we started this study, in our hospital database 13 of the 61 patients were 
documented to be deceased. The remaining 48 patients received by “snail”-mail a paper 
questionnaire (Appendix 1) about the quality and quantity of their memories of the 
perioperative period and the sources of possible discomfort they experienced through-
out the procedure. We mailed the questionnaire once; no reminder was sent; patients 
received a free and addressed envelope to return their answers. In an accompanying 
letter the goal of the study was explained and a contact address was given in case of any 
questions or distress caused by the questionnaire.
The perioperative process was depicted into 11 consecutive steps according to our local 
protocol. Table 1 shows these steps and the sedative drugs given during the respective 
step.
The quantity of the memories the patients could rate from 0 = remember nothing, 1= 
remember a little, 2 = remember partially, 3 = remember quite a lot, 4 = remember (almost) 
everything; for the quality of the memories they could rate from 0 = absolutely negative, 1 = 
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The quantity of the memories the patients could rate from 0 = remember nothing, 1= 
remember a little, 2 = remember partially, 3 = remember quite a lot, 4 = remember 
(almost) everything; for the quality of the memories they could rate from 0 = absolutely 
negative, 1 = more negative than positive, 2 = neutral, 3 = more positive than negative, 4 
= absolutely positive. Patients reporting no memories for a certain step of the procedure 
(quantity = 0) were excluded from analysis of the quality of the memories for the respec-
tive step.
Furthermore, patients were asked specifically whether they experienced any dis-
comfort by the possible causes of discomfort (Mayfield clamp, position on the table, 
restricted movement, shaving of the hair, lying under the drapes, iv / arterial catheters, 
urinary catheter, dry mouth, local anesthesia of the surgical field, body temperature). 
Multiple answers were possible for that question. 
The time-interval between the surgical procedure and answering the questionnaire var-
ied between the patients from 0-37 months. Because this variation might have an effect 
on the quantity of memories, we analyzed, whether there was a correlation between the 
average amount of memories of all 11 steps and the time between the procedure and 
the questionnaire.
Statistical analyses were performed using SPSS software version 22.0.0 (SPSS Inc., 
Chicago, IL) and figures were plotted using R version 3.1.3. Categorical variables are pre-
sented as numbers and percentages. Continuous data are presented as mean ± standard 
deviation (SD) when normally distributed or as median values and corresponding 25th 
and 75th percentiles when data was skewed. Quantity and quality of memories of each of 
the 11 steps up were summed to quantity and quality sum-scores, respectively (possible 
range 0-44 for both scores). Differences in sum-scores between subgroups of patients 
were analyzed using the non-parametric Mann-Whitney test or Kruskal Wallis test, when 
appropriate. Correlations were assessed using Spearman’s correlation coefficient. Sig-
nificance was set at a two-sided P-value < 0.05. 
REsUlts
The procedure could be performed in all patients as planned. In no patient we had to 
perform invasive airway measures (intubation, laryngeal mask airway, mechanical venti-
lation), no patient was converted to general anesthesia.
Of the total 48 patients who received a questionnaire, 36 patients responded (75%, 
19 women, 17 men). Their basic characteristics are shown in table 2. The excluded 13 
patients who died, all but one suffered from a high-grade brain tumor compared to half 
(18/36) of the responding patients. Of the remaining 12 non-responding patients, 10 
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(18/36) of the responding patients. Of the remaining 12 non-responding patients, 10 were 
documented as alive when the study was performed, two had their follow-up in another 
hospital and could not be tracked any further despite our efforts.  
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were documented as alive when the study was performed, two had their follow-up in 
another hospital and could not be tracked any further despite our efforts. 
Patients who responded were more often ASA class 1 (36%) compared to non-responders 
(0%). All patients undergoing awake craniotomy have been conscious and cooperative 
during the preoperative evaluation. The medical conditions making patients ASA class 
>I were not neurological, but mostly for cardiovascular and respiratory reasons.
No significant differences between responders and non-responders were observed in 
age, side of the tumor, pathological diagnosis, or complete resection. All patients re-
ported to have filled in the questionnaire on their own.
The results on the quantity of the memories can be found in figure 1. Obviously, the 
majority of patients has only partial memories of the whole perioperative period, 
despite the fact that they were completely conscious and cooperative at least during 
the preparation on the ward, the intraoperative neuropsychological testing and the first 
night on the PACU, where they underwent hourly neurological controls. 
figure 2 shows the quality of the memories. The absolute majority of the memories 
are neutral or even more positive than negative. The craniotomy itself has the most 
memories with a negative score (2/6, 33%); however, only 6 patients had any memories. 
The most positive memories can be found during the period of neuropsychological 
monitoring. A positive correlation was observed between the quantity sum-score and 
quality sum-score (r=.636, p<.001). 
Among the possible causes of discomfort, 50% of the patients choose the application of 
the Mayfield clamp as the most important item. Lying on the OR-table with movement 
restrictions is the second most important cause, mentioned by 28% of the patients. 
Details can be found in table 3. 
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We could not find any correlation between the average amount of memories and the 
time passed since the procedure. We also were unable to detect a correlation between 
the quantity of memories and the dose of propofol given or the completeness of the re-
section. However, we found a significant higher quantity of memories in patients treated 
with enzyme inducing anti-epileptic drugs (Carbamazepine, Phenytoin) compared with 
those using other drugs or without anti-epileptic treatment (sum-scores 22 (IQR 11-28) 
vs. 11 (IQR 4-18) vs. 13 (IQR 11-28) (p=.043). The use of anti-epileptic drugs did not lead 
to significant differences in the dosages of propofol used for sedation. We also found a 
higher quantity sum-score in patients with a tumor located in the left hemisphere com-
pared with a right-sided tumor (sum-scores 18 (IQR 11-25) vs. 11 (IQR 4-13) (p=.030)).
DisCUssion
Our patients have limited, but mostly positive memories of the perioperative period, 
even of the relatively long periods of tumor resection when they were fully awake and 
cooperative. 22% of our patients had absolutely no memories of being neuropsycho-
logically tested, a number in line with previous published data by Whittle et al.6 who 
state that 8-37% of the patients won’t remember of being awake intraoperatively. In 
another study, where the procedure was also analysed in several steps, only 33% of the 
patients remembered the stimulation of the cerebral cortex to map language and motor 
centres.12 However, in a large recent study 17% of the patients had no recollections at all 
We could not find any correlation between the average amount of memories and the time 
passed since the procedure. We also were unable to detect a correlation between the 
quantity of memories and the dose of propofol given or the completeness of the resection. 
However, we found a significant higher quantity of memories in patients treated with 
enzyme inducing anti-epileptic drugs (Carbamazepine, Phenytoin) compared with those 
using other dr s or without anti-epileptic tr atment (sum-scores 22 (IQR 11-28) vs. 11 
(IQR 4-18) vs. 13 (IQR 1-28 =.043). The use of anti-epileptic drugs di  not lead to 
significant differences in the dosages of propofol used for sedation. We also found a higher 
quantity sum-score in patients with a tumor located in the left hemisphere compared with a 
right-sided tumor (sum-scores 18 (IQR 11-25) vs. 11 (IQR 4-13) (p=.030)).   
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about their awake operation.13 So, the quantity and the quality of memories in patients 
undergoing awake craniotomy is varying. The mean age of our patients is 43 ± 12.4 
years, memory loss due to physiological aging is improbable.
It should be noticed, that - despite the fact that the most memories are positive - we 
found a positive correlation between the quality and the quantity of memories, which 
can be summarized as: the more the patient remembers, the more positive the memo-
ries are. This finding deserves further study, because many recent articles about the 
management of awake craniotomies promote the use of dexmedetomedine, which 
induces less amnesia and thus more awareness than the use of propofol.14-18 However, 
in our own practice (after this study) we had two patients undergoing a re-craniotomy, 
who received propofol during the first and dexmedetomidine during the second proce-
dure. Both complained over the fact that they were more aware than during their first 
procedure and felt less comfortable. Furthermore, the risk of intraoperative epileptic 
seizures should be considered.15.19
Recently published articles address the impact of different tumor grades and locations 
on the neuropsychological performance of patients undergoing brain tumor resection 
(awake and under general anesthesia).20,21 However, we were not able to find a convinc-
ing explanation for the right-left-differences in the quantity of memories we observed 
in our patients. Frontal tumors might interfere with memory formation more than other 
locations. However, we did not have many frontal tumors in our patient group, because 
most frontal tumors safely can be resected under general anesthesia as they don’t affect 
eloquent areas.
It is surprising, that the average quality of the recollections of our patients is neutral or 
positive, even of the situations that are linked to some painful interventions. This can 
be explained at least partially by the high level of intrinsic motivation and the posi-
tive attitude, which is typical for patients undergoing awake procedures.12 This might 
be a kind of “selection bias” compared with patient satisfaction-scores in other surgical 
procedures. 
All patients also received perioperatively (starting in general some days before the 
procedure) dexamethasone, which is known to mediate an acute energizing effect, 
but induces dysphoria in case of prolonged administration.22 Therefore we think that a 
“euphoric bias” by dexamethasone is quite improbable. However, for the use of propofol 
such an “euphoric bias” cannot be excluded.23,24
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Furthermore, intense management of patients’ expectations as recently recommended 
by others25 has been for years a crucial part of our protocol. Preoperative information 
in our institution is always done by the responsible anesthetist and includes a 90-120 
minutes talk with the patient a relative including a slide-show with photographs and 
some videos from the whole perioperative course. Positive effects of this extra attention 
to the patient are suggested by literature, but not yet quantified.26
Despite a bolus of remifentanil and efficient local anesthesia, 50% of our patients expe-
rienced the application of the Mayfield clamp as the most relevant source of discomfort, 
followed by lying for a long time with restricted movement on the OR-table. These 
results confirm previous data.4,9,13 However, the detailed data on the quality of memories 
in figure 2 clearly show, that the average memories of this step of the procedure still are 
much more positive than negative. In our protocol, the Mayfield clamp is placed with 
the patient awake. Our idea behind this regimen is, that if we keep the patient sedated 
throughout positioning, placement of the clamp and preparation of the surgical field 
with all drapes and blankets, they will wake up in a completely different situation than 
they were, when sedation was started, which might cause agitation and irritation. The 
Mayfield clamp does not only prevent accidental head-movements of the patient under 
the surgeon’s microscope, but also enables the reliable use of neuro-navigation tech-
niques. Therefore, we feel no need to change our protocol based on these findings. 
The 75% response rate of the patients still alive in a once mailed questionnaire without 
a second reminder is very high and might reflect the loyalty and thankfulness of the 
responding patients. Furthermore, the positive results of the questionnaire match with 
the verbal feedback we receive from the patients during the routine postoperative visits 
on the ward. 
Nevertheless, a small number of patients with significant fear or even Post-Traumatic-
Stress-Disorder-like symptoms after awake craniotomy have been published by other 
groups.10,27,28 However, we think that this should not be used as a general argument 
to withhold the awake procedure when indicated, because awake resection enables a 
maximum of tumor resection with a minimal risk of functional damage, which in conclu-
sion means: a longer survival without disability for the majority of the patients.1-3
limitations of the study
The retrospective design might be a limitation of our study, especially due to the broad 
variation of time interval between the procedure and answering the questionnaire. 
As we know from pain studies, recall of acute events is more accurate than recall of 
chronic events.29 However, by addressing not only the quality, but also the quantity of 
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the memories, we tried to deal with the known phenomenon of fading recall. Finally, we 
could not find any influence of the time interval between the procedure and answer-
ing the questionnaire and the quantity of memories. Nevertheless, a selection bias in 
patients choosing to respond is possible.
Another limitation might be, that this is a single-center study, where a strict protocol for 
preoperative information of and perioperative sedation was used. Extrapolation of our 
results to other settings and other protocols might be difficult. However, our sedation 
regimen is based on propofol only with a spontaneously breathing patient without any 
invasive airway management. The chance of recall in our population should be much 
higher than in other settings, where an asleep-awake-asleep-technique including the 
continuous application of opioids, the use of a laryngeal mask airway or even endotra-
cheal intubation is used. 
We have chosen for a not validated method to grade patients’ memories because there 
are no comparable studies in patients undergoing awake craniotomy. Splitting the 
procedure in separate steps and describing them might promote recall compared with 
an open question like “tell me all you remember…”. However, the relatively low quantity 
of memories makes a strong recall-promoting effect quite unlikely.
It must be expected, that awake craniotomies will be performed more frequently in the 
next years, and maybe even as a day-care procedure.30 However, the patients must be se-
lected carefully, to avoid a failing procedure.31,32 Not all recent studies reported a better 
outcome of awake patients compared to patients operated under general anesthesia.33 
ConClUsions
In conclusion, our results support that patients are operated awake for brain tumor 
resection. Despite being awake for a major part of the perioperative period the quantity 
of explicit memories of awake operated patients is limited. The quality of the memories 
in our patients is neutral to positive. We found no patient with signs of traumatic psy-
chologic experiences due to the awake technique. The key to successful awake neuro-
surgery is ensuring a well-informed patient who is calm, comfortable and co-operative 
throughout the procedure.8 This can be achieved reliably by propofol-sedation and local 
anesthesia. The finding that propofol provides a pleasant, quite strong amnesia even for 
the longer periods when the patient is fully awake is notable. Our results can be used, to 
inform the patients preoperatively about the possible recall of (parts of ) the procedure 
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132 Chapter 7
AnxiEty, mEmoRiEs AnD CoPinG in PAtiEnts UnDERGoinG 
intRACRAniAl tUmoR sURGERy.
AbstRACt
objectives: The diagnosis and the surgical removal of a brain tumor can have serious 
impact on the quality of life of a patient. The question rises, whether having more or just 
less memories of the procedure is better for coping with such an event. Furthermore, for 
preoperative information of future patients it is important to know how patients process 
their emotions and memories. The primary objective of this study was to investigate 
the link between preoperative anxiety, the perioperative experience and the quantity 
and quality of postoperative memories in patients who underwent intracranial tumor 
surgery. 
Patients and methods: This study was a retrospective observational study; all patients 
who underwent intracranial tumor surgery at the Erasmus Medical Centre Rotterdam 
between January 1st 2014 and December 31st 2015 were identified. In May 2016, all 
patients who were not registered as deceased were sent a questionnaire about their 
anxieties, perceptions and memories of the perioperative period. 
Results: In total 476 patients were included. 272 patients responded, which resulted in 
a response rate of 57.14%. In the general anesthesia (GA) group there was a significant 
negative correlation between anxiety in the perioperative period and the quantity and 
quality of memories. In the awake craniotomy group, there was a significant negative 
correlation between anxiety after the operation and the quantity of memories. 
Conclusion: Patients in the GA group who experienced anxiety in the perioperative 
period had less quantity and quality of memories and less patient satisfaction. Patients 
in the AC group who experienced anxiety after the operation had only a lower quantity 
of the memory; there was no correlation with patient satisfaction. 
key words: Anesthesia; anxiety; awake craniotomy; brain tumor; coping; memory; 
neurosurgery; patient satisfaction.
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intRoDUCtion
The diagnosis of a brain tumor and the surgical removal of this tumor can have serious 
impact on the quality of life of the patient. As patient centered care and value-based 
health care have become increasingly important, information about the quality of 
postoperative recovery and management of patient expectations are especially relevant 
[1,2]. Patients may undergo this procedure awake or under general anesthesia (GA), 
which has impact on the quantity, but possibly also on the quality of the memories 
about the perioperative period. It may be questioned, whether more or less memories 
about the procedure are an advantage for coping with such a major life event? 
Only a few earlier studies investigated patient experience of patients who underwent 
an awake craniotomy (AC) [3-5]. These studies showed that according to the patients’ 
memories this anesthesia technique is well tolerated by the patients, but nevertheless 
still can have considerable impact. This impact did not only reflect on the direct periop-
erative period, but also on the period of recovery and rehabilitation after the procedure. 
Therefore, we strived to learn more about how patients process and cope with their 
emotions and memories of the perioperative period in order to better inform future 
patients and manage their expectations about the operation. 
Recently, we published data of a different, previous, small patient population on the 
quality and quantity of memories in patients who all underwent an awake craniotomy 
[6]. These data showed, that patients did not remember a lot of the procedure despite 
being awake during the whole period of resection, but also that the majority of these 
memories were very positive. 
Inspired by these findings, this study is the first one to compare the correlation between 
anxiety and the quantity and quality of memories of the perioperative period, in patients 
who underwent brain tumor resection awake or under general anesthesia. The primary 
objective of this study was to investigate the link between preoperative anxiety, the 
perioperative experience and the quantity and quality of postoperative memories. Our 
hypothesis was, that preoperative anxiety will result in more negative memories and 
less patient satisfaction. 
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mAtERiAls AnD mEthoDs
The institutional medical ethics committee of the Erasmus University Medical Centre 
approved this study (MEC-2016-125). Written informed consent was obtained from all 
patients who participated in this study. 
study design
For this study, all consecutive adult patients who underwent neurosurgery at the Eras-
mus Medical Centre Rotterdam between January 1st 2014 and December 31st 2015 were 
identified. Based on surgery coding, 739 patients with an intracranial tumor resection 
were found.
Participants 
In May 2016, after excluding patients registered as deceased in our hospitals patient 
registry, 503 of these 739 patients received a questionnaire about their perception of 
the perioperative period. Patients who did not reply, were sent a reminder in August 
2016. Non-responders were included in the final analysis to check for structural factors 
differing significantly between responders and non-responders. 
setting
In case of general anesthesia, the technique was chosen by the responsible anesthetist 
(Total Intra-Venous Anesthesia or balanced anesthesia). Our standardized technique of 
awake craniotomy has been described previously and has not been changed for the 
patients included in this study [6]. In summary, we rely on a detailed, personal preop-
erative patient information and psychological preparation. Intraoperatively we use a 
combination of local anesthesia with propofol sedation during craniotomy and closure 
in spontaneous breathing patients with a nasal oxygen probe (non-invasive asleep-
awake-asleep technique).
study size
In this study, all adult patients who underwent (stereotactical) biopsies, intra-cranial 
tumor surgery and pituitary adenoma surgery were included. After removing double 
cases (of patients who had multiple operations in this period only the first procedure 
was included), a total number of 739 cases remained (see figure 1).
Patients undergoing a supratentorial tumor resection were mostly extubated on the OR, 
patients with infratentorial tumors were frequently transferred intubated to the Inten-
sive Care Unit / Post Anesthesia Care Unit (ICU/PACU), where extubation was performed 
on a later moment. For uniformity reasons in our questionnaire extubation was put after 
the transport to the PACU / ICU. It is worth mentioning, that in our hospital the PACU is a 
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high dependency unit with the option for mechanical ventilation, which is independent 
from the recovery room and dedicated to postoperative care for up to the first 24 hours. 
variables 
Our questionnaire focused on anxiety and memories. Questions addressing anxiety re-
ferred to different time-points of the perioperative process and to the patients and their 
relatives. The measured anxiety in the relatives of patients was reported by the patients. 
These questions could be answered on a 10-point scale (0= no anxiety, 10 = maximum 
anxiety). The questions addressing the quality and quantity of memories were divided 
in 13 sub-questions, referring to the consecutive events during the perioperative period, 
e.g. preoperative night on the ward, arrival on the OR etc. (see table 1). The question-
naire is added (appendix). 
later moment. For uniformity reasons in our questionnaire extubation was put after the 
transport to the PACU / ICU. It is worth mentioning, that in our hospital the PACU is a high 
dependency unit with the option for mechanical ventilation, which is independent from the 
recovery room and dedicated to postoperative care for up to the first 24 hours.  
Figure 1: Flowchart of the study-inclusion 
Variables  
figure 1: Flowchart of the study-inclusion
136 Chapter 7
All 13 sub-questions could be answered on a 5-point scale. For the sub-questions in 
question 1 the scale ranged from no memory at all (1) to a full and complete memory 
(5) and in question 2 the scale ranged from totally negative (1) to totally positive (5). To 
analyze the quantity and quality of memories the authors computed a sum score per pa-
tient of all given answers. If the patient underwent an awake craniotomy the answers to 
the questions about in- and extubation were not taken into account for the sum scores 
concerning the quantity and quality of the memories. So, the maximum sum scores of 
questions 1 and 2 were 11 x 5 (=55) (table 1). Furthermore, if the patient received general 
anesthesia, the answers to the question about testing of the brain function were not 
taken into account for the sum scores of the quantity and quality of the memories. So 
the maximum sum scores of question 1 and 2 in the general anesthesia group was 12 x 
5 (=60) (table 1).
If the respondent did report to have no memories of the specific sub-question of the 
perioperative period when asked about the quantity, any quality score on that specific 
sub-question was considered invalid and not taken into account. 
If the respondent did report to have any memory of the specific sub-question of the 
perioperative period, answered “no memories” when asked about the quality, the quality 
score was counted as ‘’neutral’’ for that specific sub-question. Furthermore, if a respon-
dent did not completely answer a question, then for the respective sub-question(s) the 
responder was counted as a non-responder.
into account for the sum scores of the quantity and quality of the memories. So the 
maximum sum scores of question 1 and 2 in the general anesthesia group was 12 x 5 (=60) 
(table 1).   
If the respondent did report to have no memories of the specific sub-question of the 
perioperative period when asked about the quantity, any quality score on that specific sub-
question was considered invalid and not taken into account.  
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Data sources
The following data were collected from the electronic patient record system of the 
Erasmus MC: age, gender and ASA (American Society of Anesthesiologists)-class of the 
patient - a rough indicator of the general state of health [1= healthy to 4 = seriously 
reduced vital functions], type and side of the tumor, pathological determination of the 
tumor and degree of resection of the tumor. The degree of resection of the tumor was 
extracted from postoperative MRI scans and was categorized as complete resection or 
a resection with remnant of tumor. If the first postoperative MRI scan was inconclusive 
due to edema or residual blood, findings from later scans were analyzed. 
Our primary outcome was the correlation between the quantity and quality of memories 
of patients and the experienced anxiety. We also analyzed the following possible influ-
encing factors on the quantity and quality of the memories: the amount of time elapsed 
between answering the questionnaire and date of surgery (time-q) and the technique 
of anesthesia (awake craniotomy or general anesthesia). Furthermore, we analyzed the 
correlation between the overall satisfaction score and the quantity and quality of the 
memories, the correlation between anxiety prior and anxiety after the surgical proce-
dure with the quantity and quality of memories and the correlation between anxiety 
prior and after the operation procedure and the overall satisfaction score. In addition, 
we analyzed which parts of the procedure were seen as discomforting by patients. 
Because we had a quite large group of patients (91/476) who underwent surgery for 
pituitary adenoma or craniopharyngeoma, we also analyzed whether there was a dif-
ference between those operated via a transphenoidal approach and those via a frontal 
craniotomy.
statistical methods
All data were gathered by two of the authors (TvA, PdS) and any inconsistencies and 
controversies were discussed with a third author (MK), until consensus was reached. 
Processing of data and statistical analysis was done using IBM SPSS Statistics, version 23, 
(Armonk, NY: IBM Corp.) Differences in mean scores for quality and quantity of memories 
between the awake craniotomy and general anesthesia group were calculated using 
Mann-Whitney U tests. Differences in mean scores for anxiety prior to surgery and look-
ing back to surgery were calculated using the paired T-test. Correlations were analyzed 
using Spearmen’s correlation coefficient. The threshold for significance was set on a 
two-sided P value <0.05. 
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REsUlts
Figure 1 shows a flowchart of the included and excluded patients.
In total, 476 patients were included. 272 patients responded, which resulted in a 
response rate of 57.14%. There were no differences found in baseline characteristics 
between responders and non-responders (table 2). 
Spearmen’s correlation coefficient. The threshold for significance was set on a two-sided P 
value <0.05. 
Results
Figure 1 shows a flowchart of the included and excluded patients. 
In total, 476 patients ere included. 272 patie ts responded, which resulted in a response 
rate of 57.14%. There wer  no differences found in ba eline characteristic  b tween 
responders and non-responders (table 2).  
Primary outcome 
In the general anesthesia group there is, as expected, a relative large percentage of 
patients who do not know anything about the operation. However, in the awake craniotomy 
group there is also a relatively high percentage of patients who do not recall anything from 
Primary outcome
In the general anesthesia group there is, as expected, a relative large percentage of 
patients who do not know anything about the operation. However, in the awake cra-
niotomy group there is also a relatively high percentage of patients who do not recall 
anything from the intraoperative events. 
Whilst almost no patients in the awake craniotomy group report ‘completely negative 
memories’ at any moment of the perioperative period (only 2 patients reported com-
pletely negative memories about their first night on the ICU/PACU), one patient in the 
general anesthesia group has ‘completely negative memories’ about the intra-operative 
period. In 3 other patients of the general anesthesia group some intraoperative memo-
ries were reported as “neutral”. 
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The mean scores for quantity of the memories of each sub-question of question 1 are 
shown in table 3. The quantity of memory in the patients who underwent an awake 
craniotomy was significantly higher for fixing the head in the Mayfield clamp (P<0.001), 
local anesthesia of surgical field (P=0.001), tumor resection (P<0.001), closure of surgical 
field (P=0.001), transport to the ICU/ PACU (P<0.001) and first night on the ICU/ PACU 
(P=0.008). Despite these significant differences, the mean scores of the patients who 
underwent an awake craniotomy still show a very low total quantity of memory in the 
period after the iv-lines were placed until the first night on the ICU/PACU.
other patients of the general anesthesia group some intraoperative memories were 
reported as “neutral”. 
The mean scores for quantity of the memories of each sub-question of question 1 are 
s own in table 3. The quantity of memory in the patients who underwent an awake 
craniotomy was significantly higher for fixing the h ad in the Mayfield clamp (P<0.001), 
local anesthesia of surgical field (P=0.001), tumor resection (P<0.001), closure of surgical 
field (P=0.001), transport to the ICU/ PACU (P<0.001) and first night on the ICU/ PACU
(P=0.008). Despite these significant differences, the mean scores of the patients who 
underwent an awake craniotomy still show a very low total quantity of memory in the period 
after the iv-lines were placed until the first night on the ICU/PACU.  
The mean score for quality of the memories of each sub-question of question 1 and of 
each sub-question of question 2 are shown in table 4. The only significant difference 
between both groups was that patients after an awake craniotomy experience the trans-
port to PACU/ICU with more positive memories than those after a general anesthesia 
(P=0.032).
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We found no significant differences in quantity and quality of the memories in the general 
anesthesia group between patients who had a pituitary adenoma, which was
transspheniodally resected, and patients who underwent a standard craniotomy.  
Four patients in the GA group reported at least some intraoperative memories of their 
craniotomy. Those patients were not positive about their memories. In all four patients, we 
reviewed the files carefully, but could not find any other indicators (e.g. hemodynamic 
changes, postoperative complaints) of unwanted intraoperative awareness. 
The mean scores for anxiety of patients and their relatives in the perioperative period for 
both the GA and AC group are shown in table 5a. Patients undergoing an awake 
craniotomy experienced less pre-operative anxiety than patients who received general 
anesthesia (P=0.020). 
We found no significant differences in quantity and quality of the memories in the 
general anesthesia group between patients who had a pituitary adenoma, which was 
transspheniodally resected, and patients who underwent a standard craniotomy. 
Four patients in the GA group reported at least some intraoperative memories of their 
craniotomy. Those patients were not positive about their memories. In all four patients, 
we reviewed the files carefully, but could not find any other indicators (e.g. hemody-
namic changes, postoperative complaints) of unwanted intraoperative awareness.
The mean scores for anxiety of patients and their relatives in the perioperative period 
for both the GA and AC group are shown in table 5a. Patients undergoing an awake 
craniotomy experienced less pre-operative anxiety than patients who received general 
anesthesia (P=0.020).
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In both groups we performed a paired t-test to investigate the change of the mean scores of 
anxiety during the perioperative period. We found a significant decrease in mean anxiety 
score after the operation procedure in the GA group (6.16 vs 4.70; P<0.001). There was 
only an insignificant decrease of the quite low mean anxiety score in the AC group (4.59 vs 
4.26; P=0.612).  However, there was a significant decrease in anxiety experienced by the 
relatives, after the operation procedure for both GA (7.48 vs 6.30; P< 0.001) and AC (7.92 
vs 6.16; P=0.006). 
There was a significant difference between men (N=131) and women (N=139) in mean 
scores for anxiety prior to surgery, (5.62 vs 6.36; P=0.032). There was no significant 
difference between men (N=127) and women (N=137) in mean scores for anxiety 
postoperatively (4.33 vs 4.96; P=0.087).  
The degree of malignancy of a tumor might add an extra impact to the patients’ coping with 
the diagnosis and the surgical removal. Therefore, we performed a sub-group-analysis, 
pairing the malignant tumors glioblastoma, astrocytoma and metastasis (97 patients in 
total) on the one side and the benign tumors meningioma, adenoma and schwannoma (132 
patients) on the other side. The only significant differences between the groups we found 
were a higher quality (16.9 vs. 13.62, P=0.002) and quantity (11.78 vs. 9.42, P=0.005) of 
memories for malignant tumors. However, when splitting the malignant group between 
those operated as an awake craniotomy and those operated under general anesthesia, it 
became evident, that not the malignancy of the tumor, but the anesthesia technique has the 
highest impact on this difference (table 5b).  
 
Table 5 b: Differ nces b tween benign and malignant tumors in sum score of quantity 
and quality of memory, overall satisfaction and preoperative anxiety. A Mann-Whitney 
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Correlation analysis 
There was a significant positive correlation between the sum scores of the answers related 
to the quantity of memories and the sum scores of the answers related to quality of 
memories (P<0,001, table 6). So, patients who remembered more, experienced the 
perioperative period in a more positive way t an pati nts who reme bered less. There was 
a significant positive correlation etween the um sc res of the answers related to th  
quality of memories and the overall satisfaction score regarding the perioperative period, 
independent of the anesthesia technique used. 
We performed a correlation analysis between the duration of anesthesia and the quality 
and quantity of memories and found for both a significant but small negative correlation, 
meaning that patients undergoing longer procedures have a lower quality and quantity of 
mories (table 6). 
In both groups we perf rmed a paired t-test to investigate the change of the mean 
scores of anxiety during the perioperative period. W  found a significant decrease 
in ean anxiety score after the operation procedure in the GA group (6.16 vs 4.70; 
P<0.001). Ther  was only an insignificant dec ase of the quite low mean anxiety score 
in the AC group (4.59 vs 4.26; P=0.612). However, there was a significant decrease in 
anxiety experienced by the relatives, after the operation procedure for both GA (7.48 vs 
6.30; P< 0.001) and AC (7.92 vs 6.16; P=0.006).
There was a significant difference between men (N=131) and women (N=139) in mean 
scores anxiety prior to surgery, (5.62 vs 6.36; P=0.032). There was no sig ificant differ-
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ence between men (N=127) and women (N=137) in mean scores for anxiety postopera-
tively (4.33 vs 4.96; P=0.087). 
The degree of malignancy of a tumor might add an extra impact to the patients’ coping 
with the diagnosis and the surgical removal. Therefore, we performed a sub-group-
analysis, pairing the malignant tumors glioblastoma, astrocytoma and metastasis (97 
patients in total) on the one side and the benign tumors meningioma, adenoma and 
schwannoma (132 patients) on the other side. The only significant differences between 
the groups we found were a higher quality (16.9 vs. 13.62, P=0.002) and quantity (11.78 
vs. 9.42, P=0.005) of memories for malignant tumors. However, when splitting the malig-
nant group between those operated as an awake craniotomy and those operated under 
general anesthesia, it became evident, that not the malignancy of the tumor, but the 
anesthesia technique has the highest impact on this difference (table 5b). 
Correlation analysis
There was a significant positive correlation between the sum scores of the answers 
related to the quantity of memories and the sum scores of the answers related to quality 
of memories (P<0,001, table 6). So, patients who remembered more, experienced the 
perioperative period in a more positive way than patients who remembered less. There 
was a significant positive correlation between the sum scores of the answers related to 
the quality of memories and the overall satisfaction score regarding the perioperative 
period, independent of the anesthesia technique used.
Table 6: Correlation analysis 
Correlation Spearman’s rho P value
Sum score quantity of memory with sum score quality of memory 0.801 <0.001
Time-q with sum score quantity of memory -0.019 0.760
Time-q with sum score quality of memory 0.023 0.708
Sum score of quantity of memory with overall satisfaction score 0.066 0.281
Sum score of quality of memory with overall satisfaction score 0.186 0.003
Sum score quantity of memory with age -0.352 <0.001
Sum score quality of memory with age -0.273 <0.001
Sum score quantity of memory with duration of anesthesia -0.143 0.018
Sum score quality of memory with duration of anesthesia -0.197 0.001
Anxiety prior to surgery with age 0.050 0.417
Anxiety looking back at surgery with age 0.022 0.725
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We performed a correlation analysis between the duration of anesthesia and the quality 
and quantity of memories and found for both a significant but small negative correla-
tion, meaning that patients undergoing longer procedures have a lower quality and 
quantity of memories (table 6).
There was a significant negative correlation between age and quantity and quality of the 
memory (P=0.013 vs P<0.001). Older patients experienced the procedure in a less posi-
tive way than patients who were younger. There was no significant correlation between 
age and anxiety prior to and after surgery (P=0.417 vs P=0.725). There was no significant 
correlation between the time passed since the procedure (time-q) and the sum score of 
the answers related to the quality and quantity of memories. A longer interval did not 
influence the memories in a more positive or more negative way.
To investigate the influence of anxiety on the quantity and quality of the memories, we 
performed a subgroup analysis for both general anesthesia and awake craniotomy. The 
sub-group analysis showed significant negative correlations between anxiety prior to 
the operation procedure and the quantity and quality of the memories in the GA group 
(P=0.012 for quantity and P=0.003 for quality, table 7). There were also significant nega-
tive correlations between anxiety after the operation procedure and the quantity and 
quality of the memories in the GA group (P=0.005 for quantity and P=0.001 for quality). 
In the AC group we found only a significant negative correlation between anxiety after 
the operation procedure and the quantity of the memories, there was not a significant 
negative correlation for quality of the memory (P=0.018 for quantity and P=0.581 for 
quality). There were no significant correlations between anxiety prior to the operation 
procedure and the quality and quantity of the memories in the AC group. 
In both groups (GA and AC) we found a significant positive correlation between anxiety 
experienced by the relatives and anxiety experienced by the patient prior and after 
surgery (table 7). 
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The mean overall satisfaction score in the studied patient group was 8.01 (S.E. mean 
0.110). There were no significant differences in overall satisfaction score between men 
(N=131) and women (N=138) (8.00 vs 8.02; P=0.545), and patients with complete resec-
tion and remnant of tumor (8.06 vs 8.00; P=0.336). The mean overall satisfaction score per 
diagnosis is shown in table 8. Three patients did not fill in an overall satisfaction score.
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When asked to recall specific events, men (N=70) and women (N=70) experienced dif-
ferent events as most discomforting. Men experienced the urinary catheterization the 
most discomforting (42.9% N=30), followed by pain after surgery (17.1% N=12). Women 
found the pain after surgery the most discomforting (24.3% (N=17), followed by the 
insertion of the intravenous cannula (14.3% N=10). 
Anesthesia technique 
There was a significant difference in the sum scores of the quantity and quality of the 
memory between patients who underwent an awake craniotomy and patients who 
received general anesthesia (P<0.001 and P<0.001, table 6). The mean of the overall 
satisfaction score, computed from the satisfaction scores given by the patients, was 
not different between patients who underwent an awake craniotomy and patients who 
received general anesthesia (8.04 vs 8.01; P=0.823). 
DisCUssion
The primary goal of this study was to investigate the link between preoperative anxiety, 
the perioperative experience and the quantity and quality of postoperative memories in 
patients who underwent intracranial tumor surgery. 
The results show that patients who remembered more, experienced the perioperative 
period in a more positive way than patients who remembered less. This suggests that 
more (positive) memories are better for coping with such a major life event. Further 
research is necessary to confirm this correlation and to identify possible mechanisms. 
Future research should focus on psychological outcomes in relation to the memory 
about the event to identify the role of memory on coping with a major life event.
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29 of the GA-patients indicated that they remembered at least something from the 
moment of intubation. We did not ask for further specification of these memories, but 
considering the reported quality of the memories it can be supposed, that these pa-
tients remember (parts of ) anesthesia induction, but not really the performance of the 
endotracheal intubation. Due to our study design this was not further explored. 
The contrast in our study between patients who received GA who stated to remember 
at least something from moments they were (supposed to be) under anesthesia and 
patients who underwent an awake-craniotomy but stated to remember nothing from 
moments they were obviously awake and cooperative is noteworthy. We were not able 
to find an appropriate explanation for this contrast except some memory blockade due 
to the initial sedation with propofol in the AC group.
For the patients who underwent an awake craniotomy, our results confirm the findings 
of our previous study in a different population of patients [6]. In the current study an 
even larger group of patients in the awake craniotomy group answered that they had 
no memories at all of the consecutive perioperative steps. The quality of the memories 
was in both studies mostly positive. 
These findings also confirm earlier studies by other authors, showing that patient’s 
acceptance and satisfaction for awake craniotomies is relatively high [7-11] and that 
an awake craniotomy is absolutely not more (and maybe even less) stressful than 
general anesthesia [12]. Our findings when comparing malignant and benign tumors 
(table 5b) support this hypothesis: even patients undergoing an awake craniotomy for a 
malignant tumor have a higher quality of memories and a tendency to less anxiety and 
more satisfaction than patients undergoing resection of a (benign) tumor under general 
anesthesia.
Our findings about anxiety in the patients and their relatives and the negative correla-
tion between anxiety and the memories especially in the GA group raises the question, 
what role the experienced anxiety (by the relatives) plays in coping with such a major 
life event for the patient? Interestingly, the mean scores for the experienced anxiety in 
the relatives were higher than the mean scores for anxiety in the patient preoperatively 
and remain higher postoperatively. A possible explanation for this finding could be the 
experienced inability to help the patient for the relatives. The relatives of the patient 
have to watch how the patient is dealing with his disease, with only limited options to 
provide help. This can be very stressful for the relatives of the patient, whilst the patient 
can sense this stress. Our findings concerning anxiety are in line with an earlier study 
of Petruzzi et al. [13], who showed that caregivers of patients diagnosed with a brain 
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tumor experience more symptoms of anxiety, than the patient himself. Therefore, it is 
important to pay attention to the anxiety in the relatives of the patient, and how they 
are coping with the situation, too.
As far as we could find in the available literature, our findings of a decreased quality and 
quantity of memories in case of longer lasting procedures have not yet been described 
before. In opposite, for colonoscopies evidence was found that lengthy procedures were 
not remembered as particularly aversive [14]. 
Our results concerning the correlation between age and anxiety and differences in 
experienced anxiety between men and women are in line with Ruis et al [15]. However, 
we found a lower pre-operative mean anxiety score, which might be due to the dif-
ference in the used questionnaires. The questions in our questionnaire were about the 
general experience of anxiety and inconveniences, whilst Ruis et al. asked about specific 
anxieties patients may have about the procedure. This could be helpful in expectation 
management in patients undergoing brain tumor surgery, too. 
In contrast, a study of Milian et al. [16] showed that 44% of the patients who underwent 
an awake craniotomy had either repetitive recollections or dreams who were related 
to the surgery, and 2 out of 16 patients were diagnosed to have PTSD. In our center, 
patients who are planned for an awake craniotomy receive an intensive information and 
preparation interview, which is done with video and slides by the responsible anesthesi-
ologist who also will provide the care for the patient during the operation. We consider 
this preparation and the quite active role for the patient during the surgery as crucial 
factors for the positive results in our population. From our point of view, it would be 
unethical to proof this by a prospective interventional trial.
Santini et al. identified psychological warning signs like fear of pain, anxiety and the in-
capability of self-control as predictive for intraoperative monitoring failures [17]. These 
criteria might be helpful in patient selection. 
This links also to the recent findings of Jenkins et al. [18], who showed that patients 
with brain tumors have more emotional changes, such as depression, and personality 
disturbances after surgery than a control group that had undergone spinal surgery. 
Another study by Richter et al. [19] suggests that white matter damage could be a cause 
for these psychological symptoms. 
In the assessment of factors that might have influenced the appreciation of the patient 
perception about the perioperative period, the quantity and quality of memories should 
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be taken into consideration. Patients who remember more about the perioperative 
period may be able to process such a major life event in a better way than patients who 
remember less. 
We studied a relative large group of patients and had a relative large group of re-
sponders (> 57%). This provided the opportunity to examine the differences between 
responders and non-responders. However, we could not identify any structural differ-
ences between these groups. In our study population no generalized seizures occurred 
during AC, local seizures due to stimulation were treated with local ice water application 
at the surgical field only.
Our data do not confirm previously published evidence [20], that men are more satis-
fied with the care provided. Almost every patient in our study went to the PACU (Post 
Anesthesia Care Unit) or ICU after the operation. On the PACU and ICU there is a lower 
patients/nurse-ratio and therefore a higher and more personal level of care provided to 
all patients than on a recovery room followed by care on a normal ward. 
In contrast to the earlier mentioned study [20], our patients who were older remem-
bered less and gave a lower score for their experience of the perioperative period. We 
were not able to reveal a convincing cause for this phenomenon; however, with an aging 
population it deserves special attention in future research.
The sum score for the quantity of memories was surprisingly low in our awake craniotomy 
group. This was mainly caused by the low score for quantity of memory about the local 
anesthesia of the operation area and the placement of the head of the patient in the 
Mayfield clamp whilst both are performed according to our protocol with an awake and 
cooperative patient. However, we routinely give a bolus of about 50 mcg remifentanil 
before the local infiltration, which might influence the memories. We were not able to 
identify other possible factors that could explain this relative low score for these items. 
limitations
There are some limitations to this study. This was a retrospective study and although 
an intracranial surgery is a major life event, this could lead to recall bias in memories 
about the surgery. “Memory” as a neuropsychological correlate is a multi-location phe-
nomenon. Memory formation might be influenced by location, grade and size of the 
tumor, too. However, these aspects cannot be clearly attributed to memory formation 
and therefore, we decided not to perform additional sub-group analyses. 
The questionnaire used in this study was based on validated questionnaires, but was by 
itself not validated before this study. The authors did not find an applicable validated 
questionnaire for the central question of this study, therefore a new approach had to be 
Anxiety, memories and coping in patients undergoing intracranial tumor surgery. 149
7
chosen. Furthermore, there could be a positive effect on patient satisfaction simply by 
showing interest in how the patient experienced the perioperative period. 
Our questions about the psychological aspects in the used questionnaire are much 
more general as the often-used Hospital Anxiety and Depression Scale (HADS), however, 
we studied a relative large patient group and our findings are largely in line with studies 
which used the HADS in patients with a brain tumor.
The anxiety scores for the relatives of the patients were reported by the patient self. 
This could lead to bias. However, the relationship between brain tumor patients and 
their family caregivers is an upcoming research topic [21], and our data only show, how 
intense the patients experienced the anxiety of their relatives. This might be influenced 
by concerns about an actual or anticipated change in physical and/or cognitive perfor-
mance of the patients due to the tumor and/or the surgery.
In our study there was a varying time interval between the operation and the moment 
the patients received our questionnaire. This might influence the results; however, we 
did not find any significant correlation between the time interval (time-q) and the quan-
tity nor the quality of the memories. 
Another limitation of this study is the fact, that we do not have any information about 
the ethnic-cultural background and educational level of the patients, whilst coping 
mechanisms most probably will be influenced by these factors. Interestingly, literature 
for brain tumor patients on this aspect is lacking.
This is a mono-center study, which might make it difficult to extrapolate our results to 
other centers working in a different way. Nevertheless, many aspects of brain tumor 
surgery show a world-wide uniformity which makes this limitation less relevant.
Our study interval is too short to come to a conclusion whether the quality and quantity 
of memories have any link with patients’ outcome. Future studies will address this ques-
tion.
ConClUsions
The quantity of memories of the perioperative period in patients undergoing brain 
tumor surgery is low and the quality of these memories is quite positive. Patients who 
underwent an awake craniotomy had a higher quantity and quality of memory about 
the procedure than patients undergoing general anesthesia. 
150 Chapter 7
We found selective aspects of unpleasant memories like the urinary catheter especially 
in men and pain in both sexes, which should be addressed better in pre-operative con-
sulting and postoperative management to further increase patient satisfaction.
However, the total quantity of memories after an awake craniotomy is much lower than 
one would expect considering the fact that the patients are literally awake and fully 
cooperative for long parts of the procedure. Planned intraoperative awareness does not 
seem to be traumatizing for the patients.
Patients who remembered more about the perioperative period, experienced the 
perioperative period in a more positive way than patients who remembered less. This is 
independent of the anesthesia technique used. A possible explanation of these findings 
is that patients who remember more are better able to cope with their perioperative 
experiences. 
Patients in the GA group, who experienced more anxiety prior to and looking back at the 
operation procedure had a lower quantity and quality of their memories. Furthermore, 
patients in this group who experienced more anxiety prior to and when looking back at 
the operation procedure had less patient satisfaction. 
In the AC group only, patients who experienced more anxiety in the days after the 
operation procedure had a lower quantity of their memories. Patients in this group who 
experienced more anxiety had not less patient satisfaction. 
ACknoWlEDGmEnts
We are grateful to Ms. G. De Jonge, M.Sc., Biomedical Information Specialist, Medical 
Library, Erasmus University Medical Centre, Rotterdam, The Netherlands for her support 
with the literature search. 
Anxiety, memories and coping in patients undergoing intracranial tumor surgery. 151
7
REfEREnCEs 
 1. Kraus DH. Living in a Patient-Centric Universe. JAMA Otolaryngol Head Neck Surg 2016;142:1231-2. 
 2. Honeybul S, Gillett GR, Ho K. Futility in neurosurgery: a patient-centered approach. Neurosurgery 
2013;73:917-22. 
 3. Palese A, Skrap M, Fachin M, et al. The experience of patients undergoing awake craniotomy: in 
the patients’ own words. A qualitative study. Cancer Nurs 2008;31:166-72. 
 4. Whittle IR, Midgley S, Georges H, et al. Patient perceptions of “awake” brain tumour surgery. Acta 
Neurochir (Wien) 2005;147:275-7; discussion 7. 
 5. Danks RA, Rogers M, Aglio LS, et al. Patient tolerance of craniotomy performed with the patient 
under local anesthesia and monitored conscious sedation. Neurosurgery 1998;42:28-34; discus-
sion -6. 
 6. Klimek M, van der Horst PH, Hoeks SE, et al. Quality and quantity of memories in patients who 
underwent awake brain tumor resection. World Neurosurg 2018;109:e258-64. 
 7. Joswig H, Bratelj D, Brunner T, et al. Awake Craniotomy: First-Year Experiences and Patient Percep-
tion. World Neurosurg 2016;90:588-96 e2. 
 8. Wrede KH, Stieglitz LH, Fiferna A, et al. Patient acceptance of awake craniotomy. Clin Neurol 
Neurosurg 2011;113:880-4. 
 9. Khu KJ, Doglietto F, Radovanovic I, et al. Patients’ perceptions of awake and outpatient crani-
otomy for brain tumor: a qualitative study. J Neurosurg 2010;112:1056-60. 
 10. Milian M, Tatagiba M, Feigl GC. Patient response to awake craniotomy - a summary overview. Acta 
Neurochir (Wien) 2014;156:1063-70. 
 11. Manninen PH, Balki M, Lukitto K, et al. Patient satisfaction with awake craniotomy for tumor 
surgery: a comparison of remifentanil and fentanyl in conjunction with propofol. Anesth Analg 
2006;102:237-42. 
 12. Hol JW, Klimek M, van der Heide-Mulder M, et al. Awake craniotomy induces fewer changes in the 
plasma amino acid profile than craniotomy under general anesthesia. J Neurosurg Anesthesiol 
2009;21:98-107. 
 13. Petrussi A, Finocchiaro CY, Lamperti A, et al. Living with a brain tumor. Reaction profiles in pa-
tients and their caregivers. Support Care Cancer 2013;21:1105-11. 
 14. Redelmeier DA, Kahneman D. Patients’ memories of painful medical treatments: real-time and 
retrospective evaluations of two minimally invasive procedures. Pain 1996;66:3-8
 15. Ruis C, Huenges Wajer I, Robe P, et al. Anxiety in the peroperative phase of awake brain tumor 
surgery. Clin Neurol Neurosurg 2017;157:7-10. 
 16. Milian M, Luerding R, Ploppa A, et al. “Imagine your neighbor mows the lawn”: a pilot study of 
psychological sequelae due to awake craniotomy: clinical article. J Neurosurg 2013;118:1288-95. 
 17. Santini B, Talacchi A, Casagrande F, et al. Eligibility criteria and psychological profiles in patient 
candidates for awake craniotomy: a pilot study. J Neurosurg Anesthesiol 2012;24:209-16. 
 18. Jenkins LM, Drummond KJ, Andrewes DG. Emotional and personality changes following brain 
tumour resection. J Clin Neurosci 2016;29:128-32. 
 19. Richter A, Woernle CM, Krayenbuhl N, et al. Affective Symptoms and White Matter Changes in 
Brain Tumor Patients. World Neurosurg 2015;84:927-32.
 20. Caljouw MA, van Beuzekom M, Boer F. Patient’s satisfaction with perioperative care: develop-
ment, validation, and application of a questionnaire. Br J Anaesth 2008;100:637-44. 
 21. Sherwood PR, Cwiklik M, Donovan HS. Neuro-oncology family caregiving: review and directions 
for future research. CNS Oncology 2016;5:41-8. 
152 Chapter 7
APPEnDix
Questionnaire with the questions used in this study.
The patients received the questionnaire with the questions in Dutch language. 
1) how much do you remember of the surgery (Please tick an answer):
Phase of surgery nothing few Partially A lot Everything
Preoperative night on the ward
Arrival on the OR
Inserting the i.v. lines
Insertion of breathing tube (intubation)
Fixing the head in the Mayfield clamp




Closure of surgical field
Transport to intensive care unit/ PACU
Removal of the breathing tube (extubation)
First night on the intensive care unit/ PACU
2) how are these memories for you? (Please tick an answer):
















Preoperative night on the ward
Arrival on the OR
Inserting the i.v. lines
Insertion of breathing tube (intubation)
Fixing the head in the Mayfield clamp




Closure of surgical field
Transport to intensive care unit/ PACU
Removal of the breathing tube 
(extubation)
First night on the intensive care unit/ 
PACU
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3) What was a cause of discomfort around or during the procedure. (1 not at all, 5 very big discom-
fort, please mark). Give an answer for each cause mentioned:






Not being allowed to move
Shaving of hair
Being covered with blankets and drapes
Inserted anesthesia cannules and tubes
Urinary catheter
Dry mouth
Injections for local anesthesia
Body temperature
Others, please specify:
4) Which of the causes mentioned at question 3) was the most discomforting at all? 
……………………………………………………………………………….
5) to what extent were you anxious by the idea of undergoing a brain tumor operation (1 is no anxi-
ety at all, 10 very anxious)?
In the days prior to the operation?
1 2 3 4 5 6 7 8 9 10
Looking back in the days after the operation?
1 2 3 4 5 6 7 8 9 10
6) to what extent were your relatives anxious by the idea that you were undergoing a brain tumor 
operation (1 is no anxiety at all, 10 very anxious)?
In the days prior to the operation?
1 2 3 4 5 6 7 8 9 10
Looking back in the days after the operation?
1 2 3 4 5 6 7 8 9 10
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7) if you reflect on the whole process around your operation and you need to give an overall satis-
faction score: Were you satisfied with the state of affairs (1 is not satisfied, 10 completely satisfied)?




Awake craniotomy in special populations

Chapter 8
Awake craniotomy for a glioblastoma in a  
nine-year-old boy.
Klimek M, Verbrugge SJC, Roubos S, van der Most E, Vincent AJPE, Klein J.
Anaesthesia 2004:59:607-9
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AWAkE CRAniotomy foR A GlioblAstomA in A ninE-yEAR-olD boy.
sUmmARy
We report the pre-operative preparation and anaesthetic management for resection of 
an intracerebral tumour during awake craniotomy in a 9-year-old boy. We believe this 
is the youngest patient reported to have undergone this procedure. The challenges of 
sedation and psychological care throughout the procedure are discussed. We conclude 
that the procedure can be performed safely and that it seems unacceptable to uphold 
an age restriction. We believe that it is the individual level of development of the child 
that determines suitability for this type of surgery.
keywords: Craniotomy: awake. Anaesthesia: paediatric. Conscious sedation
Awake craniotomy for a glioblastoma in a nine-year-old boy. 161
8
During brain tumour resection with intra-operative neuropsychological monitoring in 
awake patients (awake craniotomy) the anaesthetist has an important role in providing 
optimal psychological care and ensuring minimal discomfort to the patient without us-
ing drugs or techniques which make functional monitoring impossible [1]. The procedure 
has been eloquently described by Pasquet as ‘vocal anaesthesia’ [2]. Awake craniotomy 
has been performed for resections of tumours and epileptic foci in adults and children 
down to the age of 11 years [3,4]. Psychological screening for suitability and extensive 
preparation for the procedure may be more important in children [5–7]. Specific prob-
lems may include agitation, restlessness, and lack of co-operation, which may become 
dangerous during open brain surgery. This paper describes the pre-operative prepara-
tion and anaesthetic management for the resection of an intracerebral tumour by awake 
craniotomy in a 9-year-old boy, which to our knowledge is the youngest patient to 
undergo brain tumour resection with intra-operative neuropsychological monitoring.
CAsE REPoRt
A 9-year-old, 32-kg boy with neurofibromatosis type I required resection of a recurrent 
high-grade glioblastoma in the left temporo-parietal region (fig. 1) using intra-operative 
neuropsychological function monitoring (awake craniotomy). Six months previously, the 
same tumour had been partially removed under general anaesthesia. Postoperatively, 
the child had a mild disturbance of fine right-sided motor function. He had re-presented 
with headache, vomiting and photophobia.
The child was evaluated by a child psychologist and found to be eligible to undergo the 
procedure. He reported nightmares more appropriate for younger children demonstrat-
ing some psychological regression. He was, however, co-operative and showed a high 
level of endurance and was able to concentrate and perform specific frustrating tasks for 
more than 3 h. Because of his handicap, he had taught himself to become left-handed. 
He showed adequate emotional reactions with a low anxiety level and a panic attack 
during the operation was considered to be unlikely. He had a strong relationship with 
his father who was asked to accompany him throughout the operative procedure. As 
preparation for intra-operative brain mapping to identify language-controlling areas, 
he was extensively trained on a modification of the Aachen Aphasia Test in correctly 
recognizing and naming pictures [8, 9]. The child and his father received a detailed ex-
planation including a video presentation of all aspects of the procedure. In particular the 
need to remain still was emphasised.
On the evening before surgery the child was given lorazepam 0.5 mg orally and he 
received piritramide 0.1 mg/kg and promethazine 0.3 mg/kg intramuscularly 0.5 h pre-
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operatively. EMLA (Astra Zeneca, Zoetermeer, the Netherlands) cream was placed on the 
back of both hands. The pre-operative regimen of dexamethasone 2 mg four times daily 
and ranitidine 37.5 mg two times daily was continued right up to surgery. In theatre 
the boy was accompanied by his father and a child psychologist. Intravenous access 
was established and an infusion of Ringer’s lactate solution (70 ml/kg) started. A nasal 
catheter was inserted and oxygen 2 l.min)1 started. He found this to be unpleasant.
Sedation with propofol (bolus 50 mg, continuous infusion 4.69 mg/kg/h) was started 
and the child became very agitated. Removal of the nasal catheter offered no relief. The 
sedation was stopped, the boy woken up and after discussion the procedure continued 
with a reduced level of sedation (propofol 2.5 mg/kg/h) which produced a calm and co-
operative state. The child was positioned comfortably and covered in a warm air blanket 
[10]. Using local anaesthetic infiltration, an arterial cannula and a central venous cath-
eter (via the antecubital fossa) were placed, and a urinary catheter inserted. To reduce 
peroperative blood loss and to decrease intracranial pressure the child was placed in a 
slight reverse Trendelenburg position [11, 12]. The scalp and periosteum were anaesthe-
tised by local infiltration with bupivacaine 0.375% and epinephrine 1 : 200 000, 25 ml. 
was accompanied by his father and a child psychologist. Intravenous access was 
established and an infusion of Ringer’s lactate solution (70 ml.h)1) started. A nasal catheter 
was inserted and oxygen 2 l.min)1 started. He found this to be unpleasant. 
Sedation with propofol (bolus 50 mg, continuous infusion 4.69 mg.kg)1.h)1) was started 
and the child became very agitated. Re oval of the nasal catheter offered no relief. The 
sedati n was stopped, the b y woken up and after discussion t e procedure continued with 
a reduced level of sedati n (propofol 2.5 mg.kg)1.h)1) which produced a calm a d co-
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The craniotomy was started and the child’s co-operation during the mapping procedure 
and subsequent tumour resection was excellent. During the mapping procedure the 
brain surface was electrically stimulated by the neurosurgeon to identify areas of func-
tional relevance, whilst the child performed different tasks such as the Aachen Aphasia 
Test, moving his arm and his leg. This was the only period which he found stressful as 
judged from an increase in heart rate. The tumour was completely resected macroscopi-
cally after 3.5 h and the procedure finished. He felt a little pain during skin closure, which 
was managed with additional bupivacaine infiltration (5 ml). 
Oxygenation was well maintained throughout the procedure and the child did not 
hyperventilate (PaO2 12.5 and 13.9 kPa without oxygen and PaCO2 5.3 and 5.0 kPa at the 
beginning and end of the procedure, respectively).
The total amount of propofol given throughout the procedure was 269 mg. Postopera-
tively, he received regular paracetamol and morphine 4 mg s.c. on demand, which was 
requested once. When visited 1 day after the operation the child could remember some 
specific details of the procedure, but had partial amnesia. He was discharged in good 
health without speech impairment or new motor disability on the fourth postoperative 
day. 
DisCUssion
Awake craniotomy allows maximal tumour resection with a reduced risk of functional 
deficits when used for brain tumours situated in functionally relevant areas [13]. In 1954, 
Pasquet noted that ‘uncooperative adults and children under 10 years’ will not tolerate 
the application of local anaesthesia, scalp incision and craniotomy [14]. This case dem-
onstrates that an awake craniotomy is feasible and can be performed safely even in very 
young patients and it seems unacceptable to uphold an age restriction. The individual 
level of development of the child determines suitability.
Propofol sedation can lead to agitation and restlessness and it is advisable to use only 
mild levels of sedation to allow the patient to voluntarily suppress such restlessness. 
Soriano et al. stated that it is imperative that candidates for an awake craniotomy are 
mature and psychologically prepared to participate in the procedure [3]. They empha-
sised the importance of the cognitive level and motivation of the patient. Based on the 
nightmares the boy suffered, some psychological regression was evident. However, other 
psychological characteristics, considered to be better indicators of his ability to endure 
the procedure, showed that the child was mature for his age. When asked to draw a tree, 
he drew one bearing fruits and blossom, symbolic of the fact that he expected to survive 
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the procedure, and a nest with two birds and a mother, symbolic of himself, his sister and 
his mother. When asked to repeat this while squeezing a ball in his impaired right hand, 
he was able to reproduce the same drawing even after 3 h of extensive concentration.
Other authors have used different techniques for sedation of older children undergo-
ing awake craniotomy. Soriano et al. used a higher dose of propofol (1–2 mg/kg bolus, 
9 mg/kg/h infusion) combined with fentanyl (0.5–2 µg/kg) [3], whilst Tobias and Jiminez 
combined midazolam (0.05 mg/kg), with fentanyl (1.2 µg/kg), and propofol (2 mg/kg 
bolus, 6–12 mg/kg/h infusion) [4]. Our decision to use propofol alone was based on 
our excellent experience with this agent in adults. The reliable pharmacodynamic and 
predictable pharmacokinetic properties of propofol make it very useful for this setting. 
However, we found that with intensive psychological care throughout the procedure we 
were able to keep the child only lightly sedated (propofol 2.5 mg/kg/h) and he remained 
co-operative. The infiltration with local anaesthetic was sufficient to block pain from 
the surgical field and the use of opioids was unnecessary. There is very little published 
about operative procedures in awake children of a similar age using local or regional 
anaesthesia. However, even for simple procedures such as venepuncture, psychological 
preparation has been shown to reduce stress [15].
There is no guarantee that such a young child will understand the importance of this 
procedure, but the preoperative psychological evaluation gave strong support to our 
belief that our patient would fully co-operate. At this point, we believe that the more 
extensive tumour resection permitted by the technique of awake craniotomy with pres-
ervation of motor and speech function will outweigh the possible loss of quality of life 
due to the emotional distress of the procedure. To our knowledge, this is the youngest 
child to undergo a successful awake craniotomy. This case shows that such a procedure 
is feasible and safe in very young people with mild levels of sedation, provided they 
are appropriately evaluated pre-operatively and adequately guided throughout the 
per- and postoperative period.
Awake craniotomy for a glioblastoma in a nine-year-old boy. 165
8
REfEREnCEs
 1 Varkey GP. Introduction to anesthetic considerations for craniotomy in awake patients. Interna-
tional Anesthesiology Clinics 1986; 24: XV–XXI.
 2 Pasquet A. Combine regional and general anesthesia for craniotomy and cortical exploration. 
Part II. Anesthestic considerations. Reprint of a lecture given 1953. International Anesthesiology 
Clinics 1986; 24: 12–20.
 3 Soriano SG, Eldredge EA, Wang FK, et al. The effect of propofol on intra-operative electrocorti-
cography and cortical stimulation during awake craniotomies in children. Paediatric Anaesthesia 
2000; 10: 29–34.
 4 Tobias JD, Jimenez DF. Anaesthetic management during awake craniotomy in a 12-year old boy. 
Paediatric Anaesthesia 1997; 7: 341–4.
 5 Girvin JP. Resection of intracranial lesions under local anesthesia. International Anesthesiology 
Clinics 1986; 24: 133–55.
 6 Girvin JP. Neurosurgical considerations and general methods for craniotomy under local anesthe-
sia. International Anesthesiology Clinics 1986; 24: 89–114.
 7 Trop D. Conscious sedation analgesia during neurosurgical treatment of epilepsies – practice at 
Montreal Neurological Institute. International Anesthesiology Clinics 1986; 24: 75–83.
 8 Huber W, Poeck K, Willmes K. The Aachen Aphasia Test. Advances in Neurology 1984; 42: 291–303.
 9 Reulen HJ, Schmid UD, Ilmberger J, Eisner W, Bise K. Cortical mapping of language and speech 
functions during surgery for space-occupying lesions under local anesthesia. Der Nervenarzt 
1997; 68: 813–24.
 10 Feindel W. Electrical stimulation of the brain during surgery for epilepsy-historical highlights. 
International Anesthesiology Clinics 1986; 24: 75–87.
 11 Mavrocordatos P, Bissonnette B, Ravussin P. Effects of neck position and head elevation on 
intracranial pressure in anaesthetized neurosurgical patients: preliminary results. Journal of 
Neurosurgical Anesthesiology 2000; 12: 101–4.
 12 Rolighed Larsen JK, Haure P, Cold GE. Reverse Trendelenburg position reduces intracranial pres-
sure during craniotomy. Journal of Neurosurgical Anesthesiology 2002; 14: 16–21.
 13 Ebel H, Ebel M, Schillinger G, Klimek M, Sobesky J, Klug N. Surgery of intrinsic cerebral neoplasms 
in eloquent areas under local anesthesia. Minimal Invasive Neurosurgery 2000; 43: 192–6.
 14 Pasquet A. Combine regional and general anesthesia for craniotomy and cortical exploration. 
Part II. Anesthestic considerations. Anesthesia and Analgesia 1954; 33: 156–7.
 15 Kolk AM, van Hoof R, Fiedeldij Dop MJ. Preparing children for venepuncture. The effect of an 
integrated intervention on distress before and during venepuncture. Child, Care, Health and 
Development 2000; 26: 251–60.

Chapter 9
Awake craniotomy versus craniotomy under general 
anesthesia for the surgical treatment of insular 
glioma: choices and outcomes.
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AWAkE CRAniotomy vERsUs CRAniotomy UnDER GEnERAl AnEsthEsiA 
foR thE sURGiCAl tREAtmEnt of insUlAR GliomA: ChoiCEs AnD 
oUtComEs.
AbstRACt
objective: To investigate differences in outcomes in patients who underwent surgery 
for insular glioma using an awake craniotomy (AC) versus a craniotomy under general 
anesthesia (GA).
methods: Data from patients treated at our hospital between 2005 and 2015 were ana-
lyzed retrospectively. The preoperative, intraoperative, postoperative, and longer-term 
follow-up characteristics and outcomes of patients who underwent surgery for primary 
insular glioma using either an AC or GA were compared.
Results: Of the 52 identified patients, 24 had surgery using an AC and 28 had surgery 
under GA. The extent of resection was similar for the two anesthesia techniques: the 
median extent of resection was 61.4% (IQR: 37.8%–74.3%) in the WHO grade <4 AC 
group versus 50.5% (IQR: 35.0%–71.2%) in the grade <4 GA group and 73.4% (IQR: 
54.8%–87.2%) in the grade 4 AC group versus 88.6% (IQR: 61.2%–93.0%) in the grade 
4 GA group. Consistent with literature, there were more early neurological deficits after 
an AC, while the GA group showed more new late neurological deficits; however, these 
trends were not significant. Survival was similar between the two groups, with 100% 
1- and 2-year survival in the grade <4 groups.
Conclusion: Our results showed that the extent of resection, neurological outcomes, and 
survival were similar using the two anesthesia techniques. Since AC is more challenging 
for the patient and for his or her caregiver after surgery, this finding has implications for 
clinical decision making.
keywords: Insula; Glioma; Awake craniotomy; General anesthesia; Retrospective
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intRoDUCtion
The insular cortex of the brain plays roles in a variety of important neurological process-
es, including somatosensory processing, gustation, balance, control of cardiovascular 
tone and language [1,2]. Neoplasms, and especially gliomas, may cause dysfunction of 
these processes [1]. Insular gliomas represent a substantial portion of all central nervous 
system neoplasms, with 25% of all low-grade gliomas and 10% of all high-grade gliomas 
found in the insula [3]. The estimated incidence rates are 0.34 per 100,000 person-years 
for low-grade insular gliomas and 0.41 per 100,000 person-years for high-grade insular 
gliomas [4].
Surgical resection of insular gliomas is challenging due to their close proximity to 
several eloquent cortical areas and other critical areas. In addition, the presence of 
critical vascular structures, especially branches of the middle cerebral artery, can further 
complicate the procedure [5,6]. Case series of insular gliomal resections show similar 
results to other gliomal resection according to postoperative cognitive function[7].
Furthermore, these studies show that radical resection can improve progression-free 
survival and overall survival [8-11]. Traditionally, neurosurgeons have had the option 
to resect or debulk an insular glioma either by performing a craniotomy under general 
anesthesia (GA) or by using an awake craniotomy (AC), which allows cortical and/or 
subcortical mapping [12]. The AC procedure was developed to allow greater resection 
with less risk of damaging eloquent cognitive brain functions [1,13-15]. There is limited 
evidence regarding the best anesthesia technique for resecting these insular tumors, 
and the number of patients in published articles is relatively low. This is likely due to the 
technical challenges of the procedure and the low incidence of the disease.
Many patients with insular tumors have been treated at our hospital during the last 
decade. The data from these patients were analyzed to gain a better understanding 
of this specific patient population and the differences in outcomes between the two 
anesthesia techniques. Our aim was to investigate the differences in survival, extent of 




First, patients were identified who underwent a craniotomy under GA or using an AC for 
the resection or debulking of a primary insular glioma between 2005 and 2015. Patient 
information was retrieved from the electronic patient registry at our hospital. It is routine 
170 Chapter 9
practice to ask neurosurgical patients at intake whether they will allow their data to be 
used anonymously for research. Informed consent for the use of all data was provided 
by all of the patients in this retrospective analysis. This study protocol was approved 
by the ethics board at our hospital (MEC 2013-090). The neurosurgeon consulted with 
the neuro-anesthesiologist and then chose which anesthesia technique to use for each 
patient. This clinical choice was investigated in this case series in which patients were 
retrospectively categorized into two groups, an AC group and a GA group. All gliomas 
were resected using a transsylvian approach. Data were extracted for the entire peri-
operative (pre-, intra-, and post-operative) period and for the follow-up period. All data 
were extracted by the first author, double-checked by the last author, and discussed with 
the co-authors. The use of the two anesthesia techniques over time was also analyzed.
Preoperative characteristics
The clinical characteristics at presentation and the tumor characteristics were de-
termined in order to investigate the factors that may have influenced the choice of 
anesthesia technique. The following clinical characteristics were assessed: the presence 
of linguistic, motor, and sensory dysfunction; whether the patient had epilepsy; tumor 
size at MRI (calculated by volumetric analysis); dominant hemispheric localization; and 
glioma type. Although the tumor glioma type could only be confirmed histologically 
postoperatively, radiological presentation often clearly correlates with the pathological 
diagnosis, especially for glioblastoma multiforme (GBM) [16,17]. Therefore, the glioma 
type was used as a preoperative characteristic. The differences in these variables were 
analyzed between groups in order to assess which factors drove the clinical decision.
Intraoperative characteristics
The duration of the procedure, the amount of blood lost, and the EOR were compared 
between the two groups to investigate whether the anesthesia type influenced these 
factors. The duration of the procedure was determined according to the anesthesia 
time, which was defined as the time in hours between the time-out procedure (TOP) 
and signout/extubation/transport to the PACU and according to the surgical time, which 
was defined as the time in hours between the first incision and the last suture.
Volumetric analysis
Brainlab neuronavigation and planning software (version 3.0.0, BrainLAB, Feldkirchen, 
Germany) was used to define the borders of the tumor and to calculate its volume in 
order to assess the percentage of tumor that was removed. The volume was calculated 
both pre- and postoperatively using MRI scans that were performed as close to the 
surgical date as possible. In general, a T2-weighted or FLAIR MRI was used for lowgrade 
gliomas and a T1-weighted MRI with contrast was used for high-grade gliomas. The 
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radiology reports were used as a reference during each assessment to confirm the tumor 
location and borders. All tumor volumes were calculated in cubic centimeters. Cystic 
components were included in the total volume, but perifocal edema and intratumoral 
hemorrhages were not. Patients who did not have an MRI scan either pre- or postopera-
tively were excluded from the volume analysis.
Postoperative characteristics
The early postoperative characteristics were compared between the two groups by 
determining the mean lengths of hospital stay and the complications that occurred as a 
result of the procedure. The 1- and 2-year survival was determined for all patients, as was 
the 5-year survival for patients who were operated on before September 2012. Survival 
data for patients that were not followed-up at our hospital were obtained by calling 
each patient’s general practitioner.
Neurological outcome
The scale used by De Witt Hamer et al. [18] was used to compare neurological outcomes 
in the two groups. Data were retrieved on new-onset postoperative neurological deficits 
that were categorized as early (up to 3 months after surgery) and late (3 months or longer 
after surgery), and data on severe and non-severe deficits were retrieved as well. Deficits 
were categorized as severe when the patient’s muscle strength was grade 1, 2, or to 3 
on the Medical Research Council scale or aphasia, severe dysphasia, hemianopsia or a 
vegetative state was present. All other deficits were considered non-severe. A deficit was 
scored when it persisted for more than one postoperative day and the patient needed 
an intervention for the deficit.
Statistical analysis
The clinical outcomes of WHO grade 4 gliomas are worse than for other gliomas that 
have similar effects on neurocognitive function at presentation [11,19]; accordingly, 
grade 4 gliomas were analyzed separately. After comparing patients with grade <4 and 
grade 4 gliomas, the GA and AC groups were compared within the grade <4 and grade 
4 groups.
Normally distributed continuous variables were compared using independent sample 
t-tests. Non-normally distributed non-nominal variables were compared using the 
Mann- Whitney U test and the exact significance was reported, while nominal variables 
were compared using Chi-squared (χ2) and Fisher’s exact test when any of the categories 
had an expected count less than 5. To assess neurological outcomes, the proportion of 
patients presenting with an early or late deficit and the proportion who suffered from 
a severe early or late deficit were calculated. Neurological outcomes were presented 
with 95% CIs. Because survival and EOR were not normally distributed, 95% CIs were 
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not reported for these outcome measures. The EOR was calculated by subtracting the 
preoperative tumor volume by the postoperative volume and dividing the result by the 
preoperative tumor volume.
To deal with missing data, only available data were analyzed. However, the percentages 
are based on the whole group, including missing cases. Because multiple hypothesis 
testing was performed, an α-level of 0.01 was considered statistically significant; this 
was estimated by the Bonferroni correction technique [19]. Furthermore, a p-value be-
low 0.05 was seen as a trend towards significance and is discussed as such. The statistical 
analysis was performed using IBM SPSS Statistics 21 (IBM Corp., 2012. IBM SPSS Statistics 
for Windows, Version 21.0. Armonk, NY: IBM Corp.).
REsUlts
Data were retrieved for 52 patients; of these, 24 patients were treated with an AC, and 28 
patients were treated using a craniotomy under GA. Over time, there was a trend toward 
using AC less often and using GA more often in our hospital (figure 1).
Results 
Data were retrieved for 52 patients; of these, 24 patients were treated with an AC, and 28 
patients were treated using a craniotomy under GA. Over time, there was a trend toward 
using AC less often and using GA more often in our hospital (Figure 1).
Patient characteristics 
The groups were similar for all descriptive variables except age (Table 1). The mean age 
was 55.2±16.0 years for patients in the grade 4 GA group versus 41.9±10.5 years for 
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Patient characteristics
The groups were similar for all descriptive variables except age (table 1). The mean age 
was 55.2±16.0 years for patients in the grade 4 GA group versus 41.9±10.5 years for 
patients in the grade <4 GA group (p=0.017; 95% CI: 2.6–24.0 years). There were no sig-
nificant differences in age between the patients in the two anesthesia groups. Variables 
that could influence the choice to use AC versus GA table 2 shows an overview of the 
variables that could influence the choice to use AC versus GA.
Clinical presentation
There were no significant differences in linguistic and motor dysfunction between the 
AC and GA groups. There was a trend towards statistical significance for differences 
in sensory dysfunction at presentation according to tumor grade in the GA group: 3 
(23.1%) patients in the grade <4 GA group suffered from sensory dysfunction vs. 9 
(60.0%) patients in the grade 4 GA group (p=0.049). 
There was also a trend towards statistical significance for differences in epilepsy accord-
ing to tumor grade in the GA group: 8 (53.3%) patients in the grade 4 GA group suffered 
from epilepsy vs. 12 (92.3%) patients in the grade <4 GA group (p=0.038). The tumor size 
was similar in the two groups for both grade <4 tumors and for grade 4 tumors. There 
the grade <4 GA group suffered from sensory dysfunction vs. 9 (60.0%) patients in the 
grade 4 GA group (p=0.049).  
There was also a tr d t wards statistical significance for differences in epilepsy according 
to tumor grade in the GA group: 8  (53.3%) patients in the grade 4 GA group suffered from 
epilepsy vs. 12 (92.3%) patients in the grade <4 GA group (p=0.038). The tumor size was 
similar in the two groups for both grade <4 tumors and for grade 4 t mors. There was a 
trend towards statistical significance for differences in tumor size according to tumor grade 
in the GA group: 54.6±25.4 cm3 in the grade <4 GA group vs. 96.5±59 cm3 in the grade 4 
GA group (p=0.02); the difference was 41.9 cm3; 95% CI: 7.0–76.8 cm3. The tumors were 
more often localized in the dominant hemisphere in the grade <4 AC group than in the 
grade <4 GA group: 17 (89.5%) versus 8 (61.5%) (p=0.021). No such trend towards 
significance was found in the grade 4 groups in terms of localization in the dominant 
hemisphere. However, there was a significant difference in the glioma type in the GA group 
174 Chapter 9
Awake craniotomy for insular glioma surgery - choices and outcomes. 175
9
was a trend towards statistical significance for differences in tumor size according to 
tumor grade in the GA group: 54.6±25.4 cm3 in the grade <4 GA group vs. 96.5±59 cm3 
in the grade 4 GA group (p=0.02); the difference was 41.9 cm3; 95% CI: 7.0–76.8 cm3. The 
tumors were more often localized in the dominant hemisphere in the grade <4 AC group 
than in the grade <4 GA group: 17 (89.5%) versus 8 (61.5%) (p=0.021). No such trend 
towards significance was found in the grade 4 groups in terms of localization in the 
dominant hemisphere. However, there was a significant difference in the glioma type 
in the GA group versus the AC group. Specifically, astrocytomas were mostly resected 
using GA, while oligodendrogliomas were all resected using an AC. GBM was more often 
treated under GA. The p-value was <0.001 for these differences. 
Intraoperative and postoperative characteristics
table 3 shows the intraoperative and postoperative characteristics of the patients in the 
GA and AC groups.
Surgical duration
There was a trend towards significance for differences in anesthesia time in the GA 
group according to tumor grade: the anesthesia time was 6.4±1.2 hours for the grade 
<4 GA group and 5.0±2.1 hours for the grade 4 GA group (p=0.036; mean difference, 1.4 
hours; 95% CI: 0.10–2.8 hours). Post-hoc analysis showed a trend towards significance 
regarding the duration of anesthesia induction and preparation of the patient in the 
GA group: the time between the TOP and the incision was 1.2±0.13 hours for patients 
in the grade <4 GA group versus 0.99±0.24 hours for patients in the grade <4 GA group 
(p=0.02; mean difference, 0.19 hours; 95% CI: 0.032–0.34 hours).
Surgical characteristics
The intraoperative blood loss was higher in the grade <4 AC group, which showed a 
mean blood loss of 584±214 ml versus 307±188 ml in the grade <4 GA group (p=0.001; 
mean difference, 277 ml; 95% CI: 127–427 ml). There was no difference in blood loss 
between the grade 4 GA group vs. the grade 4 AC group or between the grade 4 and the 
grade <4 glioma groups within the two groups. Even though blood loss was greater in 
the grade <4 AC group, none of the patients received a blood transfusion. The EOR was 
similar in the grade <4 groups and in the grade 4 groups, but the EOR in the grade 4 GA 
group was significantly higher than in the grade <4 GA group: 82.4% (IQR: 60.1%– 92.8%) 
in the grade 4 group, and 50.5% (IQR: 35.0%–71.2%) in the grade <4 group (p=0.003)
(figure 2). One patient was excluded from the analysis because a postoperative MRI 
scan was not available, as the patient had pneumonia and was in the intensive care unit 
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Postoperative characteristics
The length of hospital stay was similar in the AC and GA groups. table 4 shows the 
complications. The 1-, 2-, and 5-year survival rates were higher in the grade <4 groups 
than in the grade 4 groups. No difference between AC and GA was found according to 1-, 
2-, and 5-year survival (figure 3). The 5-year survival time could be determined for the 
AC group, but some information was missing for the GA group.
Neurological outcome
Early onset deficits developed in 67% (95% CI: 46%–88%) of the patients in the AC 
group and in 57% (95% CI: 37%–77%) of the patients in the GA group. Severe early onset 
deficits developed in 25% (95% CI: 6%–44%) of the patients in the AC group and in 11% 
(95% CI: 0%–24%) of the patients in the GA group. Late onset deficits developed in 48% 
(95% CI 26%–70%) of the patients in the GA group and in 33% (95% CI: 10%–56%) of the 
patients in the AC group. Severe late onset deficits developed in 12% (95% CI: 0%–27%) 
of patients in the GA group and in 5% (95% CI: 0%–17%) of the patients in the AC group. 
None of the differences between the groups were significant. The groups were too small 
to analyze differences between grade 4 and grade <4 groups (figure 4).
One patient was excluded from the analysis because a postoperative MRI scan was not 
available, as the patient had pneumonia and was in the intensive care unit for 20 days. An 
MRI has not been performed in the ICU. 
Postoperative characteristics 
The length of hospital stay was similar in the AC and GA groups. Table 4 shows the 
complications. The 1-, 2-, and 5-year survival rates were higher in the grade <4 groups than 
in the grade 4 groups. No difference between AC and GA was found according to 1-, 2-,
and 5-year survival (Figure 3). The 5-year survival time could be determined for the AC 
group, but some information was missing for the GA group. 
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Neurological outcome 
Early onset deficits developed in 67% (95% CI: 46%–88%) of the patients in the AC group 
and in 57% (95% CI: 37%–77%) of the patients in the GA group. Severe early onset deficits 
developed in 25% (95% CI: 6%–44%) of the patients in the AC group and in 11% (95% CI: 
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Summary of results:
To summarize, a total of 52 patients underwent primary insular glioma resection at our 
hospital. This retrospective case series analysis found that over the course of the study 
period, the GA procedure was used more often than the AC procedure. Astrocytomas 
and GBMs were more often treated under GA, while oligodendrogliomas were more 
often treated using AC. Intraoperative blood loss was greater in patients with grade <4 
tumors in the AC group than in the GA group. The EOR was similar between the AC and 
GA groups, but the mean EOR was greater in the grade 4 GA group than in the grade <4 
GA group. The 1-, 2-, and 5-year mortality was similar between the AC and GA groups, 
but patients with grade 4 gliomas had worse survival than those with grade <4 tumors. 
New early deficits were more prevalent in the AC group, and new late deficits were more 
prevalent in the GA group, but the differences were not significant. 
DisCUssion
This retrospective analysis of patients with insular gliomas who were treated by an AC 
or by a craniotomy under GA was performed to gain insights into the effects of these 
two techniques on the patients, especially on EOR, survival, and neurological outcome.
Choice of anesthesia technique
In the later part of the investigated period, the GA technique was preferred over the 
AC technique because the GA procedure is less challenging for the patient and has 
advantages for the doctors. GA was also preferred for grade 4 gliomas, which more 
often present perivascularly and with adhesions to the M2 and M3 branches of the 
0%–24%) of the patients in the GA group. Late onset deficits developed in 48% (95% CI 
26%–70%) of the patients in the GA group and in 33% (95% CI: 10%–56%) of the patients 
in the AC group. Severe late onset deficits developed in 12% (95% CI: 0%–27%) of 
patients in the GA group and in 5% (95% CI: 0%–17%) of th  pati nts in the AC group. 
None of the differences between the groups were s gnificant. The groups wer  too s all to 
analyze differences b tween grade 4 a d grade <4 grou s (Figure 4).
Summary of results:
To summarize, a total of 52 patients underwent primary insular glioma resection at our 
hospital. This retrospective case series analysis found that over the course of the study 
period, the GA procedure was used more often than the AC procedure. Astrocytomas and 
GBMs were more often treated under GA, while oligodendrogliomas were more often 
treated using AC. Intraoperative blood loss was greater in patients with grade <4 tumors in 
the AC group than in the GA group. The EOR was similar between the AC and GA groups, 
but the mean EOR was greater in the grade 4 GA group than in the grade <4 GA group. 
The 1-, 2-, and 5-year mortality was similar between the AC and GA groups, but patients 
with grade 4 gliomas had worse survival than those with grade <4 tumors. New early 
deficits were more prevalent in the AC group, and new late deficits were more prevalent in 
the GA group, but the differences were not significant.  
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middle cerebral artery [21]. Pressure on these branches is painful for AC patients, so 
GA is typically used for grade 4 gliomas. The neurosurgeons at our hospital found that 
surgeries performed using AC were often quite long; the patients became fatigued, 
reducing the advantages of performing an awake surgery. Since craniotomy under GA 
showed good results, neurosurgeons who became comfortable resecting these tumors 
more often opted to use GA. However, AC was still preferred for patients with frontal 
opercular extension, especially when the dominant frontal operculum was involved 
and the patients presented with speech problems following an epileptic insult. Indeed, 
patients were more often treated with an AC if they presented with a tumor localized 
in their dominant hemisphere. Note that linguistic dysfunction as a symptom did not 
differ significantly between the groups. Because linguistic function resides mostly in 
the dominant hemisphere [22], AC may have been chosen for these patients to allow 
resection while ensuring clear demarcation of the functional language area in order to 
preserve this function [23].
Oligodendrogliomas were more often operated on using AC, and astrocytomas more 
often resected under GA. This is most likely because oligodendrogliomas are more often 
located in the frontal operculum than astrocytomas; therefore, AC is more often used 
for these tumors. A study on the use of AC for the resection of tumors in eloquent areas 
showed that all tumors had an oligodendrogliomal component [24].
Outcomes
The EOR was similar using AC and GA, but the EOR was smaller within the GA group 
for grade <4 tumors than for grade 4 tumors. This group also had a larger preoperative 
tumor volume, and this might explain the higher EOR. Since the edges of the tumor are 
the most difficult to resect, a larger tumor with a smaller surface area-to-volume ratio, 
could result in a higher EOR. In addition, GBMs with central necrosis are easier to distin-
guish from normal brain tissue than are low grade gliomas, allowing easier resection 
without the need to map the region. In the literature, the median EOR for insular gliomas 
varies from 83.4% to 86.2% [7, 10, 23]. However, only Lang et al. reported the EOR for 
the non-glioblastoma group separately (median EOR, 86%) [5]. However, it seemed that 
in this study, the population that presented with grade <4 tumors mainly had small 
diffuse tumors that were hard to resect. Diffuseness was not measured, so it cannot be 
compared to reports in the literature, but tumor size was measured. The mean tumor 
size was 61.2 cm3 in the AC group and 54.6 cm3 in the GA group, which contrasts with, for 
example, the mean tumor size of 107.7cm3 reported in the study by Alimohadi et al. [23].
The neurological outcomes observed in our population suggested that the AC results in 
fewer late neurological deficits than the GA technique, although the difference was not 
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significant. For a power of 80%, a sample size of 49 per group would be needed to find 
the same difference in the occurrence of early deficits, as in the study by De Witt Hamer 
et al. (α=0.01) [18]. For a power of 80%, a sample size of 1953 per group would be needed 
to detect the same difference in late deficits using the same assumptions. These larger 
sample sizes may not be attainable for this rare disease. Nevertheless, the trends of more 
early-onset neurological deficits after AC and more late-onset neurological deficits after 
GA are consistent with the literature [18]. De Witt Hamer et al. hypothesized that an AC 
enables more extended resection and more tumor control, resulting in the preservation 
of neurological functions that can be mapped at the cost of early transient neurological 
deficits. 
Differences in 1- and 2-year mortality were not observed between the two anesthesia 
groups. GA was preferred for the treatment of astrocytomas, which have a worse survival 
prognosis than oligodendrogliomas [11,25]. This apparent contradiction is explained by 
the small sample size in this study. Furthermore, the literature suggests that survival 
curves start to diverge after more than two years. Since most GA procedures were per-
formed in the second half of the study period, data were not available for some patients 
for the 5-year survival analysis, and conclusions regarding 5-year survival cannot be 
drawn. Our results indicated that 1 and 2 years after surgery for insular glioma, there 
were no differences in survival using AC versus GA. 
Other findings
In the GA group, patients in the grade <4 group were younger than patients in the grade 
4 group and more often presented with epilepsy. These findings can be explained by 
differences in the pathogenesis of primary and secondary GBM. Primary GBMs are most 
likely derived from neurological progenitor cells, while secondary GBMs are most likely 
derived from dedifferentiated glial cells [26]. Primary GBMs are more frequently diag-
nosed and often express wild type isocitrate dehydrogenase 1 or 2 (IDH1/2); in contrast, 
73%–88% of the patients with secondary GBMs express mutated IDH1 or IDH2 [26]. The 
epidemiological distribution of IDH1/2 mutations, which are associated with epilepsy, in 
the types of GBMs could explain the lower frequency of epilepsy in the grade 4 group in 
our population. It is more likely that this group mostly had primary GBMs that expressed 
wild type IDH1/2, which would explain the lower prevalence of epilepsy in the grade 4 
group than in the grade <4 group [27]. Since epilepsy is a symptom that can be sugges-
tive of brain tumors, secondary GBMs might be diagnosed in an earlier stage, e.g. as an 
astrocytoma, which could explain the lower prevalence of secondary GBMs as well as 
the younger age at which they are diagnosed [26].
Intraoperatively, blood loss was greater in the grade <4 AC group than in the grade <4 
GA group. This can be explained by the higher mean arterial blood pressure in awake 
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patients. There was no indication that this results in a clinically relevant difference in 
outcome. The anesthesia time was longer in the grade <4 GA group than in the grade 
4 GA group. The 1.4-hour difference between the groups could not be explained by the 
subanalysis, which showed a difference of 0.2 hours between the induction and prepara-
tion time between the grade <4 GA group and the grade 4 GA group. The difference 
between these groups cannot be fully explained. However, it can be more difficult to 
determine the borders of an insular LGG than the borders of an HGG, and therefore for 
this step may take longer when treating insular LGGs.
Limitations
This study had some limitations. First, this was a retrospective, single-center study of 
a disease that has a low incidence, so a larger sample size was not available. Some real 
differences may have been missed because of the size of the study. However, the sample 
size was comparable to or even larger than studies that have been published previously 
by other groups. Because the insula is a relatively common location for gliomas [3] and 
because insular gliomas have distinctive clinical features [10], this patient population is 
worth analyzing. Considering the low incidence of insular glioma, this study contributes 
to the existing body of knowledge about these patients.
Second, patients with WHO grade 4 glioma were compared with patients with grade 
<4 glioma, but it could be argued that WHO grade 3 and 4 groups should have been 
compared with WHO grade 1 and 2 groups. In this study, patients were divided based 
on similar clinical presentation and survival, but other authors have frequently grouped 
patients with grade 3 glioma with patients with grade 4 glioma [7]. However, the grade 4 
group in this study was large enough to merit its own group, especially considering the 
distinctive clinical features of GBMs.
Finally, there are some limitations due to the retrospective design of the study, and 
additional prospective studies are needed to validate these observations. The advan-
tage of our approach is that it provides a starting point for further study of additional 
research questions. For example, these results suggest that the value of AC for patients 
who present with linguistic dysfunction should be investigated further, as should the 
possible clinical relevance of higher blood loss during AC versus GA. Notably, there 
is an alternative technique that can be used to protect motor function in which the 
cortical processes are mapped using motor evoked potentials while the patient is under 
GA [28]. However, this technique was not performed at our hospital before 2015, so it 
is not discussed in this case series. It may be interesting to evaluate tumor extension 
into the temporal or frontal operculum as well as tumor extension medially beyond the 
lenticulostriate perforators; however, the subgroups were too small to draw any conclu-
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sions. Use of the transcortical approach for the resection of this type of tumor is another 
technique that is not performed in our hospital, even though it may provide greater 
exposure of the insula and therefore might facilitate a greater EOR [29]. However, in our 
experience, this technique is not in widespread use, plus it should be critically evaluated 
as it involves the use of an approach through healthy brain tissue. 
ConClUsion
AC was used more often for the resection of dominant hemispheric tumors and oligo-
dendrogliomas, while GA was used more often for astrocytomas and GBMs. However, 
both anesthesia techniques resulted in similar EORs, similar neurological outcomes, and 
similar 1- and 2-year survival in patients with similar tumor grades. Therefore, the added 
value of the more challenging AC procedure should be carefully considered for each 
patient. Prospective studies are needed to further evaluate the relative value of these 
techniques.
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Chapter 10
Awake craniotomy versus craniotomy under general 
anesthesia for supratentorial glioblastoma in 
eloquent areas: A retrospective controlled- matched 
study.




AWAkE CRAniotomy vERsUs CRAniotomy UnDER GEnERAl 
AnEsthEsiA foR sUPRAtEntoRiAl GlioblAstomA in EloQUEnt AREAs: 
A REtRosPECtivE ContRollED-mAtChED stUDy.
AbstRACt
background
Awake craniotomy with electrocortical and subcortical mapping (AC) has become the 
mainstay of surgical treatment of supratentorial low-grade gliomas in eloquent areas, 
but not as much for glioblastomas.
objective
This retrospective controlled-matched study aims to determine whether AC increases 
gross total resections (GTR) and decreases neurological morbidity in glioblastoma pa-
tients as compared to resection under general anesthaesia (GA, conventional).
methods
Thirty-seven patients with glioblastoma undergoing AC were 1:3 controlled-matched 
with one hundred eleven patients undergoing GA for glioblastoma resection. The two 
groups were matched for age; gender; preoperative Karnofsky Performance Score (KPS); 
preoperative tumor volume; tumor location; and type of adjuvant treatment. Primary 
outcomes were extent of resection and the rate of postoperative complications. The 
secondary outcome was overall postoperative survival. 
Results
After matching, there were no significant differences in clinical variables between 
groups. Extent of resection was significantly higher in the AC group: mean extent of 
resection in the AC group was 94.89% (SD=10.57) compared to 70.30% (SD=28.37) in the 
GA group (p=0.0001). Furthermore, the mean rate of late minor postoperative complica-
tions in the AC group (0.03; SD=-0.16) was significantly lower than in the GA group (0.15; 
SD=0.39) (p=0.05).
Conclusion
These findings suggest that resection of glioblastoma using AC is associated with 
significantly greater extent of resection and less late minor postoperative complica-
tions as compared with craniotomy under GA. These data suggest that in patients with 
glioblastoma near eloquent areas AC should be implemented in standard treatment. A 
prospective randomized study is therefore warranted. 
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intRoDUCtion
Glioblastomas are malignant brain tumours with an annual incidence of six per 100,000. 
Treatment options include surgery, along with chemo(radio)therapy. Glioblastomas are 
of infiltrative nature, have a relatively poor radio- and chemotherapy sensitivity and are 
therefore invariably lethal. The median survival for glioblastoma multiforme (GBM) after 
treatment is approximately 15 months[1-3]. Due to the invasive nature of gliomas, com-
plete resection in high grade gliomas is not possible. Surgeons strive to resect as much 
of the visible part of the tumor on MRI as possible, since the extent of this resection is 
correlated with survival and various predictive and prognostic factors[4-7]. Especially 
gross total resection (GTR) has been shown to increase survival in patients with high 
grade glioma, although at the risk of higher morbidity[4,8].
Awake craniotomy (AC) is the technique in which the patient is awake and cooperative 
during the resection of the tumor[9]. This allows the surgeon, together with cortical and 
subcortical mapping to prevent damage to eloquent cortical and subcortical areas dur-
ing resection. AC is now widely used to optimize the extent of resection while minimiz-
ing the risk of complications[10,16]. Therefore, AC is mainly preferred over craniotomy 
under GA in patients with low-grade glioma because of the usually near-eloquent loca-
tion of these tumors[10-12]. However, so far, AC has not yet been implemented routinely 
in high grade glioma surgery, although preservation of quality of life in these patients 
should be the first concern due to the limited prognosis. Only very few studies have re-
ported the use of AC in glioblastomas, but are only descriptive or studied in a systematic 
review which included also low grade gliomas or WHO grade 3 gliomas[13,14].
This retrospective cohort-matched study aims to determine whether AC increases the 
extent of resection and decreases neurological morbidity in patients with high grade 
glioma as compared to resection under general anesthaesia (GA).
mEthoDs
Anesthesia, Surgical procedure and Postoperative Management
All patients in the AC group were extensively prepared for the procedure by the anes-
thetist with audiovisual media. AC-patients were sedated with propofol for craniotomy 
and closure and completely awake during resection of the tumor. Oxygen was provided 
by a nasal canula, patients were spontaneously breathing throughout the whole proce-
dure. Local anesthesia was performed with Lidocaine 1% and Bupivacaine 0.25% and 
Adrenaline 1:200.000 for the pins of the Mayfield clamp and Bupivacaine 0.375% with 
Adrenaline 1:200.000 for the surgical field. After surgical incision, craniotomy and open-
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ing of the dura, propofol was discontinued, allowing the patient to wake up. During 
the resection of the tumor, standard electrocortical and subcortical stimulation and 
monitoring of speech and motor function were applied to resect the glioma[15]. After 
resection of the tumor the patient was sedated again with propofol until the termina-
tion of the operation.
GA patients were anesthetized with propofol, remifentanil and a non-depolarizing 
relaxant, intubated and mechanically ventilated throughout the procedure. In patients 
of both groups arterial blood pressure was measured invasively via the radial artery, 
and all patients received a urinary catheter. Mannitol, 200 ml 15% was given during 
the craniotomy period to all patients. After suturing, all patients were brought to the 
post-anesthesia-high-care-unit, where they spent the first 24 hours postoperatively. 
Morphine and paracetamol were given as postoperative analgesics routinely. 
Inclusion criteria
Two cohorts were selected from a database of patients with supratentorial glioblasto-
mas surgically treated using either AC or resection under GA at the Erasmus University 
Medical Center Rotterdam, Dept. of Neurosurgery, the Netherlands. All patients were 
treated for glioblastoma (WHO grade IV) between January 2005 and January 2015. 
Both techniques were used at the institute, but neurosurgeons not familiar with AC 
performed tumor resection under GA. Most neurosurgeons operated the patients with 
GBM under GA. In all cases, neuronavigation was used. Other adjuncts to surgery such 
as 5-ALA, intraoperative MRI or ultrasound were not used.
Criteria for inclusion in the study were as follows: 1) isolated GBM without evidence 
of multicentric or multifocal enhancement; 2) pathological diagnosis of glioblastoma 
multiforme (WHO Grade IV); 3) supratentorial lesion location; 4) preoperative KPS ≥60; 
5) elective surgery; 6) No crossover between groups, meaning that no individuals under-
went craniotomy under both AC and GA. No patients whose craniotomy was started as 
AC were converted to GA during the procedure.
Data collection
Patient characteristics were collected from a database and the hospital records, and 
presenting symptoms, neuroimaging findings, and data on pre- and postoperative 
neurological function and adjuvant treatment were documented. Preoperative KPS 
was assigned by the clinician at the time of evaluation and available in the chart for 
review in all cases. The MRI characteristics that were recorded included the lesion’s size, 
specific lobe involvement, presence of a hemorrhagic component, and the degree of 
mass effect. The size of the lesion before and after surgery (residual tumor) was calcu-
lated based on T1-MR-images with contrast, using the method described by (among 
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others) Shah et al[18] in three directions. Extent of resection (EOR) as a percentage was 
calculated as: (preoperative tumor volume - postoperative tumor volume)/preoperative 
tumor volume. Operative data were reviewed for the use of AC with motor and lan-
gugage mapping. Postoperative complications were classified in four categories: early 
minor-, early major-, late minor-, and late major complications. Classification of postop-
erative complications was used as described in the meta-analysis of colleagues de Witt 
Hamer et al[13]. The distinction between early- and a late complication was 6 months 
postoperatively. Late complications, even minor-, are clinically important since these 
indicate permanent neurological complications from the surgery. Note that patients 
can experience multiple postoperative complications. To count more than one post-
operative complication for one patient in the total number of complications (Table 6), 
the complications have to occur independently from each other. However, if a patient 
experiences an early complication that becomes permanent, this will solely be counted 
as an early complication.
Statistics: Matching procedure
The number of cases meeting the inclusion criteria was 37 in de AC group and 368 in 
the GA group. Patient characteristics of both groups before matching are shown in 
Tables 1 and 2. Because the number of patients who underwent craniotomy under GA 
in the same study period was disproportionately higher, a controlled matched selec-
tion of cases from the entire operative pool was performed based on the well known 
strongest prognostics[16,17]: 1) age, 2) gender, 3) preoperative KPS, 4) preoperative 
tumor volume, 5) tumor location, 6) type of adjuvant treatment (none, radiotherapy, 
chemotherapy, chemoradiotherapy). Propensity score matching was used to match con-
ventional to awake patients based on the covariates gender, treatment, age, KPS_preop, 
Volume_preop, and Tumor_location. Balance between the conventional and awake 
whereas for median survival the log-rank test was used. No adjustment for multiple testing 
has been done. The significance level was set to 5%. 
Results 
Baseline characteristics 
The AC and GA cohorts were matched for v riables that could affect the mean age, 
preoperative KPS, preoperative tumor volume, type of adjuvant treatment, gender and 
tumor location (Table 1-4). Before matching, there were significant differences in mean age 
(p<0.0001) and preoperative KPS (p=0.03) (Table 1 and 2).  
Preoperative tumor volume (p=0.23), type of adjuvant treatment (p=0.61), gender (p=0.73) 
and tumor location (p=0/08) did not differ significantly between groups (Table 1 and 2).  
192 Chapter 10
groups was checked with summary measures of QQplots comparing the covariates in 
the matched groups, and optimal results were achieved with a 1:3 matching ratio.
Statistics: Analysis after matching
111 cases were included in the GA cohort after matching. Patient characteristics of both 
groups after matching are shown in Tables 3 and 4. After matching, differences between 
the AC- and GA-groups in the matched data for the primary outcomes were tested: 1) 
extent of resection; 2) postoperative survival; and 3) rate of postoperative complica-
tions. Analysis of the matched data set was based on non-parametrics tests, namely for 
the outcomes Resection and Number of Complications Mann-Whitney tests were used, 
whereas for median survival the log-rank test was used. No adjustment for multiple test-
ing has been done. The significance level was set to 5%.
Preoperative tumor volume (p=0.23), type of adjuvant treatment (p=0.61), gender (p=0.73) 
and tumor location (p=0/08) did not differ significantly between groups (Table 1 and 2).  
After matching, there were no significant differences between groups in mean age (p=0.41), 
preoperative KPS (p=0.64), preoperative tumor volume (p=0.77), adjuvant treatment 
(p=0.89), gender (p=0.84) or tumor location (p=1.00) (Table 3 and 4).  




The AC and GA cohorts were matched for variables that could introduce bias: age, 
preoperative KPS, preoperative tumor volume, type of adjuvant treatment, gender and 
tumor location (Table 1-4). Before matching, there were significant differences in mean 
age (p<0.0001) and preoperative KPS (p=0.03) (Table 1 and 2). 
Preoperative tumor volume (p=0.23), type of adjuvant treatment (p=0.61), gender 
(p=0.73) and tumor location (p=0/08) did not differ significantly between groups 
(Table 1 and 2). 
Furthermore, tumors were equally distributed between the left-right hemispheres in the 
groups (p>0.05). 
Patient outcomes 
Extent of resection 
Resection  u der AC in glioblastoma patients proved to be superior to resections under GA 
regarding extent of resection. The ean extent of resection in the AC group was 94.89% 
(SD=10.57; IQR=6.76)), as compared to 70.30% (SD=28.37; IQR=44.76) in the GA group. 
The median extent of resection in the AC group was 100%, and 79.73% in the GA group. 
Table 5 and Figure 1 provide the extent of resection per group, showing significance (p < 
0.0001, Mann-Whitney test). 
groups (p>0.05). 
Patient outc m s 
Extent of resection 
0.0001, Mann-Whitney test). 
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After matching, there were no significant differences between groups in mean age 
(p=0.41), preoperative KPS (p=0.64), preoperative tumor volume (p=0.77), adjuvant 
treatment (p=0.89), gender (p=0.84) or tumor location (p=1.00) (Table 3 and 4). 




Resections under AC in glioblastoma patients proved to be superior to resections under 
GA regarding extent of resection. The mean extent of resection in the AC group was 
94.89% (SD=10.57; IQR=6.76)), as compared to 70.30% (SD=28.37; IQR=44.76) in the 
GA group. The median extent of resection in the AC group was 100%, and 79.73% in 
the GA group. Table 5 and Figure 1 provide the extent of resection per group, showing 
significance (p < 0.0001, Mann-Whitney test).
Postoperative complications 
Postoperative complications 
Table 6 presents the distribution of postoperative complications in all patients before 
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Postoperative complications
Table 6 presents the distribution of postoperative complications in all patients before 
matching. The total number of postoperative complications in 405 patients was 260, of 
which 176 early- and 84 late postoperative complications. 16 of the 176 early postop-
erative complications occurred in the AC group (rate=0.43), and 160 in the GA group 
(rate=0.41). 3 of the 84 late complications occurred in the AC group (rate=0.081), and 81 
in the GA group (rate=0.21). 
Since the main objectives of AC is to minimize postoperative complications while 
maximizing the extent of resection, the distribution and nature of the postoperative 
complications is of particular interest in this group. The 16 early postoperative 
complications in the AC group consisted of: N. VII palsy (n=5), aphasia (n=4), monoparesis 
grade 4 (n=3), unspecified cranial nerve deficit (n=2), hemiparesis (n=1) and parietal 
syndrome (n=1). The 3 late postoperative complications in the AC group consisted of: 
hemiparesis (n=2) and monoparesis grade 4 (n=1). The AC group experienced 19 
complications in total (16 early and 3 late). These 19 complications were divided over 11 
patients (total: 37; rate=0.30), while 182 of the 368 patients in the GA group experienced a 
complication (rate=0.49). 
Since the main objective of AC is to minimize postoperative complications while 
maximizing the extent of resection, the distribution and nature of the postoperative 
complications is of particular interest in this group. The 16 early postoperative complica-
tions in the AC group consisted of: N. VII palsy (n=5), aphasia (n=4), monoparesis grade 4 
(n=3), unspecified cranial nerve deficit (n=2), hemiparesis (n=1) and parietal syndrome 
(n=1). The 3 late postoperative complications in the AC group consisted of: hemiparesis 
(n=2) and monoparesis grade 4 (n=1). The AC group experienced 19 complications in 
total (16 early and 3 late). These 19 complications were divided over 11 patients (total: 
37; rate=0.30), while 182 f the 368 patients in the GA group experienced a complication 
(rate=0.49).
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complications in total (16 early and 3 late). These 19 complications were divided over 11 
patients (total: 37; rate=0.30), while 182 of the 368 patients in the GA group experienced a 
complication (rate=0.49). 
Table 7 summarizes the rate of postoperative complications in both groups after match-
ing (Mann-Whitney test). Complications were classified in four categories: early minor 
(E_min); early major (E_maj); late minor (L_min); and late major (L_maj). The mean rate of 
early minor postoperative complications in the AC group was 0.24 (SD=0.64), while this 
was 0.22 (SD=0.46) in the GA group (p=0.71). The mean rate of early major postoperative 
complications in the AC group was 0.19 (SD=0.40), as compared to 0.25 (SD=0.48) in the 
GA group (p=0.54). We found a significantly higher rate of late minor postoperative com-
plications in the GA group than in the AC group: 0.15 (SD=0.39) versus 0.03 (SD=0.16) 
(p=0.05). The mean rate of late major postoperative complications was 0.05 (SD=0.23), 
and 0.12 (SD=0.32) in the GA group (p=0.27).
Table 7 summarizes the rate of postoperative complications in both groups after matching 
(Mann-Whitney test). Complications were classified in four categories: early minor (E_min); 
early major (E_maj); late minor (L_min); and late major (L_maj). The mean rate of early 
minor postoperative complications in the AC group was 0.24 (SD=0.64), while this was 0.22 
(SD=0.46) in the GA group (p=0.71). The mean rate of early major postoperative 
complications in the AC group was 0.19 (SD=0.40), as compared to 0.25 (SD=0.48) in the 
GA group (p=0.54). We found a significant higher rate of late minor postoperative 
complications in the GA group than in the AC group: 0.15 (SD=0.39) versus 0.03 (SD=0.16) 
(p=0.05). The mean rate of late major postoperative complications was 0.05 (SD=0.23), 
and 0.12 (SD=0.32) in the GA group (p=0.27). 
M dian postoperative survival 
Groups were compared for post perative survival usi g Kaplan-Meier curve  (Figure 2, 
Logrank test). Although we f nd a trend to longer median survival times in the AC group, 
this did not reach statistical significance (p=0.297; χ2=1.1). Median survival time in the AC 
group was 17 months (CI: 12.0 ; 36.0); as compared to 15 months (CI: 13.0 ; 18.0) in the 
GA group.
Discussion 
This matched controlled study shows that patients undergoing awake craniotomy for a 
single supratentorial GBM had significant greater extent of resection of their tumor 
compared with patients undergoing resection under GA. Moreover, the rate of late minor 
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Median postoperative survival
Groups were compared for postoperative survival using Kaplan-Meier curves (Figure 2, 
Logrank test). Although we found a trend towards longer median survival times in the 
AC group, this did not reach statistical significance (p=0.297; χ2=1.1). Median survival 
time in the AC group was 17 months (CI: 12.0; 36.0); as compared to 15 months (CI: 13.0; 
18.0) in the GA group.
DisCUssion
This matched controlled study shows that patients undergoing awake craniotomy for 
a single supratentorial GBM had significantly greater extent of resection of their tumor 
compared with patients undergoing resection under GA. Moreover, the rate of late mi-
nor postoperative complications in the AC group was significantly lower than in the GA 
group. Despite a higher resection percentage, no significant increase of median survival 
was found after AC. This could be explained by the low number of AC patients which 
remained after the matching procedure.
These results suggest that AC should be implemented as a routine technique for surgery 
of high grade tumors near eloquent areas of the brain. There is increasing evidence in 
the scientific literature that extensive resections are significant predictors of longer sur-
vival time in malignant glioma. However, a higher risk of morbidity has been reported 
before as the potential cost of pursuing gross-total resection (GTR)[4-8].
Surgical techniques have evolved, and the introduction of AC has proved to be a major 
stepping-stone in acquiring a greater extent of resection without an increased risk of 
morbidity. AC with cortical and subcortical stimulation has the advantage to control 
neurological function during brain tumor surgery and to increase the extent of resec-
tion in glioma surgery. However, AC has yet mainly been implemented for low-grade 
gliomas. Surgery of GBM is usually performed under GA. Hence, resections are not as 
aggressive as possible, due the chance of seriously damaging the patient with a rather 
low life expectancy. Our results show that surgery with the AC technique can preserve 
quality of life of these patients by decreasing the risk of postoperative morbidity. Our 
data also shows that an increased resection with AC can attain improvement in progno-
sis in GBM patients.
Other studies have found similar results regarding postoperative complications and ex-
tent of resection after AC. De Witt Hamer et al[13] conducted an extensive meta-analysis 
including 8.091 adult patients who had surgery for supratentorial infiltrative glioma 
(high and low grade glioma), with or without intra-operative stimulation mapping (ISM; 
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e.g. awake craniotomy). They found that glioma resections using ISM were associated 
with fewer late major neurologic deficits and more extensive resection. Although this 
was a mixed group of patients, these findings are entirely in line with our results in 
glioblastoma patients. 
Yoshikawa et al[14] conducted a study in 42 glioblastoma patients. They concluded that 
radical surgery with neurophysiological monitoring improved the functional outcome 
in glioblastoma patients. Moreover, Sacko et al[12] prospectively studied two groups 
of patients with supratentorial masses (n = 575), comparing AC with craniotomy under 
GA. They found that using AC in glioma surgery proved to be superior to craniotomy 
under GA regarding neurological outcome and quality of resection (p < 0.001). The 
findings from these studies are in harmony with our results. Peruzzi et al[11] add a new 
dimension by evaluating the length of hospital stay and inpatient costs after ICU care for 
glioma patients who were treated with AC and surgery under GA. They concluded that 
patients undergoing glioma resection using AC had a significantly shorter hospital stay 
with reduced inpatient hospital expenses after postoperative ICU care.
The major limitation is the retrospective nature of this study. Firstly, we expected a 
strong selection bias for patients operated with AC. Younger patients with higher KPS 
are usually selected for AC when the tumor is situated near eloquent areas. However, we 
minimized the risk for this bias by the using a matched controlled study design. Of course, 
biases caused by other factors than age, KPS, tumor location, tumor volume and type 
of adjuvant therapy could play a role, but are prevented as much as possible with this 
matched controlled study. The matching procedure also shows that many patients with 
tumors in eloquent areas were operated under GA. Secondly, the matching procedure 
did not take into account IDH-1 mutations which are associated with longer survival in 
patients with GBM. However, IDH-mutation is mainly present in younger patients and 
only expressed in 10%-20% of high grade gliomas. It is unlikely that these mutations 
would influence the matching procedure.
ConClUsions
Resection of glioblastoma using AC is associated with significantly greater extent of 
resection and less minor late postoperative complications as compared with craniotomy 
under GA. No significant difference in median survival was found. Our findings confirm 
preliminary findings of other authors with smaller group sizes and urge the need for a 
randomized clinical trial to further reduce potential bias.
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PAin in nEURosURGiCAlly tREAtED PAtiEnts: A PRosPECtivE 
obsERvAtionAl stUDy.
AbstRACt
object: This is the first observational study to compare perioperative pain character and 
intensity in patients undergoing different types of elective neurosurgical procedures.
methods: A structured questionnaire was used to inquire about pain intensity, charac-
ter, and management during the perioperative course, and the anticipated visual ana-
logue scale (VAS) score in 649 patients during a 1-year period. The anticipated maximal 
postoperative VAS score was lower than the actual postoperative maximal VAS score and 
was independent of operation type and preoperative VAS score. Patients undergoing 
craniotomy experienced less pain than those undergoing spinal surgery. A majority of 
patients did not receive analgesic medication after surgery. Patients undergoing spinal 
surgery experienced higher preoperative VAS scores than those undergoing other neu-
rosurgical treatments, with a shift from preoperative referred pain to postoperative local 
pain. After lumbar flavectomy, referred pain was greater than local pain. Patients with 
preoperative pain suffered significantly more postoperative pain than those without 
preoperative pain. In patients with postoperative surgery-related complications, VAS 
scores were higher than in those without complications. 
Conclusions: Neurosurgical procedures cause more pain than anticipated. Anticipated 
pain intensity is independent of the operation type and preoperative pain intensity. 
Postcraniotomy on-demand analgesic medication is appropriate, if the nurses on the 
ward react quickly. Otherwise, patient-controlled analgesia might be an option. Other 
neurosurgical procedures require scheduled analgesic therapies. Spinal surgery requires 
intensive preoperative pain treatment; a shift in pain character from preoperative 
referred pain to postoperative local pain is expected. Patients with referred pain after 
lumbar flavectomy are prone to the most intense pain. Patients with preoperative pain 
experience more postoperative pain than those without preoperative pain and require 
more intensive pain management. Increased postoperative VAS scores are associated 
with surgery-related complications.
KEY WORDS • pain	•	neurosurgery	•	visual	analog	scale	•	observation	•	complication
Abbreviations used in this paper: ACS = aneurysm clip surgery; ANOVA = analysis of 
variance; ASA = American Society of Anesthesiologists; CS = cervical spondylodesis; LF 
= lumbar flavectomy; LTR = laminectomy with tumor resection; MCP = miscellaneous 
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cranial procedure; MEXP = miscellaneous extremity procedure; MSP = miscellaneous 
spinal procedure; SBICPM = skull boring with intracranial pressure measurement; THR = 
trephination and hematoma removal; TSO = transsphenoidal operation; TTR = trephina-
tion with tumor resection; VAS = visual analog scale; VPS = ventriculoperitoneal shunt; 
WHO = Word Health Organization
intRoDUCtion
Little is known about perioperative pain in patients undergoing neurosurgical procedures. 
There is a conventional accepted clinical impression that a trephination is associated with 
a small degree of postoperative pain whereas the opposite is true, for example, with spi-
nal neurosurgical procedures.[8,10,26,27] There is controversy in the literature regarding 
the occurrence of pain and its intensity in patients undergoing neurosurgical procedures.
[8,10] A different approach to postoperative pain management has been advocated for 
craniotomy procedures,[13,26,30] compared with lumbar disc surgery,[12] because the 
risk of severe sedation and cardiorespiratory instability seems lower. Moreover, different 
clinicians use different pain therapies for the same neurosurgical procedures,[27] and dif-
ferent types of pain therapy have been advocated for the same neurosurgical procedure.
[13,26,30] Risk factors for postoperative pain have been extensively investigated and in-
clude female sex, preoperative pain severity, younger age, surgical procedure, expected 
incision size, and psychological profile.[3,4,7,14,15,19,24,29] The authors of these studies, 
however, have not provided appropriate insights to allow comparison of all different 
types of neurosurgical procedures regarding pain intensity, character, and course after 
neurosurgical procedures. To our knowledge, no large observational study has been con-
ducted to compare different types of neurosurgical procedures performed in one clinical 
center to determine perioperative VAS scores related to patient characteristics, pain 
type, pain intensity, and anticipation of postoperative pain. Therefore, we conducted a 
1-year observational study on pain intensity and pain character covering all categories of 
patients undergoing an elective neurosurgical procedure in a university hospital. 
CliniCAl mAtERiAl AnD mEthoDs
The study was approved by the Medical Ethical Committee of the University Medical 
Centre of the University of Cologne, Germany. The investigators fully respected and 
followed the declaration of Helsinki in the current version (Edinburgh, Scotland 2000). 
During a 1-year period, all patients undergoing an elective neurosurgical procedure 
were considered for inclusion in the study. Patients in same-day surgery (for example, 
those undergoing carpal tunnel release) were excluded from the study. 
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The patients enrolled in this study were visited the day before surgery by one of two 
investigators. All patients were admitted to hospital the day before surgery. The first 
visit was on the evening before surgery. Further postoperative visits took place on the 
1st, 3rd, and 5th postoperative days between 4:00 p.m. and 8:00 p.m. Each visit lasted 
approximately 5 to 10 minutes. 
Patients were excluded from the study if any of the following variables applied to 
them: were unable to estimate the amount of pain because of decreased awareness; 
could not speak appropriate German; were undergoing an emergency operation; were 
unresponsive to questions; were not willing to cooperate; or were younger than 18 years 
of age.
On the first visit, the patient was informed about the study. Special attention was paid to 
the fact that the patient would be observed by the investigator, that these observations 
would be documented but that the patient would not receive special pain manage-
ment, and that the anesthetic procedure planned by the anesthesiologist would not be 
changed. The neurosurgeon was responsible for pain management on the ward, and 
the patient could withdraw from the study at any time. Written informed consent was 
obtained from all patients. We made no differences in the pain management methods 
between patients undergoing procedures that were expected to cause significant (for 
example, most spine procedures) and those that were expected to produce only little 
pain (for example, all trephinations for tumors and aneurysms).
To measure the extent of pain, we used a VAS, in which the scores ranged from 0 (no 
pain) to 100 (worst pain imaginable). To record responses, the patient had to move a thin 
bar on a 10-cm line between the two extremes, which was demonstrated each time by 
our research team. 
On the preoperative day, the current pain treatment and type of treatment were re-
corded. The patient’s weight, age, sex, and ASA classification[18] (a reflection of the 
severity of preoperative comorbidities) were recorded. At the time of premedication, 
the preoperative VAS score was registered. The nature of the pain was characterized as 
follows: no pain, sharp local pain, diffuse local pain, referred pain, sudden-onset pain, 
normal headache, and other pain types. The patients were asked if they needed (further) 
pain treatment. Finally, the patients were asked about the maximal postoperative pain 
that they anticipated.[2]
During the perioperative period, the operation type and duration were noted. Moreover, 
after the operation had been performed, the investigators documented from the drug 
charts the type and dose of analgesics used on the day of operation.
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On the 1st, 3rd, and 5th postoperative days, all patients were asked about the following: 
their VAS score at the initial visit, the pain character, if they had informed the staff about 
the pain, and whether they received adequate treatment after they had informed the 
staff. The patient was asked if they had received analgesic medication in the last 6 hours 
prior to the visit, and the kind of treatment was noted from the drug charts. 
Some additional questions were asked. On the 1st postoperative day, the patient was 
asked to determine the maximal VAS score on the day of surgery and at what time 
this pain occurred.[1] On the 5th postoperative day, the medical staff was asked if any 
surgery-related complications (wound infection, reoperation, a second procedure, or a 
postoperative bleeding) occurred in any of the study patients. 
With the visit on the 5th postoperative day, the period of observation ended. All enrolled 
patients were admitted to hospital until at least the 5th postoperative day. Participation 
in this study did not delay discharge from the hospital. The discharge decisions were 
made by the neurosurgeons only. It was current practice during the entire study period 
that patients undergoing lumbar flavectomy, for example, were hospitalized for at least 
1 week postoperatively. Similarly, in the group of patients undergoing miscellaneous 
extremity procedures (for example, neurolysis of the median nerve), only two of the nine 
patients were monitored until postoperative Day 5. A patient was excluded from the 
study if still intubated 24 hours after surgery, if not aware enough to answer questions, 
or if unwilling to cooperate further, for any other reason.
Statistical Analysis
To analyze the data, the patients were grouped by surgical procedure. Each separate 
study group required 10 or more patients. There were 10 different procedures with 
10 or more patients per group: TTR, VPS placement, TSO, SBICPM, THR, ACS, CS, LF, 
laminectomy, and LTR. One hundred nine patients underwent procedures that were 
performed fewer than 10 times (for example, lumbar fixation or frontobasal covering); 
these patients were divided into three groups: MSPs, MCPs, and MEXPs. The results of 
the preoperative interviews were analyzed if the patient was excluded on or after the 
1st postoperative day. If a patient had to undergo reoperation for a surgery-related 
complication, the results obtained before the complication were still analyzed. The VAS 
scores and findings of the second operation were analyzed as if the data were obtained 
in a new case.
Intergroup comparisons for age, weight, operative time, maximal anticipated VAS score, 
maximal VAS score, and VAS score on the 1st, 3rd, and 5th postoperative days were 
conducted using an ANOVA with a Bonferroni posttest or a nonparametric Kruskal–Wal-
208 Chapter 11
lis test when appropriate. Intergroup comparisons for ASA class distribution and male/
female ratios were analyzed with the chi-square test for independence.
Intragroup comparisons of VAS scores over time were made using a repeated-measures 
ANOVA with a Bonferroni posttest or a Friedman nonparametric test when appropriate. 
A Student t-test was used to demonstrate a significant difference between the maximal 
anticipated VAS score and the maximal real postoperative VAS score.
Visual analog scale scores were stratified according to several characteristics: 1) age 
range (0–19, 20–39, 40–59, and ≥60 years); 2) sex; 3) ASA classification; 4) pain character 
over time, within the different treatment groups; 5) different types of postoperative pain 
medication (patients receiving no pain medication; those receiving WHO Class I, II, or 
III pain medication;[31,32] or different types of pain medication), within the different 
study groups; 6) whether patients asked for pain medication after surgery, within the 
different study groups; 7) whether patients received adequate treatment after informing 
the personnel about pain, within the different study groups; 8) a complicated compared 
with an uncomplicated postoperative course; and 9) whether patients had pain before 
surgery. table 1 provides a summary of WHO classes of pain medication. 
tAblE 1 WHO classification of pain treatment
Class Description Examples
I nonopioid analgesic drugs nonsteroidal antiinflammatory drugs, acetaminophen
II weak opioids (+ nonopioid analgesic drugs) tramadol, codeine
III strong opioids (+ nonopioid analgesic drugs) morphine, piritramid, meperidine
Intergroup comparisons of VAS intensity scores were analyzed using an ANOVA with a 
Bonferroni posttest, a nonparametric Kruskal–Wallis test, or a t-test, as appropriate. Dif-
ferences in patient numbers and pain character (distribution) within groups, after strati-
fication, were analyzed using a chi-square test for independence. Intragroup VAS scores 
over time, measured after stratification, were compared using a repeated-measures 
ANOVA with a Bonferroni posttest or a Friedman nonparametric test, as appropriate.
Statistical significance was accepted at a probability value less than 0.05. 
REsUlts
Clinical and surgical data are summarized in table 2; significant intergroup differences 
are indicated. table 3 illustrates the VAS scores in the different study groups over time; 
significant differences between groups and over time are indicated. The maximal VAS 
score was significantly higher than the maximal anticipated VAS score overall and in the 
TSO, SBICPM, THR, LF, MSP, and MCP groups.
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The distribution in pain character over time, with different operation types, is shown 
in table 4; significant differences in pain distribution and VAS scores for the different 
pain categories are indicated. table 5 illustrates data pertaining to patients who did and 
who did not ask for analgesic medication; significant differences are indicated. table 6 
provides a summary of data pertaining to patients who did and did not feel the relief 
of pain was adequate after receiving analgesic medication, with significant intergroup 
differences indicated.
On the 1st postoperative day, the VAS scores were significantly lower among patients 
receiving WHO Class I medication than those receiving WHO Class II medication overall 
and in the CS and LF groups; however, the scores were lower than those in patients 
receiving WHO Class III medication overall. On the 1st postoperative day the VAS score 
was significantly lower in patients receiving WHO Class III medication than in those 
receiving Class II medication in the LF group. On the 3rd postoperative day, the VAS 
score was significantly lower in patients receiving WHO Class I medication than in those 
receiving WHO Class II medication overall and in those in the LF group, and lower than 
those in patients receiving WHO Class III medication in the overall population. Finally, 
on the 5th postoperative day, the VAS score was significantly lower in patients receiving 
WHO Class I medication compared with WHO Class II medication overall and in the CS 
and LF groups; they were also lower than in patients receiving WHO Class III medication 
overall and in the LF group. 
In the overall patient population, the VAS scores on the 1st, 3rd, and 5th postoperative 
days were significantly lower in patients without preoperative pain (16.6 ± 19.7; 10.2 ± 
14.9; and 6.1 ± 12.9, respectively) than in patients with preoperative pain (28.1 ± 21.8; 
20.7 ± 21.4; and 15.0 ± 18.0, respectively). The pain character was also significantly dif-
ferent between patients with and without preoperative pain. 
Patients with pain before surgery experienced significantly more sharp and referred 
pain after surgery (on Days 1, 3, and 5). Patients without pain before surgery more often 
reported “no pain” during the postoperative period (on Days 1, 3, and 5). Additionally, 
the VAS scores were significantly lower in patients without presurgical pain than in those 
with pain before surgery on Days 1, 3, and 5 in patients in the TTR and MSP groups; on 
Day 1 for those in the TSO group; on Days 3 and 5 for those in the LF group; and on Day 
5 for those in the VPS placement, SBICPM, THR, and LTR groups.
The VAS score was independent of patient’s gender. On the 5th postoperative day, 
patients with ASA Class III morbidities suffered significantly more pain than those with 
ASA Class I morbidities. The preoperative VAS score was significantly higher in patients 
in the 40 to 59–year-old age group than in those 0 to 19 years of age. The maximal 
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postoperative VAS score was significantly higher in patients in the 20 to 39–year-old age 
group than in those older than 60 years of age.
Overall, 36 patients sustained relevant surgery-related complications such as delayed 
wound healing (one case), meningitis (two cases), fluid-filled fistula (three cases), early 
VPS-related problems (three cases), and early relapse of lumbar hernia (10 cases). Sev-
enteen patients had to undergo a reoperation during the study period (one each in the 
THR, ACS, and MSP groups; four in the CS group; and 10 in the LF group).
In the overall patient population, the VAS scores were significantly higher on the 3rd and 
5th postoperative days in patients with surgical complications (30.5 ± 24.8 and 38.4 ± 
28.8) than in those without surgical complications (16.4 ± 19.0 and 11.2 ± 15.5, respec-
tively). The same applied on Day 5 to patients in the MCP group (53.0 ± 1.4 compared 
with 9.8 ± 11.62); on Days 3 and 5 to patients in the TTR group (27.8 ± 29.4 and 31.0 ± 
30.0 compared with 10.47 ± 15.7 and 6.73 ± 10.0) and to patients in the LF group (29.8 ± 
28.6 and 45.0 ± 24.8 compared with 18.1 ± 18.2 and 11.8 ± 15.2); and on Days 1, 3, and 5 
in the CS (44.13 ± 14.0, 45.8 ± 16.7, and 59.5 ± 28.3 compared with 22.63 ± 19.8, 16.8 ± 
21.0, and 12.1 ± 16.6) and MSP (58.3 ± 36.1, 51.0 ± 24.9, and 48.7 ± 42.2 compared with 
30.9 ± 20.9, 20.8 ± 19.8, and 16.1 ± 17.9) groups, respectively.
DisCUssion
Not surprisingly, in the different surgical groups, VAS scores decreased significantly over 
time after surgery. More interestingly, the patients in the TTR group had significantly 
less pain on the day of operation and on postoperative Days 1, 3, and 5 than those in 
the other groups (except for the SBICPM group), and this was significantly different from 
groups CS and LF. This finding is supported by another study in which investigators 
found that craniotomy procedures were associated with lesser analgesic requirements 
than extracranial procedures.[10] Some patients undergoing trephination, however, do 
suffer serious postoperative pain.[22] In those patients, codeine phosphate has been 
shown to be more effective than tramadol.[4] Scalp nerve blocks can decrease the pain 
severity after craniotomy, and this effect is long lasting, possibly due to a preemptive 
mechanism.[20] In patients undergoing craniotomy, postoperative pain is treated 
insufficiently with acetaminophen alone and should be combined with tramadol or 
nalbuphine.[30] In contrast to the general accepted clinical impression that craniotomy 
is associated with less perioperative pain, De Benedittis and coworkers[8] have indi-
cated that postoperative pain in patients undergoing craniotomy is an important and 
neglected clinical problem that, to provide better and more appropriate treatment, 
deserves greater attention by surgical teams. In our study, in the preoperative phase, 
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the patients in the TTR group asked for analgesic agents less frequently than those in 
the other groups. Most patients in this group did not receive any analgesic medication 
before surgery (150 cases), although a few did (six cases). Also in the postoperative 
phase, the mean VAS scores in the TTR group were lower than those in the other groups, 
except for the SBICPM group. Directly after surgery, 99 of the 145 patients undergoing 
TTR required no analgesic agents. On Days 1, 3, and 5 after surgery, only 38 of 145, 21 
of 141, and 20 of 140 patients, respectively, needed analgesic medication. When these 
patients needed analgesic relief, more than 60% of them used WHO Class II medica-
tion, a finding in agreement with data published in the current literature. There were 
no significant differences in VAS scores in the patients receiving different WHO class 
medications. Based on these data, we conclude that for patients undergoing trephina-
tion, on-demand analgesic treatment seems justified.
Compared with the TTR group, patients undergoing neurosurgical spinal procedures 
experience a different perioperative course in terms of pain character and pain intensity. 
Patients in the CS and LF groups suffered more pain before surgery than those in the TTR 
and VPS placement groups. Interestingly, however, all patients in the different groups 
expected to have the same amount of postoperative pain, despite their varying preopera-
tive pain scores. Moreover, the maximal anticipated VAS score was lower than the actual 
maximal VAS score in the following groups: TSO, SBICPM, THR, ACS, CS, LF, laminectomy, 
MSP, and MCP. This leads us to conclude that the anticipated maximal VAS score is inde-
pendent of the neurosurgical procedure or the extent of preoperative pain and that post-
operative pain in patients who have undergone a neurosurgical procedure is greater than 
anticipated. However, anticipated pain might be influenced by preoperative teaching. In 
our study, we did not take this into account. When visited by the examiner preoperatively, 
only approximately one half of the patients were informed by the surgeon. Additional 
studies may be undertaken to evaluate the impact of adequate preoperative teaching 
about pain management options on postoperative pain and patient satisfaction.
Referred pain can be described as a radicular pain with a possible projecting and/or neu-
ropathic component. Because this pain is difficult to treat with opioid agents, the use of 
anticonvulsant and antidepressive drugs should be seriously considered. The mean VAS 
score in patients with referred pain was significantly higher than that in patients with 
local pain in the LF group on the 3rd and 5th postoperative days, whereas in patients 
undergoing TTR and VPS placement normal headache was more painful than local pain, 
as measured on the 5th relative to the 3rd postoperative day. These findings underscore 
that the pain character can direct the physician to the patients who are expected to 
suffer the most intense postoperative pain. In addition, in the CS and LF groups there 
was a shift from preoperative referred pain to local pain postoperatively. This finding 
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suggests that after spinal surgery nerve decompression decreases the extent of referred 
pain and the pain originates in the operative wound, resulting in local pain; however, 
some patients still suffered from referred pain after surgery. These patients experienced 
greater pain than those with other pain characteristics, which suggests that patients 
with referred pain after CS and LF require more intensive pain management than do 
those with local pain.
During the entire observation period in the CS and LF groups, there was significantly 
more referred pain than in the other groups. The following factors have been found to 
be predictive of surgical outcome after lumbar disc surgery: prolonged current pain at-
tack, report of long-term illness, anxiety, severe pain reported immediately after surgery, 
employment status, and the presence of complete herniation at surgery.[25] The authors 
of another study also found a predictive value for the outcome after anterior cervical 
decompression; [21] the main value by which to predict postoperative pain intensity 
was the magnitude of the preoperative kyphosis. In our study, age, ASA class, and sex 
were not predictive of pain character, pain intensity, or the need for reoperation in any 
treatment group. Overall, however, the mean VAS score for patients with a postsurgical 
complication was significantly higher than that for patients without complications. This 
finding may suggest that clinicians should be mindful of patients with extremely high 
VAS scores because postoperative complications may occur. We realize, however, that 
patients who experience surgery-related complications may have anxiety or other fac-
tors that could influence the VAS score. We are also aware of the fact that in patients who 
must undergo a second procedure, some tolerance or tachyphylaxia to the analgesic 
medication used may have developed. This might bias the results. Ours, however, was 
an observational study reflecting daily clinical routine; thus, the number of patients 
undergoing a second procedure during the study period was small. The impact of a 
reoperation on pain medication requirements may well be the subject of another study.
Analysis of our results shows that patients with preoperative pain suffer significantly 
more postoperative pain than patients without preoperative pain. In another study 
investigators also found that patients with preoperative pain suffer more pain postop-
eratively;[14] however, they investigated all surgical procedures except heart and intra-
cranial neurosurgical procedures. Using a scoring system to assess quality of recovery 
after cranial and spinal surgery, one group has reported that postoperative pain and 
neurological deficits correlated with poor postoperative recovery.[17] Evaluation of our 
data also suggests that neurosurgical patients who suffer preoperative pain require more 
intensive pain management after surgery than patients without preoperative pain. Age, 
sex, expected incision size, and surgical procedure have also been shown to affect the 
postoperative pain intensity.[14] We found no significant difference between males and 
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females in terms of pain intensity, but we did find a correlation with age. Whereas there 
was a trend toward higher preoperative VAS scores in older patients, there was likewise 
a trend toward higher postoperative VAS scores in younger patients. Therefore, in young 
patients the increase in pain during the entire observation period was greater than that 
in old patients. Moreover, patients with ASA Class III morbidity had significantly more 
pain than those with ASA Class I morbidity on the 5th postoperative day; however, this 
was an isolated finding, and it may be too early to draw any conclusions from it.
The mean VAS score for patients who asked for medication was significantly higher 
than the VAS score for those who did not ask for medication. On Days 1 and 3, patients 
in the ACS group asked for pain medication significantly more often than those in the 
other groups; however, we assumed that this group was adequately treated with the 
given pain medication because, during the observation period, significantly increased 
VAS scores were not documented in these patients. It has been reported that patients 
are not afraid to ask for analgesic drugs[6] and that nurses underestimate postoperative 
pain intensity of patients.[11] Moreover, there are indications that individual pain assess-
ment is poorly documented and that a nurse’s record of a patient’s postoperative pain 
experience differed from the patient’s self-assessment.[5] Analysis of our data showed 
that in patients who asked for pain medication VAS scores were significantly higher and 
the patients needed to be treated accordingly. The mean VAS score in patients who felt 
they had not been adequately treated was significantly higher than that in patients who 
felt they had received adequate treatment. This finding suggests that the VAS score is 
not only useful for estimating pain intensity but can also be used to review current pain 
management protocols.
In patients who underwent CS and LF and who received WHO Class I medication, the 
mean VAS score was significantly lower during the postoperative period than that in 
patients receiving WHO Class II medication, whereas the mean VAS score in patients 
receiving WHO Class III medication was lower again. This leads us to conclude that in 
a subgroup of patients undergoing CS or LF and who do not benefit from WHO Class I 
medication alone, WHO Class II medication is also insufficient, and the patient should be 
treated with WHO Class III medication directly.
One limitation of the present study may have been that we did not separate the different 
opioid agents used intraoperatively; however, the anesthesiologists were not involved 
in the study, and the use of opioid agents was left to their discretion. Thus, the results 
of this observational study reflect a clinical routine. Older patients reported greater pain 
before surgery than younger patients whereas younger patients reported more pain 
after surgery than older patients. The postoperative recovery takes longer in patients 
with serious comorbidity compared with a faster recovery in otherwise healthy patients. 
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The anticipated pain intensity is independent of the operation type or the preoperative 
pain intensity perceived.
ConClUsions
Based on our findings, we can conclude that neurosurgical procedures are more pain-
ful than anticipated by the patient. The idea that pain associated with neurosurgical 
procedures is insufficiently managed was recently addressed in an editorial titled, 
“Postcraniotomy pain remains a real headache!”[28] However, considering the high 
number of patients without postoperative pain, patients undergoing craniotomy can be 
treated with on-demand analgesic medication, but only if the nurses on the ward react 
promptly. Therefore, patient-controlled analgesia may be an effective and safe option.
[23] Recently, a detailed review on acute and chronic postcraniotomy pain was pub-
lished; the authors addressed the different modes of pain treatment after craniotomy 
and the causative factors for the development of chronic postcraniotomy pain.[9]
Patients undergoing all other types of neurosurgical procedures should receive 
scheduled treatment of analgesic drugs at least on the 1st postoperative day. Patients 
undergoing spinal surgery need intensive pain treatment in the preoperative phase; in 
these patients, a shift in pain character from referred pain preoperatively to local pain 
postoperatively is expected. A referred pain character after LF can direct the physician 
to those patients expected to suffer the most intense pain. In patients with preopera-
tive pain, postoperative pain is more intense than in those without pain before surgery, 
and clinicians must undertake more intensive pain management in the patients after 
surgery. Patients who ask for analgesics or those who claim to be undertreated need 
to be taken seriously and treated accordingly. Receiving more pain treatment does not 
always lead to lower pain scores. Increased analgesic intake might still not be enough 
for some patients. It should be anticipated in patients with increased postoperative 
VAS scores that surgery-related complications will occur. In patients undergoing spinal 
surgery, there is a subset that does not benefit from WHO Class I medication alone, and 
WHO Class III medication should be provided directly.
In summary, we have shown the importance of pain and its sufficient treatment after 
neurosurgical procedures in an observational study setting. At present, pain is consid-
ered to be the “fifth vital sign.”[16] Patients and regulatory agencies (for example, the 
Joint Commission on Accreditation of Healthcare Organizations) are paying much more 
attention to the appropriate and timely treatment of pain. It is our hope that the findings 
of this study will be used by neurosurgeons and neuroanesthesiologists as a reference for 
future studies in an effort to optimize pain management after neurosurgical procedures. 
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In the last 22 years the author has provided anesthesiological care for much more than 
300 patients undergoing an awake craniotomy for brain tumor resection. Over the years, 
the anesthesiological regimen has not changed much. Based on clinical observations, 
small modifications were performed to increase patients’ comfort and safety. These 
measures and the scientific evaluation of their effects has been described in the pre-
vious chapters. This chapter provides a summarizing view on the procedure and the 
presented findings, together with a perspective on the ongoing discussions and future 
developments:
This thesis:
Chapter 1 and 2 describe the anesthesiological practice of the awake craniotomy at 
Erasmus University Medical Center Rotterdam. Relevant aspects of patient selection, 
patient preparation and monitoring are discussed in chapter 1, whilst chapter 2 focusses 
on the use of local anesthetics in these patients. In summary, we have developed a 
quite “minimalistic” regimen (no complex airway management, anesthesia relying on 
local anesthesia by surgical field infiltration combined with propofol-sedation during 
craniotomy and closure), which has turned out to be safe and feasible. This regimen pays 
a lot of attention to the psychological preparation of the patient and ‘vocal anesthesia’.
Despite practice for years and a lot of successful and positive examples are described 
in scientific and non-scientific media, the idea of being awake whilst the neurosurgeon 
is operating inside their brain still is supposed to be stressful and frightening for many 
patients. Chapters 3 and 4 provide clear evidence, that the metabolic stress-response 
of patients undergoing an awake craniotomy is definitively not higher and maybe 
even lower than in patients undergoing a tumor resection under general anesthesia. 
Chapter 5 summarizes the current ideas to improve patient’s comfort during an awake 
craniotomy and brain tumor resection. Much attention should be paid to basic comfort 
measures (e.g. lying on the table, temperature management, treating a dry mouth) and 
psychological guidance (vocal anesthesia) of the patient.
In chapter 6 and 7 we addressed the question: how awake is awake? Surprisingly, we 
found that patients have a) very limited and b) mostly positive memories of their awake 
craniotomy, despite the fact that they were completely awake and cooperative for long 
parts of the procedure. These findings show, that planned intraoperative awareness is 
experienced by patients completely different to unexpected, unplanned (and maybe 
even painful), accidental intraoperative awareness. On the other side, we could show 
that those patients who report more memories have also more positive memories. Being 
awake and cooperative does not automatically include the creation of memories – we 
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observed a lot of amnesia. On the other side, the association of a higher quantity with 
the better quality of the memories suggests, that the psychological coping with such a 
major life event is not automatically improved by amnesia. 
In chapters 8, 9 and 10 the added value of an awake craniotomy in selected, less common 
patient groups is discussed. Chapter 8 is a case-report about a brain tumor resection in 
a 9-year old boy. Next to the psychological guidance of the child and its parents through 
the perioperative period, another important aspect is the possible limitation of the 
amount of local anesthetics, which can be used due to the weight-dependency of the 
toxic upper dose limit. In chapter 9 we studied patients operated for an insular glioma, 
a rare, but challenging tumor location, which requires a special surgical approach, a 
fissurotomy, which makes it lasting longer than a standard cortical tumor resection. In 
these patients, awake craniotomy is much more exhausting for the patient than in case 
of cortical tumors. In this population, the added value of an awake craniotomy seems 
limited: when the tumor resection is performed under general anesthesia, a comparable 
extent of resection with a comparable risk of neurological damage can be achieved. This 
is in contrast with the findings of chapter 10: here we examined patients scheduled for 
resection of a glioblastoma multiforme. This most devastating tumor has a very poor 
prognosis - with and without surgery. However, there is a clear link between the extent 
of resection and the duration of survival. Our retrospective data support the use of the 
awake technique for a more radical resection and less neurological long-term deficits. 
However, these data have to be confirmed by a prospective study before a new standard 
can be established.
Postoperative pain control after craniotomy is the topic of chapter 11. Here we studied 
the pain experience and the analgesic needs of neurosurgical patients. Our data show, 
that the level of pain experienced after a craniotomy is in average low, but shows a 
broad variation. From low pain with no need of an opioid to severe pain with repeated 
need of opioids all can be observed.
In summary, the safety and feasibility of the technique of awake craniotomy for brain 
tumor resection has been clearly demonstrated, even under challenging circumstances 
like in children or for insula gliomas. 
Ongoing scientific discussions:
When looking at the ongoing discussions in scientific literature referring to the technique 
of awake craniotomy, 2 major aspects get a lot of attention: the airway-management 
and the sedation regimen.
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Whilst our airway management may be called “minimalistic”, there is a lot of literature 
recommending much more invasive measures and devices: Sivasankar et al. promote 
the use of a nasopharyngeal airway[1], Matsunami et al. recommend the use of the i-gel 
laryngeal mask airway [2], whilst others perform the craniotomy with a laryngeal mask 
airway and intubate the patients endotracheally for closure after the resection [3] – just 
to give some ideas of the current practice. There is mutual link between the airway 
management and the sedation regimen: the more invasive the airway management, the 
more sedation is needed to make the patient tolerating it and vice versa: the more seda-
tion is given, the more respiratory depression might occur and the more invasive airway 
measure might become necessary. It should be stressed, that the use of sedation during 
an awake craniotomy is a comfort measure, and that the use of one sedative drug, e.g. 
propofol, should be sufficient, as long as the local anesthesia is performed well. 
Therefore, we have decided to use a “minimalistic” sedation regimen, too, as we work with 
propofol only. During the last years, dexmedetomidine has become the most frequently 
used alternative as sedative agent [4], but other authors routinely use combinations of 
propofol and remifentanil in doses requiring invasive airway management [5].
Future perspectives:
Right now, the value of the awake craniotomy for a maximum of brain tumor resec-
tion with a minimal risk of functional damage has been established worldwide. Future 
developments are, the combination of this technique with other techniques to further 
increase the extent of (safe) tumor resection. One option is the use of an intraoperative 
MRI-scan in patients undergoing an awake craniotomy [6]. Another is the use of 5-ami-
nolevulinic acid (Gliolan®) in combination with an awake craniotomy [7]. However, most 
of these reports show only limited added value of the extra techniques, so that there 
still remains an open field for future developments. It should be noted, that all extra 
techniques applied intraoperatively are more or less time-consuming, and the possible 
duration of surgery is limited by a) the effect of the local anesthesia and b) the ability of 
the patient to cooperate. 
Another aspect getting more and more attention is the possibility to perform a brain 
tumor resection as an outpatient / day-care-procedure [8]. Because the neurosurgical 
procedure of brain tumor resection is more or less the same in awake and anesthetized 
patients, it has been shown, that it can be done not only for patients after an awake 
craniotomy, but also after a general anesthesia. However, careful patient selection is a 
keystone when doing so, and “outpatient” in the most studies publishing on this topic 
means “in a hotel close to the hospital”, because postoperative bleeding still remains the 
most threatening early complication after these procedures. 
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Now, after the safety and feasibility of the awake craniotomy have been demonstrated, 
an extension of the indications is coming up: The first series of successfully awake 
clipped cerebral aneurysms are published [9]. 13 years after our case report of successful 
awake craniotomy in a 9-years old child, in 2017 the case of an 8-years old child who 
has undergone successful awake resection of a frontal brain tumor was published [10]. 
Several case reports describe the successful use of an awake craniotomy-technique for 
tumor- and non-tumor-neurosurgery in patients with congenital heart disease and/or 
pulmonary hypertension, which make a general anesthesia with mechanical ventilation 
very risky [e.g. 11]. Recently, the ongoing extension of indications cumulated in the 
question, whether a tumor resection under general anesthesia for some patients (low 
grade glioma with no or little functional deficits) still is ethically acceptable and whether 
not only language, but also sensorimotor, visuospatial, higher cognitive and emotional 
functions must be monitored intr aoperatively in the awake patient [12]?
Finally, there is also a rising interest in psychosocial and ethical aspects of the awake 
craniotomy, which can be felt in discussions on conferences, but is not yet fully mirrored 
in scientific literature: the first cases of post-traumatic stress disorder after an awake 
craniotomy have been diagnosed and described [13], which we did not observe in our 
patients up to now. 
Two other very important questions remain still unanswered: what does it do with the 
patient and the medical team, when despite mapping and neuromonitoring an intraop-
erative functional decline (not only a temporary epileptic insult) occurs? In practice, we 
see emotional reactions of all people involved, and mostly the decision is taken to stop 
further resection attempts. However, this phenomenon is not yet covered in a scientific 
manner. 
The other question is even more difficult to answer: is there any non-functional brain? 
Until now, the surgeon removes the (suspect) tissue, if during cortical and subcortical 
stimulation no functional changes occur, always aiming for a maximum resection. How-
ever, during these stimulations one can only monitor the functions you are searching 
for, possibly missing others, which are less overt. More input from basic-neuroscientists 
is strongly needed to get a clearer picture of the complexity of the brain and its possibly 
hidden functions.
In summary, after the publication of this thesis, there remain a lot of unanswered ques-
tions and challenges for the patient undergoing and the team performing an awake 
craniotomy for brain tumor resection. There is no doubt, that all efforts must be taken, 
to make the procedure for the patient as safe, as effective, and as pleasant as possible. 
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This is most probably warranted by an experienced and dedicated team, with intensive 
counselling of the patient [14] – which is routine at Erasmus MC.
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This thesis aims to provide a solid framework of the anesthesiological aspects linked 
to an awake craniotomy procedure for brain tumor resection. To begin with, it should 
be clarified, that the term ‘anesthesiological’ in case of the awake craniotomy covers 
the whole non-operative/non-surgical context, including metabolic and psychological 
aspects, too - and not only sedation and analgesia.
The introduction shows the historical developments in the fields of anesthesiology 
(e.g. local anesthetics, injection needles, fast-in-fast-out sedatives) and neurosurgery 
(e.g. microsurgery, functional anatomy of the brain) that were mandatory to make this 
procedure safe and feasible. Based on this background, 5 key-questions are addressed 
in the findings presented here:
Question 1: What are the pre-requisites for a successful awake craniotomy?
Chapter 1 addresses the unique role of the anesthetist in a setting, where no general 
anesthesia is applied, whilst open brain surgery is performed: a careful patient selection, 
an intensive preparation of the patient, a minimalistic anesthesia regimen (no invasive 
airway management, light sedation with propofol) and a goal directed (psychological) 
guidance of the patient throughout the procedure (“vocal anesthesia”) are described as 
the cornerstones. Chapter 2 focusses on the use and the added value of local anesthetics 
for brain tumor resections. Next to the surgical field block, the technique of direct nerve/
scalp block is described and discussed in detail; whilst the first must be considered the 
easy and reliable routine technique, the second remains a useful tool in extraordinary 
situations (e.g. small patients, re-craniotomies).
Question 2: is an awake craniotomy for the patient more or less stressful than a 
brain tumor resection under general anesthesia?
Chapter 3 and 4 are biochemical approaches to address the metabolic response of the 
patient on the theoretical stress of an awake brain tumor resection. Because all patients 
received dexamethasone, measuring cortisol was not an option. Therefore, levels of 
plasma amino acids and inflammatory mediators were measured as alternative “objec-
tive” stress-markers. Our studies showed, that - in contrast with what many people might 
expect - undergoing an awake craniotomy in our routine setting is not more, but maybe 
even less stressfull than a brain tumor resection under general anesthesia. The fact that 
awake-craniotomy patients have a shorter length of stay in the hospital supports these 
findings.
After the safety and feasibility of the awake craniotomy has been established, the next 
level is the maximization of patients’ comfort. This topic is addressed in chapter 5, where 
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several technical solutions (e.g. transparent drapes, music) and other measures (e.g. not 
keeping the patients fasted) are reviewed.
Question 3: the patients undergoing an awake craniotomy must be cooperative 
during the procedure, but: what do they remember of the perioperative period 
and how do they deal with it?
Chapter 6 shows, that patients undergoing an awake craniotomy, have only partial (and 
mostly positive) memories of their procedure. This is surprising, because they are awake 
for more than an hour intraoperatively and cooperate closely whith the whole team. 
Furthermore, we could demonstrate, that planned and pain-free intraoperative aware-
ness does not have to cause a problem for the coping of the patient. These findings were 
confirmed by the research presented in chapter 7. Here we found, that patients under-
going an awake craniotomy have more, and more positive memories of the periopera-
tive period than patients operated for an intracranial tumor under general anesthesia. 
Furthermore, we could identify that being operated - awake or not - has more impact on 
the quality and quantity of memories than the question whether a benign or malignant 
tumor has been resected. We also addressed anxiety in patients and their relatives and 
found that the patients experienced their relatives as more anxious than themselves. 
This finding deserves attention in future research. 
Question 4: What is the added value of an awake craniotomy in selected patient 
populations? 
Within the large patient population treated, some selected sub-groups asked for special 
attention. Chapter 8 gives a detailed description of an awake craniotomy in a 9-year-
old boy who underwent an awake craniotomy for glioblastoma resection. Next to the 
biological age and weight of the patient (e.g. dose of local anesthetics), especially the 
psychological guidance of the child and the parents throughout the perioperative pe-
riod are challenging. However, the encouraging result of this case is, that it can be done 
safely and successfully.
Chapter 9 describes the choices for and against awake craniotomies and the related 
outcomes in patients suffering from a brain tumor in the insula. Surgery in this part of 
the brain is challenging even under general anesthesia, and not frequently performed 
nor published. However, we could show, that with a careful patient selection, it is 
not mandatory to perform all these insula-tumor resections as an awake craniotomy. 
Complications and long-term-prognosis after general anesthesia are similar. This must 
be taken into account when counselling future patients. In chapter 10 the question, 
whether patients suffering from a (suspected) glioblastoma multiforme have advantage 
by an awake craniotomy is addressed by a retrospective, controlled-matched study. It 
turned out, that resection of glioblastoma as an awake craniotomy is associated with 
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significantly greater extent of resection and less late minor postoperative complications 
as compared with craniotomy under general anesthesia. We hope that in the future a 
prospective randomized trial can be performed clarifying this issue definitively.
Question 5: What is the adequate postoperative pain-treatment after an (awake) 
craniotomy?
Chapter 11 shows that patients after a trepanation for brain tumor resection have a 
relatively low pain score and do not require opioids postoperatively routinely. However, 
there are patients, who experience severe post-craniotomy pain, and therefore the ac-
cess to fast and strong working opioids must be warranted.
In the final general discussion, the findings of the presented papers are reviewed and 







Dit proefschrift heeft als doel een onderbouwd overzicht te bieden van de anesthesiolo-
gische aspecten die bij een wakkere hersentumor resectie aan bod komen. Om te begin-
nen: het moet helder zijn dat “anesthesiologisch” in deze samenhang niet alleen sedatie 
en pijnbestrijding, maar alle niet-chirurgische aspecten omvat, en dus ook metabole en 
psychologische effecten worden bekeken.
De inleiding vat de historische ontwikkelingen samen op de gebieden van de anesthe-
sie (zoals locale anesthetica, injectienaalden, snelwerkende sedativa) en van de neuro-
chirurgie (zoals microchirurgie, functionele anatomie van de hersenen). Deze waren 
noodzakelijk om de wakkere craniotomie veilig en überhaupt uitvoerbaar te maken. 
Tegen deze achtergrond worden in dit proefschrift vijf sleutelvragen besproken:
vraag 1: Wat zijn de randvoorwaarden van een succesvolle wakkere craniotomie?
hoofdstuk 1 behandelt de unieke rol van de anesthesioloog bij een operatie waar geen 
algehele anesthesie wordt toegediend, terwijl open hersenchirurgie wordt uitgevoerd: 
een zorgvuldige selectie van de patiënten, intensieve voorbereiding van de patiënt, een 
minimalistisch anesthesie-beleid (geen invasief luchtwegmanagement, lichte sedatie 
met propofol) en een doelgerichte (psychologische) sturing van de patiënt door de 
hele procedure heen (“vocale anesthesie”) zijn de beschreven hoekstenen. hoofdstuk 
2 focust op het gebruik en de toegevoegde waarde van locale anesthetica bij hersentu-
morresecties. Naast het chirurgische veldblok wordt de techniek van het directe zenuw/
scalp-blok beschreven en bediscussiëerd. Terwijl het veldblok een simpele en betrouw-
bare routinetechniek is, is het directe zenuwblok een reservemiddel voor buitengewone 
omstandigheden (bijvoorbeeld kleine/lichte patiënten, re-operaties).
vraag 2: is een wakkere craniotomie voor de patiënt meer of minder stressvol dan 
een hersentumorresectie onder algehele anesthesie?
hoofdstuk 3 en 4 beschrijven biochemische pogingen om het metabole antwoord 
van de patiënt op de theoretische stress van een wakkere hersenoperatie in kaart te 
brengen. Gezien alle patiënten met dexamethason worden behandeld, is het “gewoon” 
meten van cortisol hiervoor geen optie. Daarom werden de plasmaspiegels van amino-
zuren en ontstekingsmediatoren gemeten als alternatieve “objectieve” stressmarkers. 
Onze resultaten laten zien dat - anders dan men zou verwachten - onze klinische stan-
daardwerkwijze voor een wakkere hersenoperatie voor de patiënt zeker niet meer, en 
mogelijk zelfs minder stressvol is dan een operatie onder algehele anesthesie. Het feit, 
dat patiënten na een wakkere hersenoperatie een kortere ziekenhuisopname hebben 
dan na een algehele anesthesie ligt in lijn met deze bevindingen.
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Nadat de veiligheid en haalbaarheid van de wakkere craniotomie duidelijk gemaakt 
waren, stond de verhoging van het comfort van de patiënt in het centrum van de aan-
dacht. hoofdstuk 5 is hierop gericht en beschrijft verschillende technische oplossingen 
(zoals transparante afdekdoeken, muziek op de operatiekamer) en andere maatregelen 
(bijvoorbeeld de patiënten voor een wakkere hersenoperatie niet volledig nuchter 
houden).
vraag 3: Patiënten die een wakkere craniotomie ondergaan moeten tijdens de 
operatie coöperatief zijn, maar: wat herinneren zich de patiënten uiteindelijk nog 
van de ingreep en hoe gaan zij hiermee om?
hoofdstuk 6 laat zien, dat patiënten na een wakkere hersenoperatie alleen gedeelte-
lijke (en meestal positieve) herinneringen van hun operatie overhouden. Dit is enigszins 
verrassend gezien de patiënten meer dan een uur tijdens de operatie wakker zijn en 
nauw en actief samenwerken met het hele behandelteam. Verder konden wij aantonen, 
dat het gepland, pijnvrij intra-operatief wakker zijn op zich geen probleem hoeft te 
betekenen voor de verwerking door de patiënt. Deze bevindingen werden bevestigd 
door het onderzoek beschreven in hoofdstuk 7. Hier vonden wij dat patiënten die een 
wakkere hersenoperatie ondergaan meer - en positievere herinneringen aan hun pro-
cedure hebben dan patiënten die onder algehele anesthesie zijn geopereerd. Hiernaast 
konden wij aantonen dat de vraag of men al dan niet wakker geopereerd werd, meer 
invloed heeft op de kwaliteit en de kwantiteit van de herinneringen bij de patiënt dan 
de vraag, of er een goed- of kwaadaardige tumor werd verwijderd. We konden ook laten 
zien dat de meeste patiënten hun naasten rondom de operatie als angstiger dan zichzelf 
ervaren. Dit vraagt zeker om aandacht bij toekomstig onderzoek.
vraag 4: Wat is de toegevoegde waarde van de wakkere hersenoperatie bij gese-
lecteerde patiëntengroepen?
Binnen de grote patiëntenpopulatie die behandeld werd, verdienen enkele geselecteer-
de subgroepen bijzondere aandacht. hoofdstuk 8 geeft een gedetaileerde beschrijving 
van een wakkere craniotomie bij een 9-jarige jongen met een glioblastoom. Naast de 
biologische leeftijd en het gewicht (in samenhang met de dosis van locale anesthetica) 
ligt hier een bijzondere uitdaging in de psychologische begeleiding en sturing van 
patiënt en ouders door de hele perioperatieve periode. Niettemin is het motiverende 
resultaat van deze casus, dat ook bij dermate jonge kinderen de procedure veilig en 
succesvol uitgevoerd kan worden.
hoofdstuk 9 beschrijft de afwegingen voor of tegen een wakkere craniotomie en 
de hieraan gerelateerde uitkomsten bij patiënten met een hersentumor in de insula-
regio. Chirurgie in deze onderdelen van de hersenen is bijzonder uitdagend, ook onder 
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algehele anesthesie. Hierdoor wordt dit soort operatie niet vaak uitgevoerd en ook niet 
gepubliceerd.
In onze grote patiëntengroep konden wij aantonen, dat met zorgvuldige selectie van 
de patiënten het zeker niet altijd nodig is, om een tumor in de insula-regio wakker te 
opereren. De complicaties en langetermijnsuitkomsten na een operatie onder algehele 
anesthesie zijn vergelijkbaar. Dit behoort bij de indicatiestelling meegenomen te wor-
den. 
In hoofdstuk 10 wordt de vraag of patiënten met een (verdenking op) glioblastoom 
voordeel hebben van een wakkere hersenoperatie geadresseerd door middel van een 
retrospectieve, controlled-matched studie. Het resultaat is, dat de tumorverwijdering 
in vorm van een wakkere craniotomie een significant ruimere resectie mogelijk maakt 
en tot significant minder late postoperatieve complicaties leidt. Wij hopen daarom ook, 
dat deze vraag voor de toekomst door middel van een prospectief gerandomiseerd 
onderzoek definitief beantwoord kan worden. 
vraag 5: hoe ziet de adequate postoperatieve pijnstilling na een (wakkere) cranio-
tomie eruit? 
hoofdstuk 11 laat zien, dat patiënten na een hersentumorresectie in het algemeen 
relatief lage pijnscores aangeven en niet routinematig postoperatief een behandeling 
met opioiden nodig hebben. Maar, er zijn ook enkele patiënten, die ernstige post-
craniotomie-pijn ervaren, en daarom vinden wij dat sterke en snelwerkende opioiden 
voor deze patiëntengroep onmiddellijk beschikbaar moeten zijn, indien nodig. 
In de afrondende general discussion worden de resultaten van de gepresenteerde 








Promoveren doe je niet alleen, zeker niet als je daar een tijdje over doet; en vandaar is 
het een behoefte en genoegen, dat ik hier alle vrienden en collega’s (specialisten, 
arts-assistenten en physician assistants van de afdelingen Anesthesiologie en 
neurochirugie, anesthesiemedewerkers, neuropsychologen en klinisch linguis-
ten, operatieassistenten van “ok 1 en 3”, de verpleegkundigen van de PACU (in 
het bijzondere van “bedje 4” ), afdeling 7 Zuid en het acute pijnteam, studenten, 
onderzoekers, de medewerkers van de preoperatieve polikliniek Anesthesiologie, 
het planbureau neurochirurgie en ”mijn” secretariaat) kan bedanken voor de jaren-
lange prettige samenwerking in de zorg (niet alleen) voor de wakkere patiënten en hun 
bijdrage, die dit mooi resultaat mede mogelijk heeft gemaakt. 
Promoveren over een klinisch onderwerp lukt ook niet zonder de medewerking en het 
vertrouwen van de patiënten, die bereid waren om bloed te geven, vragenlijsten in te 
vullen en hun ervaringen met ons te delen – hiervoor dank en respect! 
Bijzondere dank gaat aan Prof. dr. Robert Jan stolker: Robert Jan, mijn promotor. Jouw 
vertrouwen, jouw belangstelling en geduld, jouw adviezen en jouw “zachte dwang” - en 
alles op de juiste tijdstip en met de juiste dosis - hebben uiteindelijk ervoor gezorgd, dat 
dit project rond is gekomen. Ik had mij geen betere promotor kunnen wensen en ben 
blij, dat onze samenwerking hier zeker niet mee zal stoppen!
De leescommissie: Prof. dr. Clemens Dirven, Prof. dr. Peter sillevis smit en Prof. dr. 
tony Absalom – het voelt als een bijzondere eer, dat jullie de moeite hebben genomen 
om het manuscript door te nemen en te opponeren bij mijn verdediging. Onze gemeen-
schappelijke motivatie om mensen met een hersentumor en andere neurologische/
neurochirurgische aandoeningen een langer leven in goede kwaliteit te bieden, heeft 
de afgelopen jaren al tot veel wederzijdse inspiratie geleid, en ik vertrouw erop dat dit 
ook na vandaag nog door zal blijven gaan.
De leden van de grote commissie: Univ.-Prof. (em.) Dr. med. Walter buzello – lieber 
Walter, ich freue mich besonders, diesen Tag auf diese Weise auch mit Dir zu erleben. Die 
Ausbildung und Begleitung, aber auch die Freiheit und das Vertrauen, das ich in Köln 
unter Deiner Regie erfahren durfte, sind für mich immer noch vorbildlich. Prof. em. Dr. 
hans knape - beste Hans, van harte bedankt dat jij - naast Tony als de huidige voorzitter 
van het Nederlands Neuroanesthesiologisch Gezelschap - ook als oud-voorzitter hier aan 
tafel wilt zitten – een van de vele banden die wij hebben. Prof. dr. Jan van busschbach 
en Prof. dr. frank huygen - bedankt voor de bereidheid tot deelname aan de oppositie. 
Zoals in de samenvatting beschreven gaat het bij de “anesthesiologische aspecten” in 
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dit proefschrift om meer dan alleen de intra-operatieve momenten, en ik ben blij dat 
dankzij jullie expertise ook de aspecten psychologie/psychiatrie en postoperatieve pijn 
de nodige aandacht krijgen.
Veel dank ook aan alle co-auteurs voor hun bijdrage tot de hier verzamelde stukken, 
waaronder ook mijn hooggewaardeerde neurochirugische collega’s dr. Arnaud vincent 
en drs. Joost schouten. Het was en is altijd een plezier om met jullie samen “een wak-
kere te doen”, en ik weet zeker dat wij ook nadat dit boekje nu af is niet met de klinische 
en wetenschappelijke output zullen stoppen: de KWF-fonds voor de SAFE-trial staat al 
klaar!
Dr. med. Christoph Weigand – lieber Christoph, es war am 14. März 1996, als wir im 
“Ausweich-OP” der Kieferchirurgie in Köln gemeinsam unsere erste Wachkraniotomie 
anästhesiologisch begleiteten. 22 Jahre und mehr als 350 Patienten später mache ich 
zu 90% die Dinge noch so, wie wir sie uns damals ausgedacht haben! Du warst mein 
klinischer Lehrmeister - nicht nur in der Neuroanästhesie - und ich bin froh und dankbar, 
dass sich aus unserem “Ober-und-Assistenzarzt–Verhältnis” schon zu Kölner Zeiten eine 
echte Freundschaft entwickelt hat.
Univ.-Prof. Dr. med. Ulf börner – Lieber Ulf, Du bist leider viel zu früh gestorben. Als 
“Doktorvater” meiner Deutschen Promotion betrachte ich Dich noch immer als meinen 
wissenschaftlichen Lehrmeister. Ich weiss, dass Du auch sehr gerne dabei gewesen 
wärst, wenn ich meine Niederländische Promotion verteidige. Unsere Schilddrüsen-
Forschung brachte uns in Kontakt mit Prof. dr. ir. theo visser, die vandaag ook helaas 
niet meer aanwezig kan zijn. Beste Theo, in jouw lab heb ik 1999 mijn eerste contacten 
met Rotterdam gehad en echt genoten van de inspirerende besprekingen met jou en 
Prof. em. dr. Georg henneman. Mede dankzij deze tijd beschouw ik mezelf nog steeds 
als een “endocrinofiele anesthesioloog”.
Prof. dr. Jan klein – beste Jan, je hebt mij in 2001 naar Rotterdam gehaald en alle 
vrijheden gegeven om me op alle vier domeinen (patiëntenzorg, onderwijs/opleiding, 
onderzoek en management/organisatie) te ontplooien. Dankzij jouw vertrouwen en die 
van Prof. em. dr. Cees Avezaat kon ik - in het begin trouw ondersteund door steven 
Roubos en later samen met drs. Chris Jansen, Dr. Aloys oberthür, dr. ismail Eralp en 
alle andere anesthesiemedewerkers - de wakkere craniotomie vanuit de anesthesio-
logie voor Rotterdam neerzetten. 
Om de klinisch-wetenschappelijke uitdagingen van het schrijven van een proefschrift 
te kunnen meesteren, heb je ook een goed “persoonlijk milieu” nodig. Dit veld om je 
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heen zorgt ervoor, dat je mentaal en fysiek enigszins “normaal” blijft, terwijl je enigszins 
“buitengewone” dingen doet. Alle mensen die hier een bijdrage aan hebben geleverd, 
mogen in dit dankwoord beslist niet worden vergeten:
mr. drs. Rembrandt Zuijderhoudt – beste Rembrandt, we hadden een afspraak… en 
hier is het resultaat. Een cognitieve dissonantie is toch iets anders dan een emotionele 
dissonantie, en soms heb je iemand nodig, die je hiervoor de ogen opent. Dank voor 
onze inspirerende gesprekken! 
ton Dunk jr. en de co-trainers van de Rotterdamsche boksvereniging van ’t hof: 
jullie zijn verantwoordelijk voor het feit dat ik fitter uit mijn promotietraject eruit kom 
dan dat ik erin ben gegaan – dank voor alle motivatie en blessurevrije uitputting! Dit 
boek is nu af, maar ik zal zeker blijven komen trainen!
liebe freunde, lieve vrienden, dear friends – I tried not to bother you with this project 
and maybe it comes even as a surprise (at least for some of you) that I finally did it, but 
be sure: without you I never would have made it! Whenever I need(ed) some distraction, 
I knew and still know to find you! Thank you so much for all the moments we enjoy(ed) 
together, I am absolutely sure: there will be even more opportunities after today!
Mijn paranimfen, drs. Eldert boudesteijn en drs. mark buunen. Jullie zijn twee lieve, 
langjarige vrienden, met wie ik al meerdere hoogte- en dieptepunten van mijn en jullie 
leven mocht delen. Ik waardeer het bijzonder, dat jullie onmiddellijk bereid waren om 
van deze dag een gemeenschappelijk hoogtepunt te maken; dit voegt nog een extra 
dimensie toe aan onze al bijzondere vriendschappen!
ilona klimek und Guido löhrer - ganz herzlichen Dank für das aussagekräftige Titel-
Design. Ihr habt da – ganz wie in alten Zeiten – zusammen mit Andrea bartsch mal 
wieder etwas richtig Tolles gemeinsam gezaubert! Auch hilmer tasto als Modell darf 
hier nicht vergessen werden! 
Meine liebe familie en lieve schoon-familie – dankzij onze regelmatige zomervakan-
ties in Domburg kan ik in mijn Nederlandse proefschrift ook het dankwoord voor jullie 
gewoon in het Nederlands schrijven en jullie snappen het allemaal (en andersom in 
het Duits zouden jullie van de schoon-familie er ook geen problemen mee hebben): 
wat ben ik blij dat jullie er zijn en dat jullie ook onderling zo’n fijne verstandshouding 
hebben! Bedankt voor jullie oprechte belangstelling en betrokkenheid, het is heel fijn 
om te weten dat ik op jullie altijd terug kan vallen, en dat ik ook ben meegenomen in 
jullie gebeden.
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Lieve thomas – het is zo ongelooflijk fijn, dat wij elkaar gevonden hebben, dat wij elkaar 
steun en uitdaging, maar ook ontspanning en afleiding kunnen bieden, dat wij samen 
de wereld verkennen, maar ook thuis gewoon samen muziek maken, Tatort-kijken of 
lekker koken en eten. Zonder jou was dit boekje mogelijk wat eerder rond geweest, maar 
dankzij jou waren de afgelopen jaren dermate veel leuker, dat ik dit helemaal niet erg 
vind – in tegendeel! Want uiteindelijk is het toch klaar: the dream-team did it again! Op 
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